WO2013151896A1 - Durable stent graft with tapered struts and stable delivery methods and devices - Google Patents
Durable stent graft with tapered struts and stable delivery methods and devices Download PDFInfo
- Publication number
- WO2013151896A1 WO2013151896A1 PCT/US2013/034654 US2013034654W WO2013151896A1 WO 2013151896 A1 WO2013151896 A1 WO 2013151896A1 US 2013034654 W US2013034654 W US 2013034654W WO 2013151896 A1 WO2013151896 A1 WO 2013151896A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- proximal
- self
- strut
- struts
- Prior art date
Links
- 0 CC(CC*)=NC(C)=C Chemical compound CC(CC*)=NC(C)=C 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
- A61F2002/067—Y-shaped blood vessels modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/825—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having longitudinal struts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
- A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
- A61F2002/9665—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod with additional retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0058—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0008—Rounded shapes, e.g. with rounded corners elliptical or oval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0019—Angular shapes rectangular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0026—Angular shapes trapezoidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/0078—Quadric-shaped hyperboloidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0036—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49863—Assembling or joining with prestressing of part
Definitions
- Some embodiments relate in part to endovascular prostheses and methods of deploying same. Embodiments may be directed more specifically to stent grafts and methods of making and deploying same within the body of a patient.
- An aneurysm is a medical condition indicated generally by an expansion and weakening of the wall of an artery of a patient. Aneurysms can develop at various sites within a patient's body. Thoracic aortic aneurysms (TAAs) or abdominal aortic aneurysms (AAAs) are manifested by an expansion and weakening of the aorta which is a serious and life threatening condition for which intervention is generally indicated.
- TAAs Thoracic aortic aneurysms
- AAAs abdominal aortic aneurysms
- Existing methods of treating aneurysms include invasive surgical procedures with graft replacement of the affected vessel or body lumen or reinforcement of the vessel with a graft.
- Surgical procedures to treat aortic aneurysms can have relatively high morbidity and mortality rates due to the risk factors inherent to surgical repair of this disease as well as long hospital stays and painful recoveries. This is especially true for surgical repair of TAAs, which is generally regarded as involving higher risk and more difficulty when compared to surgical repair of AAAs.
- An example of a surgical procedure involving repair of a AAA is described in a book titled Surgical Treatment of Aortic Aneurysms by Denton A. Cooley, M.D., published in 1986 by W. B. Saunders Company.
- TAAs tissue grafts
- W.L. Gore & Associates, Inc. of Newark, DE.
- a commercially available stent graft for the treatment of TAAs is the TAGTM system manufactured by W.L. Gore & Associates, Inc.
- a flexible and low profile stent graft and delivery system for passage through the various guiding catheters as well as the patient's sometimes tortuous anatomy.
- Many of the existing endovascular devices and methods for treatment of aneurysms while representing significant advancement over previous devices and methods, use systems having relatively large transverse profiles, often up to 24 French. Also, such existing systems have greater than desired lateral stiffness, which can complicate the delivery process.
- the sizing of stent grafts may be important to achieve a favorable clinical result. In order to properly size a stent graft, the treating facility typically must maintain a large and expensive inventory of stent grafts in order to accommodate the varied sizes of patient vessels due to varied patient sizes and vessel morphologies.
- intervention may be delayed while awaiting custom size stent grafts to be manufactured and sent to the treating facility.
- minimally invasive endovascular treatment of aneurysms is not available for many patients that would benefit from such a procedure and can be more difficult to carry out for those patients for whom the procedure is indicated.
- What have been needed are stent graft systems and methods that are adaptable to a wide range of patient anatomies and that can be safely and reliably deployed using a flexible low profile system.
- Some embodiments are directed to a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state.
- the stent may also include a longitudinal axis, a proximal end, a distal end, and a plurality of resilient struts configured to exert an outward radial force in the constrained state.
- At least one of the resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state. At least some of the enlarged longitudinal sections may be in axial alignment with each other.
- the enlarged longitudinal sections of the struts may be enlarged in one transverse dimension of the struts.
- the enlarged longitudinal sections may be enlarged along a circumferential direction about the longitudinal axis of the stent and the struts may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent.
- the enlarged longitudinal section may have an enlarged transverse dimension that is about 1 .5 times to about 3 times the nominal transverse dimension of the strut in a direction of the enlargement for some embodiments.
- Certain embodiments are directed to an endovascular stent graft, having a main body portion including at least one tubular portion made from at least one layer of flexible material and a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state.
- the stent may also include a longitudinal axis, a proximal end, a distal end, a plurality of resilient struts configured to exert an outward radial force in the constrained state.
- At least one of the resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state.
- All resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize at least one strut relative to the position of adjacent struts while the stent is in a constrained state in some embodiments.
- at least some of the enlarged longitudinal sections may be in axial alignment with each other.
- the enlarged longitudinal sections of the struts may be enlarged in one transverse dimension of the struts.
- the enlarged longitudinal sections may be enlarged along a circumferential direction about the longitudinal axis of the stent and the struts may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent.
- the enlarged longitudinal section may have an enlarged transverse dimension that is about 1 .5 times to about 3 times the nominal transverse dimension of the strut in a direction of the enlargement in some embodiments.
- Some embodiments are directed to a method of loading a delivery catheter system with an endovascular stent graft.
- the endovascular stent graft may have a main body portion including at least one tubular portion made from at least one layer of flexible material, and a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state.
- the self-expanding cylindrical stent may include a longitudinal axis, a proximal end, a distal end, a plurality of resilient struts configured to exert an outward radial force in the constrained state.
- At least one of the resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to separate and stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state.
- the self-expanding cylindrical stent of the stent graft may be constrained about a bushing of the delivery system such that the enlarged longitudinal section of the at least one resilient strut stabilizes the position of the at least one strut relative to the position of adjacent struts in the constrained state.
- the stent may be releasably secured in the constrained stabilized state.
- an endovascular stent graft may include a main body portion having at least one tubular portion made from at least one layer of flexible material and a self-expanding anchor member.
- the self-expanding anchor member may include a constrained state, a relaxed expanded state, a proximal stent portion, and a distal stent portion.
- the endovascular stent graft may be configured such that a proximal end of the distal stent portion is secured to a distal end of the proximal stent portion and a distal end of the distal stent portion is secured to a proximal end of the main body portion.
- the endovascular stent graft may also be configured such that the axial length of the self-expanding anchor member as a whole divided by the axial length of the proximal stent portion is a ratio of about 1 .75 to about 2.0.
- a self-expanding anchor member include a constrained state, a relaxed expanded state, a proximal stent portion, and a distal stent portion.
- the anchor member may be configured such that a proximal end of the distal stent portion is secured to a distal end of the proximal stent portion and the axial length of the self-expanding anchor member as a whole divided by the axial length of the proximal stent portion is a ratio of about 1 .75 to about 2.0.
- an endovascular stent graft may include a main body portion including at least one tubular portion made from at least one layer of flexible material and a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state.
- the self-expanding cylindrical stent may include a longitudinal axis, a proximal end, a distal end, and a plurality of resilient struts configured to exert an outward radial force in the constrained state.
- At least one of the resilient struts may have a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and be configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state.
- all of the resilient struts of the stent may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and be configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state.
- at least some of the enlarged longitudinal sections may be in axial alignment with each other.
- the enlarged longitudinal sections of the struts may be enlarged in one transverse dimension of the struts or the enlarged longitudinal sections may be enlarged along a circumferential direction about the longitudinal axis of the stent and the struts may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent.
- the enlarged longitudinal section may have an enlarged transverse dimension that is about 1 .5 times to about 3 times the nominal transverse dimension of the strut in a direction of the enlargement.
- the enlarged longitudinal section includes an undulating configuration of the nominal strut or an oval enlargement of the nominal strut.
- each strut of the stent may include an enlarged longitudinal section with only one enlarged longitudinal section or an enlarged longitudinal section with a plurality of enlarged longitudinal sections.
- the struts having enlarged longitudinal sections may be disposed in a substantially longitudinal orientation between the proximal end and distal end of the stent when the stent is in the constrained state.
- the struts may be disposed in an undulating pattern.
- the self- expanding cylindrical stent of the stent graft may include a superelastic alloy such as NiTi alloy.
- FIG. 1 illustrates an elevation view of an embodiment of an endoluminal prosthesis in the form of a stent graft for treatment of a patient's vessel.
- FIG. 1A is an enlarged view of the encircled portion 1A of FIG. 1 including a proximal self-expanding stent member and proximal connector ring of the stent graft embodiment of FIG. 1 .
- FIG. 2 illustrates the stent graft embodiment of FIG. 1 in a constrained configuration disposed on a distal section of a delivery catheter within a lumen of a patient's vessel.
- FIG. 3 shows an enlarged view of the encircled portion 3 of the stent graft of FIG. 2 including the proximal self-expanding stent member in a constrained configuration but without the constraining releasable belts for clarity of illustration.
- FIG. 3A is a transverse cross sectional view of the proximal self-expanding stent member and delivery catheter system of FIG. 3 taken along lines 3A-3A of FIG. 3.
- FIG. 4 illustrates the stent graft of FIG. 2 in a deployed unconstrained state.
- FIG. 5 is a schematic view of an embodiment of a section of a stent that illustrates features of struts of the stent.
- FIGS. 6A and 6AA illustrate paired transverse cross section views of a strut embodiment of FIG. 5 taken along the lines 6A-6A and 6AA-6AA of FIG. 5.
- FIGS. 6B and 6BB illustrate paired transverse cross section views of another strut embodiment of FIG. 5.
- FIGS. 6C and 6CC illustrate paired transverse cross section views of another strut embodiment of FIG. 5.
- FIGS. 6D and 6DD illustrate paired transverse cross section views of another strut embodiment of FIG. 5.
- FIGS. 6E and 6EE illustrate paired transverse cross section views of another strut embodiment of FIG. 5.
- FIG. 7A illustrates a strut embodiment in longitudinal section taken along lines 7A- 7A of the stent embodiment in FIG. 5.
- FIG. 7B illustrates another strut embodiment in longitudinal section.
- FIG. 7C illustrates another strut embodiment in longitudinal section.
- FIG. 8 illustrates a portion of an embodiment of a stent including struts having a stepped taper configuration.
- FIG. 9 illustrates a portion of an embodiment of a stent including struts having a continuous taper, barbs, and tuck pads with tuck slots.
- FIG. 10A illustrates a portion of a cylindrical stent embodiment in a constrained configuration including struts having coaxial enlarged portion embodiments.
- FIG. 10B illustrates a portion of a cylindrical stent embodiment in a constrained configuration including struts having coaxial enlarged portion embodiments.
- FIG. 10C illustrates a portion of a cylindrical stent embodiment in a constrained configuration including struts having undulating deflected portions configured to physically separate adjacent struts in a circumferential direction.
- FIG. 1 1 illustrates a portion of a cylindrical stent embodiment in a constrained configuration shown flattened including struts having coaxial enlarged portion
- FIG. 12 is a transverse cross section view of the stent portion of FIG. 1 1 taken along lines 12-12 of FIG. 1 1 .
- FIG. 13 is an elevation view of a bifurcated stent graft embodiment.
- FIG. 14 illustrates and embodiment of the stent graft of FIG. 13 partially deployed within a patient's aorta.
- FIG. 15 is a perspective view of a proximal anchor member embodiment.
- FIG. 16 is an elevation view of a cut away portion of the proximal anchor member embodiment of FIG. 15.
- FIG. 17 is an elevation view of a cut away portion of the proximal anchor member embodiment of FIG. 16.
- FIG. 18 shows a distal portion of the cut away portion of the proximal anchor member of FIG. 16.
- FIG. 19 is an enlarged view of the encircled portion 19-19 in FIG. 18.
- Embodiments of the invention are directed generally to methods and devices for treatment of fluid flow vessels with the body of a patient.
- Treatment of blood vessels may be specifically indicated for some embodiments, and, more specifically, treatment of aneurysms, such as abdominal aortic aneurysms.
- Devices for such treatment modalities may include stents, grafts and stent graft assemblies that include at least one stent secured to a graft member.
- the modular graft assembly may be bifurcated for treatment of an abdominal aortic aneurysm.
- a graft assembly embodiment may include a bifurcated main body member, an ipsilateral graft extension and contralateral graft extension.
- the main body may have a wall portion that binds a main fluid flow lumen disposed therein.
- An ipsilateral leg of the main body may have an ipsilateral port and an ipsilateral fluid flow lumen that is in fluid communication with the main fluid flow lumen and the ipsilateral port.
- a contralateral leg of the main body may have a contralateral port and a contralateral fluid flow lumen that is in fluid communication with the main fluid flow lumen and the contralateral port.
- the main body, ipsilateral leg, and contralateral leg may form a bifurcated "Y" shaped configuration.
- the main fluid flow lumen of the main body generally may have a larger transverse dimension and area than a transverse dimension and area of either of the fluid flow lumens of the ipsilateral leg or contralateral leg.
- a proximal anchor member may be disposed at a proximal end of the main body.
- the proximal anchor member may include a proximal self-expanding stent that is formed from an elongate element having a generally serpentine shape with four crowns or apices at either end. Each proximal apex or crown of the proximal stent may be coupled to alternating distal crowns or apices of an eight crown distal self-expanding stent.
- the distal self-expanding stent may be formed from an elongate element having a generally serpentine shape.
- a distal end of the distal stent may be mechanically coupled to a connector ring which may be embedded in graft material of the proximal end of the main body, or directly coupled to perforations in the proximal edge region of the main body.
- Embodiments of the connector ring may be generally circular in shape having regular undulations about the circumference that may be substantially sinusoidal in shape.
- the proximal stent may include outwardly extending barbs, that may be integrally formed with the struts of the stent for some embodiments, having sharp tissue penetrating tips that are configured to penetrate into tissue of an inside surface of a lumen within which the proximal stent is deployed in an expanded state.
- the proximal anchor member may include self-expanding stents, similar stents may be used that are configured to be inelastically expanded with outward radial pressure as might be generated by the expansion of an expandable balloon from within either or both stents.
- the connector ring coupled to the proximal stent may also be inelastically expandable.
- proximal refers to a location towards a patient's heart and the term “distal” refers to a location away from the patient's heart.
- distal refers to a location that is disposed away from an operator who is using the catheter and the term “proximal” refers to a location towards the operator.
- FIGS. 1 -4 illustrate an embodiment of a stent graft assembly 150 which may include a main graft member or main body portion 152 which is not bifurcated.
- the main body 152 may be tubular in shape and have a wall portion 153 that bounds a main fluid flow lumen
- the main body 152 may include a proximal end 154, a distal end
- the main body 152 of the stent graft assembly 150 may include at least one flexible layer of material such as PTFE, polymer meshes, composites of same or the like.
- a proximal anchor member or stent may be disposed at the proximal end 154 of the main body 152.
- the proximal anchor member embodiment shown in FIG. 1 includes a single proximal self-expanding stent member 160 disposed about a proximal end 154 of the main body 152.
- the proximal self-expanding stent member 160 may be formed from an elongate element having a generally serpentine shape with eight crowns or apices at either end.
- a distal end 162 of the proximal self- expanding stent member 160 may be mechanically coupled to a proximal connector ring 164 which may be embedded in graft material generally about the proximal end 154 of the main body 152, or directly coupled to perforations in the proximal end 154 region of the main body 152.
- a distal self-expanding stent member 170 may be disposed at the distal end 156 of the main body 152 and may be configured to engage an interior luminal surface 132 within the patient's vasculature 130.
- the distal self-expanding stent member 170 shown in FIG. 1 includes a single self-expanding stent member disposed along the distal end 156 of the main body 152 of the stent graft assembly 152.
- the distal self-expanding stent member 170 may be formed from a resilient elongate element having a generally serpentine shape with eight crowns or apices at either end.
- a proximal end 172 of the distal self-expanding stent member 170 may be mechanically coupled to a distal connector ring 174 which may be embedded in graft material generally about the distal end 156 of the main body 152, or directly coupled to perforations in the distal end 156 region of the main body 152.
- Embodiments of either the proximal connector ring 164 or distal connector ring 174 may be generally circular or cylindrical in shape with regular undulations about the circumference that may be substantially sinusoidal or zig-zag in shape.
- proximal or distal self-expanding stent members 160, 170 may include outwardly extending barbs 165 (see FIG. 1A).
- Such barbs 165 may be integrally formed with the struts 168 of either the proximal self-expanding stent member 160 or distal self-expanding member 170.
- the barbs 165 may have sharp tissue penetrating tips that may be configured to penetrate into tissue of an inside surface of a lumen within which either the proximal self-expanding stent member 160 or distal self- expanding member 170 may be deployed into an expanded state.
- proximal and distal self-expanding stent members 160 and 170 of the stent graft 150 has generally been described as including self-expanding stents
- the proximal and distal self-expanding stent members 160 and 170 may also include similar stents that are configured to be inelastically expanded with outward radial pressure as might be generated by the expansion of an expandable balloon from within either the proximal self-expanding stent member 160 or distal self-expanding stent member 170.
- at least one of the proximal self-expanding stent member 160 and distal self- expanding stent member 170 may be made from or include a superelastic alloy, such as NiTi alloy.
- the stent graft 150 may further include an optional inflation conduit (not shown) which may serve as a fill manifold for inflation of the inflatable portion 158 of the stent graft 150.
- the inflation conduit may include a distal end with an inflation port in fluid
- the stent graft 150 may include radiopaque markers 1 16 that may be used to facilitate alignment of the stent graft 150.
- a radiopaque marker 1 16 configuration and imaging system may be used for alignment during positioning of the stent graft 150 in a patient.
- FIG. 1A illustrates an enlarged view of a portion of the stent graft 150 with portions of the stent graft 150 not shown for clarity of illustration.
- FIG. 1A illustrates the proximal end 154 of the main body 152, the proximal self-expanding stent member 160, and a plurality of radiopaque markers 1 16 disposed about a circumference of a distal end 162 of the proximal self-expanding stent member 160.
- the plurality of radiopaque markers 1 16 may include helically wound wire members which may be disposed about connector members 216, as shown in FIG. 1A.
- the connector members 216 may be configured to mechanically couple the proximal self-expanding stent member 160 to the proximal connector ring 164 disposed within the proximal end 154 of the main body 152 of the stent graft 150.
- the stent graft 150 may additionally or alternatively include a plurality of radiopaque markers 1 16 circumferentially disposed about a tubular portion of the endovascular stent graft 150.
- the radiopaque markers 1 16 may lie in a plane that is substantially orthogonal or parallel to a longitudinal axis 186 of the tubular main body 152 of the stent graft 150.
- the distal self-expanding member 170 may include one or more radiopaque markers 1 16.
- any number of features may be incorporated into the stent graft 150 which may enable detection of all or part of the stent graft 150 under fluoroscopy or other suitable forms of imaging.
- the radiopaque markers 1 16, or other detection features may be used to facilitate orthogonal orientation of the imaging axis or view. Once a substantially orthogonal view angle is achieved, an accurate axial position of the partially deployed stent graft 150 relative to the patient's vasculature may be achieved, avoiding parallax, ensuring precise placement of the stent graft 150 relative to significant branch vessels or other anatomic reference points. Parallax in some circumstances may cause error in axial placement of the stent graft 150 relative to the intended target site. Accurate positioning may be achieved with axial movement and adjustment of the stent graft 150 by manual manipulation of a proximal portion of the delivery catheter 100.
- the stent graft 150 may be positioned such that the proximal end 154 of the main body 152 of the stent graft 150 is aligned distal of the ostium of the renal arteries.
- an outer sheath 102 of the delivery catheter 100 may be proximally retracted.
- the stent graft 150 may remain in a partially constrained state with the proximal self-expanding stent member 160 restrained by a pair of proximal releasable belts 104 and 106 releasably disposed about the proximal self-expanding stent member 160.
- the distal self-expanding stent member 170 may be constrained by another set of distal releasable belts 108 and 1 10 which may be releasably disposed about the distal self-expanding stent member 170.
- Each of the releasable belts 104, 106, 108 and 1 10 may be configured to be independently released by retraction of one or more respective release wires 120.
- Release wires 120 may be disposed within an end loop or loops of the releasable belts 104, 106, 108 and 1 10 with the one or more release wires 120 holding the loops in fixed relation to each other. For this arrangement, retraction of one or more release wires 120 from the end loops releases the loops to allow them to move relative to each other which in turn removes the constraint of the belt members 104, 106, 108 and 1 10 about the respective proximal and distal self-expanding stent members 160 and 170. After at least partial deployment of the proximal stent member 160, finalizing the axial position of the stent graft 150 relative to the anatomy of the patient's vasculature 130 and treatment site may then be made.
- the axial positioning may be accomplished in some embodiments with the use of one or more radiopaque marker devices 1 16, as described above.
- the proximal self- expanding stent member 160 may then be fully deployed in order to engage and become secured to the luminal wall or interior luminal surface 132 of the patient's vasculature 130, as shown by way of example in FIG. 4.
- the inflatable portion 158 of the stent graft 150 including the network of inflatable channels, may be inflated with a fill material.
- the network of inflatable channels may be filled from a desired site within the inflatable portion 158. More specifically, the inflatable portion 158 may be inflated with fill material from a proximal end 154 of the main body 152.
- the proximal self-expanding stent member 160 may be disposed at and secured to a proximal end 154 of the main body 152.
- the proximal self-expanding stent member 160 may have a first self-expanding stent member 200 secured to a second self- expanding stent member 202.
- Both the first and second self-expanding stent members 200 and 202 may have a somewhat tubular shape and may be secured together by one or more struts 168.
- Some embodiments of the struts 168 may have one or more cross sectional areas 169 that vary along the length of the strut 168.
- the proximal self-expanding stent member 160 may include at least one barb 165 and/or enlarged portion 180 on each strut 168, every other strut 168 or combinations thereof.
- One proximal self-expanding stent member 160 embodiment may have a repeated strut 168 pattern having a more proximally placed barb 165 on one strut 168, an adjacent neighbor strut 168 with a more distally placed barb 165, and a following adjacent strut 168 with a centrally placed enlarged portion 180, as shown in FIG. 3.
- a proximal self-expanding stent member 160 embodiment may have a first self-expanding stent member 200 secured to a second self-expanding stent member 202 where the first self-expanding stent member 200 (or more proximal stent) may have alternating more distally placed barbs 165 along the struts 168 with more proximally placed barbs 165 along the struts 168, as shown in FIG 9.
- Another proximal self-expanding stent member 160 embodiment may include one or more struts 168 having enlarged portions 180 generally centrally placed along the length of the struts 168, followed by alternating more distally placed barbs 165 with more proximally placed barbs 165 along the struts 168, as shown in FIG. 1 1 .
- the first self-expanding member 200 of the proximal self- expanding stent member 160 may further include a plurality of barbs 165 having sharp tissue engaging tips that are configured to extend radially outward and distally in a deployed expanded state.
- This configuration may be useful in order to engage tissue of an inner luminal surface 132 of a patient's vasculature 130 and mechanically anchor the stent graft 150 to the vasculature 130, in addition to the anchoring function provided by the outward radial force of the proximal self-expanding stent member 160 against the inner luminal surface 132 of the patient's vasculature 130 when the stent graft 150 is in a deployed state.
- the second self-expanding member 202 of the proximal self-expanding stent member 160 may be secured to the proximal end 154 of the main body 152 of the stent graft 150 with one or more struts 168 and/or connector members 216 mechanically coupled to a proximal connector ring 164.
- the first and second self-expanding members 200, 202 of the proximal self-expanding stent member 160 may be radially constrained by releasable belts 104 and 106 which may be releasably held in a
- FIG. 2 shows an embodiment of the proximal self-expanding stent member 160 where the first self-expanding member 200 is being radially constrained by a first releasable belt 104 and the second self-expanding member 202 is being radially constrained by a second releasable belt 106.
- the first releasable belt 104 may be released by a first release wire 120 and the second releasable belt 106 may be deployed by the second release wire 120.
- the first and second self-expanding members 200 and 202 of the proximal anchor member may only be released after the outer sheath 102 has been retracted, as shown in FIG. 2, in order to expose the stent graft 150.
- the strut 168 structure of the proximal self-expanding stent member 160 and/or distal self-expanding stent member 170 may be formed from a cylindrical metal tube structure which is carved or bore by laser or other cutting device. Thereafter, the cut tube may be heat set into two separate forms or states such as an expanded state and non- expanded/contracted state.
- Fig. 3 shows an example of a non-expanded state.
- the proximal self-expanding stent member 160 and/or distal self-expanding stent member 170 may include one or more barbs 165.
- a barb 165 may be any outwardly directed protuberance, typically terminating in a sharp point that is capable of at least partially penetrating a body passageway in which the stent graft 150 is deployed (typically the initial and medial layers of a blood vessel such as the abdominal aorta).
- the number of barbs 165, the length of each barb 165, each barb 165 angle, and the barb 165 orientation may vary from barb 165 to barb 165 within a single anchor member or between multiple anchor members (i.e., proximal self-expanding stent member 160 and/or distal self-expanding stent member 170) within a single stent graft 150.
- barbs 165 may be attached to or fixed on the struts 168, it may be preferred that they are integrally formed as part of the struts 168.
- barbs 165 may be designed to work in conjunction with the distally-oriented blood flow field. In this location, the barbs 165 may penetrate the tissue and prevent axial migration of the stent graft 150. As such, the barbs 165 may be oriented proximally with respect to the main body 152 section.
- the number, dimensions, configuration and orientation of barbs 165 may vary significantly, yet be within the scope of the present invention.
- the staged deployment of the proximal self-expanding stent member 160 may also facilitate self-alignment of the stent graft 150.
- the graft may be free to expand and enable distal fluid flow to flow through the stent graft 150 and create a "windsock" effect. That is, the distal fluid flow may apply a slight distal force generally upon the main body 152.
- This distal force may help to align at least the main body 152 and proximal self-expanding stent member 160 within the patient's vasculature 130, which may be particularly advantageous during deployment of the stent graft 150 within the angulated vasculature 130, for example.
- one or more struts 168 may include tuck pads 166. Additionally, the one or more struts 168 may have tuck pads 166
- each barb 165 may be placed, for example, behind an adjacent strut 168 and/or tuck pad 166 in order to prevent the barbs 165 from radially extending and contacting the inside of a outer sheath 102 or delivery catheter 100 during delivery of the stent graft 150, as well as to prevent undesired contact of the barbs 165 with the inside luminal surface 132 of a patient's vasculature 130.
- the struts 168 may have various circumferential
- Enlarged portions 180 of a strut 168 may also include varying radial lengths generally along a longitudinal axis of the strut 168. Enlarged portions 180 may be aligned with barbs 165 and/or located at a generally unstable portion of a strut 168.
- enlarged portions 180 when the stent (i.e., proximal self-expanding member 169) is in a compressed state, enlarged portions 180 may abut each other and may have one or more flat sides which prevent slippage by each other. Adjacent enlarged portions 180 that abut each other and circumferentially interfere with each other may be axially coextensive. In a radially compressed state, for example, the one or more enlarged portions 180 may be compressed to a radial diameter that is no greater than the remaining part of the stent 168.
- one or more struts 168 may have a tapered section 300.
- one or more struts 168 may have a tapered section 300 in order to evenly distribute strain induced at least when the stent is in a constrained state.
- the strut 168 may taper from a first end portion of the strut 168 to a smaller transverse cross section towards a middle portion of the strut 168.
- a strut 168 embodiment may taper from a proximal end 400 portion towards a respective middle portion 402 and taper to a reduced transverse cross section from a distal end portion 404 towards a respective middle portion 402.
- the strut 168 may taper over half or approximately half of the length of the strut 168.
- the strut 168 may taper generally over the entire length of the strut 168, such as from the apex or crown of the anchor member or stent to the middle of the strut or to the first discontinuity feature (i.e., an enlarged portion 180, barb 165, tuck pad 166 and the like).
- the struts 168 may taper in at least one transverse dimension of the strut 168.
- the struts 168 may taper along a circumferential direction about the longitudinal axis of the struts 168 may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent, such as the proximal self-expanding stent member 160.
- the struts 168 may taper along a radial direction relative to the longitudinal axis of the anchor member or stent and the struts 168 may have a substantially constant thickness in a circumferential direction about the longitudinal axis of the anchor member or stent.
- the taper angle of a tapered section 300 of a strut 168 may be about 1 degree to about 3 degrees inclusive, about 1 .5 degree to about 2.5 degrees inclusive, or about 1 .75 degree to about 2.25 degrees inclusive.
- the strut 168 embodiments may taper continuously from each end portion to the respective middle portions, such as is shown by way of example in FIG. 9.
- the struts may include a stepped taper embodiment 302 which tapers in discrete steps rather than a smooth continuous taper from the distal and proximal end portions 404 and 400 of the respective middle portions 402 in either radial direction about the longitudinal axis. Such and embodiment is shown by way of example in FIGS. 7C.
- the struts may also taper in a circumferential direction about the longitudinal axis, as shown in FIG. 8.
- the tapered sections 300 of the struts 168 may extend from proximal and distal end portions 400 and 404 of the struts 168 to respective strut structures (i.e., enlarged portions 180) disposed in, for example, the middle portion 402 of the respective strut 168, as shown by way of example in FIG. 8.
- FIG. 5 illustrates a portion of a stent 500 embodiment which may function as a proximal self-expanding stent member 160.
- the stent 500 may include a plurality of struts 168 extending axially between the proximal end 402 and distal end 404 thereof.
- the stent 500 may be oriented in either direction, depending on the application.
- Both the proximal and distal ends 400 and 404 may have a plurality of crowns adjoining adjacent struts 168.
- the distal end 404 may have a plurality of connecting members 216 configured to connect the stent 500 to the main body 152 or other structure.
- the stent 500 embodiment may have various features (i.e., tuck pads 166, etc.) and structures and is not limited to the strut 168 features and structures illustrated herein.
- the stent 500 may have a body defined by a lattice structure or a helical structure.
- Optional taper may be incorporated into one or more of the struts 168 of the various stent 500 embodiments, as well as the various connector members 216.
- incorporating one or more tapers into one or more of the struts 168 in one or more stents 500 may provide greater space in the tapered section 300 to accommodate alternative features such as barbs 165 and tuck pads 166.
- it may allow for a smaller deployment profile when the components are in a radially collapsed delivery configuration.
- the various stents 500 When configuring the various stents 500 into this reduced diameter delivery profile (non-expanded/constrained state), the stents 500 may experience a large degree of bending strain that may be poorly distributed. Tapering certain stent 500 struts 168 in particular locations may help to distribute this strain more evenly throughout the stent 500 and/or strut 168 which may assist in preventing strain damage to the stent 500.
- FIG. 5 illustrates a section of a stent 500, such as a proximal self-expanding stent member 160, in which the struts 168 taper from a proximal end 400 width to a minimum width about the middle portion 402 of the strut 168.
- An example transverse cross-section of the strut 168 taken along line 6AA-6AA, which is generally located in the proximal end 400 region of a strut 168, of FIG. 5 is shown in FIG. 6AA (which may or may not equal a width of strut 168 in the apex region or distal end 404).
- FIG. 6A Another example transverse cross- section of the strut 168 taken along line 6A-6A, which is generally located in the minimum width, or near the middle portion 402 region of the strut 168, of FIG. 5 is shown in FIG. 6A.
- the optional taper which may be expressed as the taper ratio, is the ratio of the maximum width (as shown, for example, in FIG. 6AA) to the minimum width (as shown in FIG. 6A) of a cross sectional area 169.
- the taper ratio may vary widely depending on, for example, the particular region of the strut 168 or connector member 216, the material used, and other factors. Taper ratios ranging from about 1 to about 10 or greater may be within the scope of the present invention. It may also be within the scope of the present invention for the struts 168 to have no taper (as shown by way of example in FIG. 7A).
- FIGS. 6A-6EE illustrate a variety of examples of varying transverse cross-sectional views taken at two different locations along a single strut 168. These figures illustrate examples of the different shapes and sizes a single cross sectional area 169 of a strut 168 may have.
- FIGS. 6A and 6AA show a pair of transverse cross section views of the strut 168 embodiment of FIG. 5 taken along the lines 6A-6A and 6AA-6AA which illustrates the rectangular shape of the cross sectional area 169 and the change in size of the cross sectional area 169 at two different locations along the strut 168.
- FIGS. 6A-6EE illustrate a variety of examples of varying transverse cross-sectional views taken at two different locations along a single strut 168. These figures illustrate examples of the different shapes and sizes a single cross sectional area 169 of a strut 168 may have.
- FIGS. 6A and 6AA show a pair of transverse cross section views of the strut 168 embodiment of FIG. 5
- FIGS. 6B and 6BB illustrate another example embodiment of paired transverse cross section views of another strut 168 embodiment which illustrates the trapezoidal shape of the cross sectional area 169 and the change in size of the cross sectional area 169 at two different locations along the strut 168.
- FIGS. 6C and 6CC illustrate another example embodiment of paired transverse cross section views of another strut 168 embodiment which illustrates the inverse trapezoidal shape of the cross sectional area 169 and the change in size of the cross sectional area 169 at two different locations along the strut 168.
- FIGS. 6D and 6DD illustrate another example embodiment of paired transverse cross section views of another strut 168 embodiment which illustrates the elliptical shape of the cross sectional area 169 and the change in size of the cross sectional area 169 at two different locations along the strut 168.
- FIGS. 6E and 6EE illustrate another example embodiment of paired transverse cross section views of another strut 168 embodiment which illustrates the circular shape of the cross sectional area 169 and the change in size of the cross sectional area 169 at two different locations along the strut 168.
- the transverse cross sectional area 169 of one or more locations along a strut 168 are not limited to the sizes and shapes disclosed herein, and may be any number of sizes and shapes that may be incorporated in a strut 168 and/or stent 500 configuration.
- a proximal self-expanding stent member 160 may have, for example, one or more struts 168 having a proximal end 400 portion and/or distal end 404 portion which may be made from NiTi and an effective maximum strut 168 width ranging from about 0.016 to about 0.032 inch; particularly from about 0.022 inch and about 0.028 inch, and a minimum strut 168 width between about 0.010 inch and about 0.026 inch; particularly from about 0.012 inch and about 0.022 inch.
- Additional tapered strut 168 embodiments are described and shown herein in the figures which may be used in other anchor members (such as the proximal and distal self-expanding stent members 160 and 170), stent 500 embodiments or connector members 216 described herein, and may be incorporated in any number of components and made from any number of materials.
- tapering of the struts 168 in any configuration described herein may improve the strain distribution at least between the proximal end 400 portions and distal end 404 portions of the struts 168.
- one or more struts 168 may include a taper having an offset radii and/or combinations of elliptical and/or circular apex radii in order to further cause the desired behavior during assembly into a reduced-diameter delivery configuration as well as effective delivery and performance in vivo.
- the proximal end 400 portion, or apex, width may be the minimum width of the strut 168 which untapers towards the middle portion 402 of the strut 168, which may have the maximum width of the strut 168.
- the tapering from the proximal end 400 portion to the middle portion 402 of the strut 168 may be continuous, stepped in discrete steps 410 with straight untapered portions between each discrete step (as shown by way of example in FIG. 7C and 8) or a combination thereof. Furthermore, untapering of the strut 168 may be in the radial and/or circumferential direction along the longitudinal length of the strut 168.
- the strut 168 may include an enlarged portion 180 located in about the middle portion 402 of one or more of the struts 168, as shown by way of example in FIG. 5.
- one or more enlarged portions 180 may be located along every other strut 168 of the stent 500.
- the one or more enlarged portion 180 may be located along a strut 168 in various locations, such as near or at the proximal end 400 portion, middle portion 402, and/or distal end 404 portion of the strut 168.
- the one or more enlarged portions 180 may be located at offset locations relative to enlarged portions 180 (or other features) along neighboring struts 168.
- the one or more enlarged longitudinal sections or enlarged portions 180 may have an enlarged transverse dimension that is about 1 .5 times to about 3 times the nominal transverse dimension of the strut 168 in a direction of the enlargement.
- the enlarged portions 180 may have an undulating configuration of the nominal strut 168. Furthermore, the enlarged portion 180 may have an oval enlargement of the nominal strut. Each strut 168 of the stent 500 having an enlarged portion 168 along the length of the strut 168 may have only one enlarged portion 180. Alternatively, each strut 168 of the stent 500 having an enlarged portion 180 along the length of the strut 168 may have more than one enlarged portion 180.
- the enlarged portions 180 are not limited to what are described and shown herein, and may be sized, featured, shaped, and proportioned in any number of ways that may assist in assembly or use of the stent 500.
- FIG. 10A shows an example portion of a cylindrical stent embodiment 500 in a constrained configuration including struts 168 having generally coaxially aligned enlarged portion 180 embodiments having circular or oval features.
- FIG. 10B shows an example portion of a cylindrical stent embodiment 500 in a constrained configuration having struts 168 with generally coaxially aligned enlarged portion 180 embodiments having square or rectangular features.
- FIG. 10A shows an example portion of a cylindrical stent embodiment 500 in a constrained configuration including struts 168 having generally coaxially aligned enlarged portion 180 embodiments having circular or oval features.
- FIG. 10B shows an example portion of a cylindrical stent embodiment 500 in a constrained configuration having struts 168 with generally coaxially aligned enlarged portion 180 embodiments having square or rectangular features.
- FIG. 10A shows an example portion of a cylindrical stent embodiment 500 in a constrained configuration including struts 168 having generally coaxially aligned enlarged portion 180 embodiments having circular
- FIG. 10C shows a portion of a cylindrical stent embodiment 500 in a constrained configuration including struts 168 having undulating deflected portions 182 which may be configured to physically separate adjacent struts 168 in a circumferential direction.
- One or more struts 168 of a stent embodiment 500 may have a stepped taper 302 feature generally along the length of the strut 168.
- one or more struts 168 may have a stepped taper 302 from the proximal end 400 to the respective middle portion 402 of the strut 168 and/or a stepped taper 302 from the distal end 404 to the middle portion 402 of the strut 168, wherein the stepped taper 302 may be in either radial direction about the longitudinal axis of the strut 168, as shown by way of example in FIG. 7C, or the circumferential direction about the longitudinal axis, as shown by way of example in FIG. 8.
- the taper characteristics of a strut 168 may be continuous, stepped or any other shape configured to evenly distribute strain induced by the constraint of the constrained non- expanded stent 500.
- FIG. 7A illustrates an example longitudinal section view taken along line 7A-7A of the strut 168 in FIG. 5 which shows a generally rectangular cross sectional area 169 having no radial tapering about the longitudinal axis.
- FIG. 7B illustrates another example of a longitudinal section view of a strut 168 which shows a generally tapered cross sectional area 169 due to radial tapering about the longitudinal axis of the strut 168.
- the strut 168 tapers continuously from each end portion (the proximal and distal ends 400 and 404) to the middle portion 402 such that the middle portion 402 generally has the minimum strut 168 width in the radial direction.
- FIG. 7C shows another example strut 168
- the strut 168 generally tapers in steps continuously from each end portion (the proximal and distal ends 400 and 404) to the middle portion 402 such that the middle portion 402 generally has the minimum strut 168 width in the radial direction.
- FIG. 8 shows a portion of an embodiment of a stent 500 including struts 168 having a circumferential stepped taper 302 configuration about the longitudinal axis of the strut 168.
- the middle portion 402 of each strut 168 may also include an enlarged portion 180 extending, for example, in a circumferential direction.
- Portions of the stepped taper 302 of a strut 168 that may be directly adjacent an enlarged portion 180 may have the minimum strut 168 width in the circumferential direction.
- any number of combinations of tapering in any direction may be used.
- FIG. 9 shows a stent embodiment 500 where the proximal self-expanding stent member 160 has a first self-expanding member 200 secured to a second self-expanding member 202 where the first self-expanding member 200 has alternating more proximally placed barbs 165 along the struts 168 with more distally placed barbs 165 along the struts 168.
- the stent embodiment 500 may have a continuous taper in the second self-expanding member 202, which is the portion of the proximal self-expanding stent member 160 adjacent the main body 152.
- Each strut 168 on the first self-expanding member 168 may have a barb 165 in a different location relative to a neighboring strut 168.
- the barbs 165 may be formed integrally with the struts 168, but may otherwise be manufactured, for example, as a separate component attached to the struts 168.
- the struts 168 and the barbs 165 of the stent embodiments 500 and anchor members may be self-expanding, that is, upon release of a constraining force, the struts 168 may move radially apart and the barbs 165 may extend radially outward.
- Other configurations, such as balloon expansion, are also contemplated within the present invention.
- stent embodiments 500 may include struts 168 including tuck pads 166, which may be positioned along a strut 168 such that the tuck pads 166 are axially aligned with a barb 165 positioned on a neighboring strut 168. Similar to the barbs 165 and enlarged portions 180, the number, dimensions, configurations and orientations of the tuck pads 166 may vary between struts 168, stent embodiments 500 and anchor members (such as the proximal and distal self-expanding stent members 160 and 170 described herein).
- anchor members such as the proximal and distal self-expanding stent members 160 and 170 described herein.
- one or more barbs 165 may be placed behind a corresponding strut 168 and/or tuck pad 166, if present, in order to prevent the barbs 165 from contacting the inside of a outer sheath 102 or delivery catheter 100 during delivery of the stent graft 150 and from undesired contact with the interior luminal surface 132 of the patient's
- a release belt may be disposed in one or more grooves (not shown) disposed on one or more struts 168 which may assist in retaining the proximal self- expanding stent member 160 in the reduced diameter delivery configuration.
- proximal self-expanding stent member 160 upon deployment of stent graft 150, and more particularly the proximal self-expanding stent member 160, (typically accomplished, at least in part, by release of one or more belts, such as the proximal releasable belts 104 and 106), the radial expansion of the proximal self-expanding stent member 160 results in a displacement of struts 168 so that the distance between them increases. Eventually, the displacement between the struts 168 become large enough to enable the barbs 165 to be released from behind the adjacent strut 168 and/or tuck pad 166 and engage the interior luminal surface 132 of the patient's vasculature 130.
- the barbs 165 may release into a position suitable for engaging the interior luminal surface 132 of a patient's vasculature with a time constant that is generally an order of magnitude lower than the time constant associated with the radial expansion of the stent 500 embodiment or anchor member (such as the proximal self-expanding stent member 160).
- the one or more barbs 165 may complete their deployment before the stent 500 or anchor member is fully expanded so that the barbs 165 may engage the interior luminal surface 132 of the vasculature 130 with maximum effectiveness.
- the proximal self-expanding stent member 160 may include struts 168, any one of which may further comprise one or more barbs 165.
- optional tuck pads 166 may be positioned along a strut 168 such that the tuck pad 166 is coaxially aligned with a barb 165 on a neighboring strut 168 in order to shield the neighboring barb 165 at least when the stent graft 150 is in its reduced diameter delivery configuration.
- Struts 168 and/or tuck pads 166 may also include a tuck slot 167 which may assist in retaining a barb 165 while the stent graft 150 (and consequently the proximal self-expanding stent member 160) is in its reduced diameter delivery
- the one or more barbs 165 may be released from respective tuck slots 167 and thereafter placed in an
- FIG. 1 1 shows a portion of a cylindrical stent embodiment 500 in a generally constrained and flattened configuration having struts 168 with a coaxial enlarged portion 180 embodiments and undulating deflected portions 182.
- the undulating deflected portions 182 may have barbs 165 positioned at offset proximal and distal locations along neighboring struts 168 which may aid in efficiently compacting the struts 168 and barbs 165 in a constrained configuration for delivery into a patient's body.
- the stent 500 may be optimally compressed.
- the undulating deflected portions 182 of a strut 168 may enable multiple lateral contact points within the stent 500. Such multiple contact points may aid in restraining or compacting the stent 500 in a constrained/non-expanded state.
- one or more struts 168 may have enlarged longitudinal sections or enlarged portions 180 that may be disposed in a substantially longitudinal orientation between the proximal end and distal end of the stent 500 when the stent 500 is in the constrained state. Additionally, the one or more struts 168 may be disposed in an undulating pattern.
- FIG. 12 shows a transverse cross section view of the stent 500 portion of FIG. 1 1 taken along lines 12-12 of FIG. 1 1 .
- FIG. 12 illustrates an example of the varying circumferential cross sectional areas 169 of the struts 168 taken along a
- a modular endovascular stent graft assembly may include a bifurcated graft member 600 with a proximal stent or anchor member 602 secured thereto.
- the main body member 604 may be formed from a supple graft material, such as ePTFE, having a main fluid flow lumen 606 therein.
- FIG. 13 illustrates such an embodiment.
- the main graft portion 604 may include an ipsilateral leg 608 with an ipsilateral fluid flow lumen 610 in communication with the main fluid flow lumen 606, a contralateral leg 612 with a contralateral fluid flow lumen 614 in communication with the main fluid flow lumen 606 and a network of inflatable channels 616 disposed on the main graft member 604.
- the main graft or main body member 604 may have an axial length of about 5 cm to about 10 cm, more specifically, about 6 cm to about 8 cm in order to span an aneurysm 622 of a patient's aorta 618 without engaging the patient's iliac arteries 620 directly with the legs 608 and 612 of the main graft member 604 (see FIG. 14).
- the inflatable channels of the network of inflatable channels 616 may be disposed on any portion of the main graft or main body member 604 including the ipsilateral and contralateral legs 608 and 612.
- the network of inflatable channels 616 may be configured to accept a hardenable fill material to provide structural rigidity to the main body 604 member when the network of inflatable channels 616 are in an inflated state and the inflation material has been cured or hardened. Radiopaque inflation material may be used to facilitate monitoring of the fill process and subsequent engagement of graft extensions.
- the network of inflatable channels 616 may also include at least one inflatable cuff 624 disposed on a proximal portion of the main body member which may be configured to seal against an inside surface of a patient's vessel, such as the aorta.
- the proximal anchor member 626 which may have a substantially tubular or cylindrical configuration, may be disposed at a proximal end 628 of the main body member 604 and secured to the main body member 604 in any suitable manner including stitching, adhesive bonding, welding, and the like.
- the proximal anchor member 626 may also be secured to the main body 604 with a resilient connector ring (not shown) which may be embedded in a proximal end or portion 628 the main body 604.
- the proximal anchor member 626 may have a self-expanding proximal stent portion 630 secured to a self- expanding distal stent portion 632.
- Each of these stent portions 630 and 632 may include an undulating elongate stent element that may be disposed in a somewhat serpentine or sinusoidal configuration, as shown above with regard to stent members 160 and 170.
- Each of the stent portions 630 and 632 of the proximal anchor member 626 of the stent graft 600 in FIG. 13 may share any or all of the features, dimensions or materials of stent members 160 and 170 discussed above.
- the proximal and distal stent portions 630 and 632 of the proximal anchor member 626 may include tapered struts 634 that extend between crown portions 636 of each respective stent portion 630 or 632.
- Such tapered struts 634 may have any or all of the features, dimensions, and materials of the struts discussed above and include a tapered strut configuration that allows for the strain imposed on the strut structure to be evenly distributed through the structure of the stent portion or portions 630 and 632.
- the proximal stent portion 630 may be secured to the distal stent portion 632 with one or more struts or strut segments 638 disposed between the respective proximal and distal stent sections 630 and 632.
- Some embodiments of such interconnecting struts 638 may have a cross sectional area that is substantially the same as or greater than a cross sectional area of proximal stent portions 630 or distal stent portions 632 adjacent the strut 638. Such configurations may be useful in avoiding points of concentrated stress in the proximal anchor member 602 or struts 638 which couple components thereof.
- the proximal stent portion 630 of the proximal anchor member 602 may further include a plurality of barbs 640 having sharp tissue engaging tips 642 that are configured to extend in a radial outward direction in a deployed expanded state (see FIG. 15).
- each stent portion 630 and 632 of the proximal anchor member 602 may include about 5 crowns 636 to about 8 crowns 636 at either end of the respective section 630 or 632 and may be made from a superelastic alloy such as superelastic NiTi alloy.
- At least one tubular ipsilateral graft extension 644 having a fluid flow lumen 646 disposed therein may be deployed with the fluid flow lumen 646 of the graft extension 644 sealed to and in fluid communication with the fluid flow lumen 610 of the ipsilateral leg 608 of the main body member 604.
- at least one tubular contralateral graft extension 648 having a fluid flow lumen 650 disposed therein may be deployed with the fluid flow lumen 650 of the graft extension 648 sealed to and in fluid communication with the fluid flow lumen 614 of the contralateral leg 612 of the main body member 604.
- the graft extensions 644 and 648 may include an interposed self- expanding stent 652 disposed between at least one outer layer and at least one inner layer of supple layers of graft material.
- the interposed stent disposed between the outer layer and inner layer of graft material may be formed from an elongate resilient element helically wound with a plurality of longitudinally spaced turns into an open tubular configuration.
- the interposed stent 652 may include a superelastic alloy such as superelastic NiTi alloy.
- the graft material of each graft extension 644 and 648 may further include at least one axial zone of low permeability for some embodiments.
- an outside surface of the graft extension 648 may be sealed to an inside surface of the contralateral leg 612 of the main body 604 when the graft extension 648 is in a deployed state.
- the axial length of the ipsilateral and contralateral legs 608 and 612 may be sufficient to provide adequate surface area contact with outer surfaces of graft extensions 644 and 648 to provide sufficient friction to hold the graft extensions 644 and 648 in place.
- the ipsilateral and contralateral legs 608 and 612 may have an axial length of at least about 2 cm.
- the ipsilateral and contralateral legs 608 and 612 may have an axial length of about 2 cm to about 6 cm, more specifically, about 3 cm to about 5 cm.
- FIG. 14 shows the stent graft 600 having an 8 crown distal stent portion 632 with marker elements 654 disposed at a distal end 656 of the distal stent portion 632.
- the stent graft of FIG. 14 may have the same features, dimensions and materials as those of the stent graft 600 shown in FIG. 13.
- the stent graft 600 of FIG. 14 is shown in a partially deployed state within an abdominal aorta 618 of a patient with the proximal end 628 of the main body 604 disposed just below and in a non-interfering relationship with the renal arteries 658 which extend from and are in communication with the patient's aorta.
- the main body 604 of the stent graft 600 also extends substantially across the aneurysm 622 of the aorta 618, however, this relationship may vary depending on the size of the graft 600 used and the morphology of the aneurysm 632.
- the proximal stent portion 630 of the proximal anchor member 602 is still constrained by a releasable member or belt 660 such that it has an outer dimension or profile suitable for delivery within a catheter assembly within the patient's vasculature.
- the distal stent portion 632 has been released from a constrained state and has expanded radially such that the distal end 656 of the distal stent portion 632 has expanded outwardly in approximation to the inner surface 662 of the patient's aorta 618.
- a proximal anchor member 602 configured to allow the distal end 656 of the distal stent portion 632 to so expand may be desirable.
- the markers 654 disposed at the distal end 656 of the distal stent portion 632 are substantially open and are close to or in contact with the inner wall 662 of the patient's aorta 68 providing good visualization of the position of the partially deployed stent graft 600 under fluoroscopy. This configuration may allow the physician deploying the stent graft 600 to visualize the position of the stent graft 600 and accurately predict what the final position of the stent graft 600 will be after complete deployment.
- such a configuration may also allow the physician to adjust the position of the stent graft 600 prior to full deployment of the proximal anchor member 602.
- the stent graft 600 and markers 654 at the distal end 656 of the distal stent portion 632 are sufficiently expanded so that the physician can easily see how the stent graft 600 will be positioned when fully deployed before the physician has deployed the proximal stent portion 630 in which case the barbs 640 or other tissue engaging members of the proximal stent portion 630 engage the tissue of the inner wall 662 of the patient's aorta 618.
- an anchor member 602 in order to configure an anchor member 602 such that the distal end 656 of the distal stent portion 632 opens or radially expands sufficiently upon release from a constrained state, that certain design parameters or criteria may be desirable.
- a stent portion 632 may benefit from a configuration that produces a good distal opening force or maximum opening force in an outward radial direction.
- a useful outward opening force may include about 0.5 to about 0.75 Ibf of force for a stent embodiment that is about 14 mm to about 16 mm in outer diameter in a relaxed
- proximal anchor member 602 includes both a proximal stent portion 630 and a distal stent portion 632
- Such an unsymmetric arrangement may be beneficial in cases such as the partial deployment sequence step shown in FIG. 14 wherein the constraint on the distal stent portion 632 has been released so as to allow radial expansion of the distal portion 632 but the proximal stent portion 630 remains constrained.
- FIG. 15 illustrates an embodiment of the proximal anchor member 602 having a 5 crown proximal stent portion 630 and a five crown distal stent portion 632.
- An attachment ring 664 is secured to each crown 636 of the distal end 656 of the distal stent portion 632.
- Such attachment rings 664 may be secured to the proximal end 628 of main body 604 by stitching the ring 664 to the flexible material of the main body portion 604 with suture or any other suitable material.
- Such attachment rings 664 may also be secured to the main body 604 by any other suitable method including any of the attachment methods and devices discussed above.
- a cutaway portion 668 of the proximal anchor member 602 is shown at the ends of arrows 665 to illustrate an element of the proximal anchor member 602 for further discussion.
- the cutaway portion 668 includes a distal crown 670 and respective stent struts 634 attached thereto from the distal stent portion 632 and a proximal crown 672 and respective stent struts 634 attached thereto from the proximal stent portion 630.
- the proximal end of the distal stent portion 632 is secured to the distal end 676 of the proximal stent portion 630 by strut segments 638.
- FIG. 16 illustrates the cutaway portion 668 of the proximal anchor member 602 of FIG. 15 with an adjacent arrow 678 that indicates the axial length of the proximal stent portion 630 and an arrow 680 that indicates the axial length of the proximal stent portion 630 together with the distal stent portion 632 or, in other words, the axial length of the proximal anchor member 602 as a whole.
- a proximal anchor member 602 having a proximal stent portion 630 and a distal stent portion 632 wherein the axial length of the proximal anchor member 602 as a whole (L stent) divided by the axial length of the proximal stent portion 630 (L pro ximai) is a ratio of about 1 .75 to about 2.5, more specifically, about 1 .75 to about 2.1 , and even more specifically, about 1 .75 to about 1 .9.
- Such a configuration may be useful for a multi-element stent or proximal anchor member 602 in order to maximize opening force and minimize peak strain within the proximal anchor member 602.
- FIG. 17 illustrates the cutaway portion 668 of the proximal anchor member 602 of FIG. 15 with an arrow 682 that indicates the axial length of the tapered portion 684 of the strut 634 that tapers from the proximal end 674 of the distal stent portion 632 towards the distal end 656 of the distal stent portion 632.
- Such a tapered portion 684 extends from the crown 686 of the distal stent portion 632 at a proximal end thereof to an axial position of minimum strut cross section 688 between the proximal crown 686 and distal crown 670 of the distal stent portion 632. Distal of the position of minimum section 688 on the strut 634, the strut 634 may begin to flare and increase in section towards the distal crown 670. Thus, the point of minimum section 688 on the strut 634 represents the endpoint of the tapered portions 684 of the strut 634 which begin at each respective crown 670 and 686 of the distal stent portion 632.
- a strut taper configuration wherein the axial length of the proximal anchor member as a whole 602 or L s tent divided by the axial length of the tapered strut 634 from the crown 686 of the distal stent portion 632 at a proximal end 674 thereof to an axial position of minimum strut cross section 688 between the proximal crown 686 and distal crown 670 of the distal stent portion 632 (L ta per) is about 3.0 to about 4.5, may be particularly useful in order to maximize opening force and reduce or minimize peak strains within the structure of the proximal anchor member 602. It should also be noted that such unsymmetric taper lengths may also be used for multi- element stents or proximal anchor members 602 having stent portions 630 and 632 of equal axial length.
- FIGS. 18 and 19 illustrate an inner crown radius R of a distal crown 670 of the distal stent portion 632 of the proximal anchor member 602.
- inner crown radii dimensions R may also be used for single element stents or proximal anchor members 160 and 170, particularly in embodiments where it is desirable to maximize opening force and minimize peak strains within the proximal anchor member.
- the proximal anchor member 602 may be configured to open to a maximum diameter of about 29 mm to about 31 mm, more specifically, about 30 mm, the proximal anchor member may have an overall axial length Lstent of about 35 mm to about 37 mm, more specifically, about 36 mm, an opening force of about 0.5 Ibf to about 0.7 Ibf, more specifically, about 0.6 Ibf, and a ratio of the axial length 680 of the anchor member 602 L s tent divided by the axial length 678 of the proximal stent portion 630 L pr0 ximai of about 2.0 to about 2.2, more specifically, about 2.1 .
- Such an embodiment 600 may also have a distal stent portion 632 with a strut taper configuration wherein the length 680 of the proximal anchor member 602 as a whole L s tent divided by the length 682 of the tapered strut 639 from the crown 686 of the distal stent portion 632 at a proximal end thereof to an axial position of minimum strut cross section 688 between the proximal crown 686 and distal crown 670 of the distal stent portion 632 (Ltaper) is about 3.0 to about 3.2, more specifically, about 3.1 .
- Many other embodiments following the design parameters discussed above may also be used in order to maximize opening force and minimize peak strain within the proximal anchor member 602.
- these design parameters may also be used singly or in any combination in order to achieve the desired results in either single element stents 160 and 170 or multi-element stents 600 having a proximal stent portion 630, distal stent portion 632 or any other number of stent portions.
- the number of barbs, enlarged portions or tapers per strut, the length of each barb, enlarged portions or tapers, each of the barb angles or tapered angle described above, and the barb, enlarged portion or tapered orientation may vary from barb to barb, enlarged portion to enlarged portion, strut to strut within a single stent or between multiple stents within a single graft.
- Embodiments illustratively described herein suitably may be practiced in the absence of any element(s) not specifically disclosed herein.
- any of the terms “comprising,” “consisting essentially of,” and “consisting of may be replaced with either of the other two terms.
- the terms and expressions which have been employed are used as terms of description and not of limitation and use of such terms and expressions do not exclude any equivalents of the features shown and described or portions thereof and various modifications are possible within the scope of the invention claimed.
- a or “an” can refer to one of or a plurality of the elements it modifies (e.g., "a reagent” can mean one or more reagents) unless it is contextually clear either one of the elements or more than one of the elements is described.
Abstract
Some embodiments relate in part to endovascular prostheses and methods of deploying same. Embodiments may be directed more specifically to stent grafts and methods of making and deploying same within the body of a patient. Stent embodiments may include tapered struts for an even distribution of strain. Stent embodiments may also include portions which are enlarged in a circumferential direction which may be configured to stabilize the stent in a constrained state.
Description
DURABLE STENT GRAFT WITH TAPERED STRUTS AND STABLE DELIVERY
METHODS AND DEVICES
Related Applications
This application claims priority from U.S. Utility Patent Application No. 13/799,207, filed March 13, 2013, by D. Parsons et al., titled Durable Stent Graft with Tapered Struts and Stable Delivery Methods and Devices, which claims priority under 35 U.S.C. 1 19(e) from U.S. Provisional Patent Application No. 61/620,362, filed April 4, 2012, by D. Parsons et al., titled Durable Stent Graft with Tapered Struts and Stable Delivery Methods and Devices. This application also claims priority directly from U.S. Provisional Patent
Application No. 61/620,362, filed April 4, 2012, by D. Parsons et al., titled Durable Stent Graft with Tapered Struts and Stable Delivery Methods and Devices. Both of these applications are incorporated by reference herein in their entirety.
Field of the Invention
Some embodiments relate in part to endovascular prostheses and methods of deploying same. Embodiments may be directed more specifically to stent grafts and methods of making and deploying same within the body of a patient.
Background
An aneurysm is a medical condition indicated generally by an expansion and weakening of the wall of an artery of a patient. Aneurysms can develop at various sites within a patient's body. Thoracic aortic aneurysms (TAAs) or abdominal aortic aneurysms
(AAAs) are manifested by an expansion and weakening of the aorta which is a serious and life threatening condition for which intervention is generally indicated. Existing methods of treating aneurysms include invasive surgical procedures with graft replacement of the affected vessel or body lumen or reinforcement of the vessel with a graft. Surgical procedures to treat aortic aneurysms can have relatively high morbidity and mortality rates due to the risk factors inherent to surgical repair of this disease as well as long hospital stays and painful recoveries. This is especially true for surgical repair of TAAs, which is generally regarded as involving higher risk and more difficulty when compared to surgical repair of AAAs. An example of a surgical procedure involving repair of a AAA is described in a book titled Surgical Treatment of Aortic Aneurysms by Denton A. Cooley, M.D., published in 1986 by W. B. Saunders Company.
Due to the inherent risks and complexities of surgical repair of aortic aneurysms, endovascular repair has become a widely-used alternative therapy, most notably in treating AAAs. Early work in this field is exemplified by Lawrence, Jr. et al. in
"Percutaneous Endovascular Graft: Experimental Evaluation", Radiology (May 1987) and by Mirich et al. in "Percutaneously Placed Endovascular Grafts for Aortic Aneurysms: Feasibility Study," Radiology (March 1989). Commercially available endoprostheses for the endovascular treatment of AAAs include the AneuRx® stent graft manufactured by Medtronic, Inc. of Minneapolis, MN, the Zenith® stent graft system sold by Cook, Inc. of Bloomington, IN, the PowerLink® stent-graft system manufactured by Endologix, Inc. of Irvine, CA, and the Excluder® stent graft system manufactured by W.L. Gore &
Associates, Inc. of Newark, DE. A commercially available stent graft for the treatment of TAAs is the TAG™ system manufactured by W.L. Gore & Associates, Inc.
When deploying devices by catheter or other suitable instrument, it is advantageous to have a flexible and low profile stent graft and delivery system for passage through the various guiding catheters as well as the patient's sometimes tortuous anatomy. Many of the existing endovascular devices and methods for treatment of aneurysms, while representing significant advancement over previous devices and methods, use systems having relatively large transverse profiles, often up to 24 French. Also, such existing systems have greater than desired lateral stiffness, which can complicate the delivery
process. In addition, the sizing of stent grafts may be important to achieve a favorable clinical result. In order to properly size a stent graft, the treating facility typically must maintain a large and expensive inventory of stent grafts in order to accommodate the varied sizes of patient vessels due to varied patient sizes and vessel morphologies.
Alternatively, intervention may be delayed while awaiting custom size stent grafts to be manufactured and sent to the treating facility. As such, minimally invasive endovascular treatment of aneurysms is not available for many patients that would benefit from such a procedure and can be more difficult to carry out for those patients for whom the procedure is indicated. What have been needed are stent graft systems and methods that are adaptable to a wide range of patient anatomies and that can be safely and reliably deployed using a flexible low profile system.
Summary
Some embodiments are directed to a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state. The stent may also include a longitudinal axis, a proximal end, a distal end, and a plurality of resilient struts configured to exert an outward radial force in the constrained state. At least one of the resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state. At least some of the enlarged longitudinal sections may be in axial alignment with each other. In some cases, the enlarged longitudinal sections of the struts may be enlarged in one transverse dimension of the struts. In some cases, the enlarged longitudinal sections may be enlarged along a circumferential direction about the longitudinal axis of the stent and the struts may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent. The enlarged longitudinal section may have an enlarged transverse dimension that is about 1 .5 times to about 3 times the nominal transverse dimension of the strut in a direction of the enlargement for some embodiments.
Certain embodiments are directed to an endovascular stent graft, having a main body portion including at least one tubular portion made from at least one layer of flexible material and a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state. The stent may also include a longitudinal axis, a proximal end, a distal end, a plurality of resilient struts configured to exert an outward radial force in the constrained state. At least one of the resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state. All resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize at least one strut relative to the position of adjacent struts while the stent is in a constrained state in some embodiments. In some cases, at least some of the enlarged longitudinal sections may be in axial alignment with each other. In some instances, the enlarged longitudinal sections of the struts may be enlarged in one transverse dimension of the struts. In some instances, the enlarged longitudinal sections may be enlarged along a circumferential direction about the longitudinal axis of the stent and the struts may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent. The enlarged longitudinal section may have an enlarged transverse dimension that is about 1 .5 times to about 3 times the nominal transverse dimension of the strut in a direction of the enlargement in some embodiments.
Some embodiments are directed to a method of loading a delivery catheter system with an endovascular stent graft. The endovascular stent graft may have a main body portion including at least one tubular portion made from at least one layer of flexible material, and a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state. The self-expanding cylindrical stent may include a longitudinal axis, a proximal end, a distal end, a plurality of resilient struts configured to exert an outward radial force in the constrained state. At least one of the resilient struts may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to separate and stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state. In some cases, the self-expanding cylindrical stent of the stent graft may be constrained about a
bushing of the delivery system such that the enlarged longitudinal section of the at least one resilient strut stabilizes the position of the at least one strut relative to the position of adjacent struts in the constrained state. In some instances, the stent may be releasably secured in the constrained stabilized state.
Some embodiments of an endovascular stent graft may include a main body portion having at least one tubular portion made from at least one layer of flexible material and a self-expanding anchor member. The self-expanding anchor member may include a constrained state, a relaxed expanded state, a proximal stent portion, and a distal stent portion. In some cases, the endovascular stent graft may be configured such that a proximal end of the distal stent portion is secured to a distal end of the proximal stent portion and a distal end of the distal stent portion is secured to a proximal end of the main body portion. The endovascular stent graft may also be configured such that the axial length of the self-expanding anchor member as a whole divided by the axial length of the proximal stent portion is a ratio of about 1 .75 to about 2.0.
Some embodiments of a self-expanding anchor member include a constrained state, a relaxed expanded state, a proximal stent portion, and a distal stent portion. In some cases, the anchor member may be configured such that a proximal end of the distal stent portion is secured to a distal end of the proximal stent portion and the axial length of the self-expanding anchor member as a whole divided by the axial length of the proximal stent portion is a ratio of about 1 .75 to about 2.0.
Some embodiments of an endovascular stent graft may include a main body portion including at least one tubular portion made from at least one layer of flexible material and a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state. The self-expanding cylindrical stent may include a longitudinal axis, a proximal end, a distal end, and a plurality of resilient struts configured to exert an outward radial force in the constrained state. At least one of the resilient struts may have a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and be configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state. For such an embodiment, all of the resilient struts of the stent may include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and be configured to stabilize the at
least one strut relative to the position of adjacent struts while the stent is in a constrained state. In some cases at least some of the enlarged longitudinal sections may be in axial alignment with each other. In some instances, the enlarged longitudinal sections of the struts may be enlarged in one transverse dimension of the struts or the enlarged longitudinal sections may be enlarged along a circumferential direction about the longitudinal axis of the stent and the struts may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent. For some embodiments, the enlarged longitudinal section may have an enlarged transverse dimension that is about 1 .5 times to about 3 times the nominal transverse dimension of the strut in a direction of the enlargement. In some cases, the enlarged longitudinal section includes an undulating configuration of the nominal strut or an oval enlargement of the nominal strut. In some instances, each strut of the stent may include an enlarged longitudinal section with only one enlarged longitudinal section or an enlarged longitudinal section with a plurality of enlarged longitudinal sections. For some embodiments, the struts having enlarged longitudinal sections may be disposed in a substantially longitudinal orientation between the proximal end and distal end of the stent when the stent is in the constrained state. In some cases, the struts may be disposed in an undulating pattern. In some instances, the self- expanding cylindrical stent of the stent graft may include a superelastic alloy such as NiTi alloy.
Certain embodiments are described further in the following description, examples, claims and drawings.
Brief Description of the Drawings FIG. 1 illustrates an elevation view of an embodiment of an endoluminal prosthesis in the form of a stent graft for treatment of a patient's vessel.
FIG. 1A is an enlarged view of the encircled portion 1A of FIG. 1 including a proximal self-expanding stent member and proximal connector ring of the stent graft embodiment of FIG. 1 . FIG. 2 illustrates the stent graft embodiment of FIG. 1 in a constrained configuration disposed on a distal section of a delivery catheter within a lumen of a patient's vessel.
FIG. 3 shows an enlarged view of the encircled portion 3 of the stent graft of FIG. 2 including the proximal self-expanding stent member in a constrained configuration but without the constraining releasable belts for clarity of illustration.
FIG. 3A is a transverse cross sectional view of the proximal self-expanding stent member and delivery catheter system of FIG. 3 taken along lines 3A-3A of FIG. 3.
FIG. 4 illustrates the stent graft of FIG. 2 in a deployed unconstrained state.
FIG. 5 is a schematic view of an embodiment of a section of a stent that illustrates features of struts of the stent.
FIGS. 6A and 6AA illustrate paired transverse cross section views of a strut embodiment of FIG. 5 taken along the lines 6A-6A and 6AA-6AA of FIG. 5.
FIGS. 6B and 6BB illustrate paired transverse cross section views of another strut embodiment of FIG. 5.
FIGS. 6C and 6CC illustrate paired transverse cross section views of another strut embodiment of FIG. 5. FIGS. 6D and 6DD illustrate paired transverse cross section views of another strut embodiment of FIG. 5.
FIGS. 6E and 6EE illustrate paired transverse cross section views of another strut embodiment of FIG. 5.
FIG. 7A illustrates a strut embodiment in longitudinal section taken along lines 7A- 7A of the stent embodiment in FIG. 5.
FIG. 7B illustrates another strut embodiment in longitudinal section.
FIG. 7C illustrates another strut embodiment in longitudinal section.
FIG. 8 illustrates a portion of an embodiment of a stent including struts having a stepped taper configuration. FIG. 9 illustrates a portion of an embodiment of a stent including struts having a continuous taper, barbs, and tuck pads with tuck slots.
FIG. 10A illustrates a portion of a cylindrical stent embodiment in a constrained configuration including struts having coaxial enlarged portion embodiments.
FIG. 10B illustrates a portion of a cylindrical stent embodiment in a constrained configuration including struts having coaxial enlarged portion embodiments. FIG. 10C illustrates a portion of a cylindrical stent embodiment in a constrained configuration including struts having undulating deflected portions configured to physically separate adjacent struts in a circumferential direction.
FIG. 1 1 illustrates a portion of a cylindrical stent embodiment in a constrained configuration shown flattened including struts having coaxial enlarged portion
embodiments and undulating deflected portions.
FIG. 12 is a transverse cross section view of the stent portion of FIG. 1 1 taken along lines 12-12 of FIG. 1 1 .
FIG. 13 is an elevation view of a bifurcated stent graft embodiment.
FIG. 14 illustrates and embodiment of the stent graft of FIG. 13 partially deployed within a patient's aorta.
FIG. 15 is a perspective view of a proximal anchor member embodiment.
FIG. 16 is an elevation view of a cut away portion of the proximal anchor member embodiment of FIG. 15.
FIG. 17 is an elevation view of a cut away portion of the proximal anchor member embodiment of FIG. 16.
FIG. 18 shows a distal portion of the cut away portion of the proximal anchor member of FIG. 16.
FIG. 19 is an enlarged view of the encircled portion 19-19 in FIG. 18.
The drawings illustrate embodiments of the invention and are not limiting. For clarity and ease of illustration, the drawings are not made to scale and, in some instances, various aspects may be shown exaggerated or enlarged to facilitate an understanding of particular embodiments.
Detailed Description
Embodiments of the invention are directed generally to methods and devices for treatment of fluid flow vessels with the body of a patient. Treatment of blood vessels may be specifically indicated for some embodiments, and, more specifically, treatment of aneurysms, such as abdominal aortic aneurysms. Devices for such treatment modalities may include stents, grafts and stent graft assemblies that include at least one stent secured to a graft member.
For some embodiments, the modular graft assembly may be bifurcated for treatment of an abdominal aortic aneurysm. Such a graft assembly embodiment may include a bifurcated main body member, an ipsilateral graft extension and contralateral graft extension. The main body may have a wall portion that binds a main fluid flow lumen disposed therein. An ipsilateral leg of the main body may have an ipsilateral port and an ipsilateral fluid flow lumen that is in fluid communication with the main fluid flow lumen and the ipsilateral port. A contralateral leg of the main body may have a contralateral port and a contralateral fluid flow lumen that is in fluid communication with the main fluid flow lumen and the contralateral port. The main body, ipsilateral leg, and contralateral leg may form a bifurcated "Y" shaped configuration.
For some bifurcated embodiments, the main fluid flow lumen of the main body generally may have a larger transverse dimension and area than a transverse dimension and area of either of the fluid flow lumens of the ipsilateral leg or contralateral leg. A proximal anchor member may be disposed at a proximal end of the main body. The proximal anchor member may include a proximal self-expanding stent that is formed from an elongate element having a generally serpentine shape with four crowns or apices at either end. Each proximal apex or crown of the proximal stent may be coupled to alternating distal crowns or apices of an eight crown distal self-expanding stent. The distal self-expanding stent may be formed from an elongate element having a generally serpentine shape. A distal end of the distal stent may be mechanically coupled to a connector ring which may be embedded in graft material of the proximal end of the main body, or directly coupled to perforations in the proximal edge region of the main body.
Embodiments of the connector ring may be generally circular in shape having regular undulations about the circumference that may be substantially sinusoidal in shape. The proximal stent may include outwardly extending barbs, that may be integrally formed with the struts of the stent for some embodiments, having sharp tissue penetrating tips that are configured to penetrate into tissue of an inside surface of a lumen within which the proximal stent is deployed in an expanded state. Although the proximal anchor member may include self-expanding stents, similar stents may be used that are configured to be inelastically expanded with outward radial pressure as might be generated by the expansion of an expandable balloon from within either or both stents. The connector ring coupled to the proximal stent may also be inelastically expandable.
With regard to graft embodiments discussed herein, such as graft assembly, and components thereof, as well as graft extensions and, the term "proximal" refers to a location towards a patient's heart and the term "distal" refers to a location away from the patient's heart. With regard to delivery system catheters and components thereof discussed herein, the term "distal" refers to a location that is disposed away from an operator who is using the catheter and the term "proximal" refers to a location towards the operator.
FIGS. 1 -4 illustrate an embodiment of a stent graft assembly 150 which may include a main graft member or main body portion 152 which is not bifurcated. The main body 152 may be tubular in shape and have a wall portion 153 that bounds a main fluid flow lumen
155 disposed therein. The main body 152 may include a proximal end 154, a distal end
156 and an inflatable portion 158. The main body 152 of the stent graft assembly 150 may include at least one flexible layer of material such as PTFE, polymer meshes, composites of same or the like. A proximal anchor member or stent may be disposed at the proximal end 154 of the main body 152. The proximal anchor member embodiment shown in FIG. 1 includes a single proximal self-expanding stent member 160 disposed about a proximal end 154 of the main body 152. In some embodiments, the proximal self-expanding stent member 160 may be formed from an elongate element having a generally serpentine shape with eight crowns or apices at either end. A distal end 162 of the proximal self- expanding stent member 160 may be mechanically coupled to a proximal connector ring
164 which may be embedded in graft material generally about the proximal end 154 of the main body 152, or directly coupled to perforations in the proximal end 154 region of the main body 152.
A distal self-expanding stent member 170 may be disposed at the distal end 156 of the main body 152 and may be configured to engage an interior luminal surface 132 within the patient's vasculature 130. The distal self-expanding stent member 170 shown in FIG. 1 includes a single self-expanding stent member disposed along the distal end 156 of the main body 152 of the stent graft assembly 152. The distal self-expanding stent member 170 may be formed from a resilient elongate element having a generally serpentine shape with eight crowns or apices at either end. A proximal end 172 of the distal self-expanding stent member 170 may be mechanically coupled to a distal connector ring 174 which may be embedded in graft material generally about the distal end 156 of the main body 152, or directly coupled to perforations in the distal end 156 region of the main body 152.
Embodiments of either the proximal connector ring 164 or distal connector ring 174 may be generally circular or cylindrical in shape with regular undulations about the circumference that may be substantially sinusoidal or zig-zag in shape. Some
embodiments of either the proximal or distal self-expanding stent members 160, 170 may include outwardly extending barbs 165 (see FIG. 1A). Such barbs 165 may be integrally formed with the struts 168 of either the proximal self-expanding stent member 160 or distal self-expanding member 170. Furthermore, the barbs 165 may have sharp tissue penetrating tips that may be configured to penetrate into tissue of an inside surface of a lumen within which either the proximal self-expanding stent member 160 or distal self- expanding member 170 may be deployed into an expanded state.
Although the proximal and distal self-expanding stent members 160 and 170 of the stent graft 150 has generally been described as including self-expanding stents, the proximal and distal self-expanding stent members 160 and 170 may also include similar stents that are configured to be inelastically expanded with outward radial pressure as might be generated by the expansion of an expandable balloon from within either the proximal self-expanding stent member 160 or distal self-expanding stent member 170. Additionally, at least one of the proximal self-expanding stent member 160 and distal self-
expanding stent member 170 may be made from or include a superelastic alloy, such as NiTi alloy.
The stent graft 150 may further include an optional inflation conduit (not shown) which may serve as a fill manifold for inflation of the inflatable portion 158 of the stent graft 150. The inflation conduit may include a distal end with an inflation port in fluid
communication with an exterior portion of the main body 152 and extending from the distal end 156 into an interior volume of the inflatable portion 158 of the stent graft 150.
Some embodiments of the stent graft 150 may include radiopaque markers 1 16 that may be used to facilitate alignment of the stent graft 150. A radiopaque marker 1 16 configuration and imaging system may be used for alignment during positioning of the stent graft 150 in a patient. FIG. 1A illustrates an enlarged view of a portion of the stent graft 150 with portions of the stent graft 150 not shown for clarity of illustration. The stent graft 150 embodiment shown in FIG. 1A illustrates the proximal end 154 of the main body 152, the proximal self-expanding stent member 160, and a plurality of radiopaque markers 1 16 disposed about a circumference of a distal end 162 of the proximal self-expanding stent member 160. Furthermore, the plurality of radiopaque markers 1 16 may include helically wound wire members which may be disposed about connector members 216, as shown in FIG. 1A. In general, the connector members 216 may be configured to mechanically couple the proximal self-expanding stent member 160 to the proximal connector ring 164 disposed within the proximal end 154 of the main body 152 of the stent graft 150. Some embodiments of the stent graft 150 may additionally or alternatively include a plurality of radiopaque markers 1 16 circumferentially disposed about a tubular portion of the endovascular stent graft 150. For example, the radiopaque markers 1 16 may lie in a plane that is substantially orthogonal or parallel to a longitudinal axis 186 of the tubular main body 152 of the stent graft 150. Additionally, the distal self-expanding member 170 may include one or more radiopaque markers 1 16.
Furthermore, any number of features may be incorporated into the stent graft 150 which may enable detection of all or part of the stent graft 150 under fluoroscopy or other suitable forms of imaging. For example, in general, the radiopaque markers 1 16, or other detection features, may be used to facilitate orthogonal orientation of the imaging axis or view. Once a substantially orthogonal view angle is achieved, an accurate axial position of
the partially deployed stent graft 150 relative to the patient's vasculature may be achieved, avoiding parallax, ensuring precise placement of the stent graft 150 relative to significant branch vessels or other anatomic reference points. Parallax in some circumstances may cause error in axial placement of the stent graft 150 relative to the intended target site. Accurate positioning may be achieved with axial movement and adjustment of the stent graft 150 by manual manipulation of a proximal portion of the delivery catheter 100.
As shown in FIG. 2, the stent graft 150 may be positioned such that the proximal end 154 of the main body 152 of the stent graft 150 is aligned distal of the ostium of the renal arteries. Once the delivery catheter 100 system has been positioned at the treatment site an outer sheath 102 of the delivery catheter 100 may be proximally retracted. Though the outer sheath 102 may have been proximally retracted, thus exposing the stent graft 150, the stent graft 150 may remain in a partially constrained state with the proximal self-expanding stent member 160 restrained by a pair of proximal releasable belts 104 and 106 releasably disposed about the proximal self-expanding stent member 160. The distal self-expanding stent member 170 may be constrained by another set of distal releasable belts 108 and 1 10 which may be releasably disposed about the distal self-expanding stent member 170.
Each of the releasable belts 104, 106, 108 and 1 10 may be configured to be independently released by retraction of one or more respective release wires 120.
Release wires 120 may be disposed within an end loop or loops of the releasable belts 104, 106, 108 and 1 10 with the one or more release wires 120 holding the loops in fixed relation to each other. For this arrangement, retraction of one or more release wires 120 from the end loops releases the loops to allow them to move relative to each other which in turn removes the constraint of the belt members 104, 106, 108 and 1 10 about the respective proximal and distal self-expanding stent members 160 and 170. After at least partial deployment of the proximal stent member 160, finalizing the axial position of the stent graft 150 relative to the anatomy of the patient's vasculature 130 and treatment site may then be made. The axial positioning may be accomplished in some embodiments with the use of one or more radiopaque marker devices 1 16, as described above. Once the partially radially constrained stent graft 150 is axially aligned, the proximal self- expanding stent member 160 may then be fully deployed in order to engage and become
secured to the luminal wall or interior luminal surface 132 of the patient's vasculature 130, as shown by way of example in FIG. 4. Once the proximal anchor member 160 is fully deployed, the inflatable portion 158 of the stent graft 150, including the network of inflatable channels, may be inflated with a fill material. For some embodiments, the network of inflatable channels may be filled from a desired site within the inflatable portion 158. More specifically, the inflatable portion 158 may be inflated with fill material from a proximal end 154 of the main body 152.
The proximal self-expanding stent member 160 may be disposed at and secured to a proximal end 154 of the main body 152. For example, the proximal self-expanding stent member 160 may have a first self-expanding stent member 200 secured to a second self- expanding stent member 202. Both the first and second self-expanding stent members 200 and 202 may have a somewhat tubular shape and may be secured together by one or more struts 168. Some embodiments of the struts 168 may have one or more cross sectional areas 169 that vary along the length of the strut 168. Such a configuration may be useful in avoiding points of concentrated stress in, for example, the proximal self- expanding stent member 160 or struts 168. The proximal self-expanding stent member 160 may include at least one barb 165 and/or enlarged portion 180 on each strut 168, every other strut 168 or combinations thereof. One proximal self-expanding stent member 160 embodiment may have a repeated strut 168 pattern having a more proximally placed barb 165 on one strut 168, an adjacent neighbor strut 168 with a more distally placed barb 165, and a following adjacent strut 168 with a centrally placed enlarged portion 180, as shown in FIG. 3. Another enlarged portion embodiment 180 may have enlarged portions 180 on every strut 168, as shown in FIG. 5. Additionally, a proximal self-expanding stent member 160 embodiment may have a first self-expanding stent member 200 secured to a second self-expanding stent member 202 where the first self-expanding stent member 200 (or more proximal stent) may have alternating more distally placed barbs 165 along the struts 168 with more proximally placed barbs 165 along the struts 168, as shown in FIG 9. Another proximal self-expanding stent member 160 embodiment may include one or more struts 168 having enlarged portions 180 generally centrally placed along the length of the struts 168, followed by alternating more distally placed barbs 165 with more proximally placed barbs 165 along the struts 168, as shown in FIG. 1 1 .
For some embodiments, the first self-expanding member 200 of the proximal self- expanding stent member 160 may further include a plurality of barbs 165 having sharp tissue engaging tips that are configured to extend radially outward and distally in a deployed expanded state. This configuration may be useful in order to engage tissue of an inner luminal surface 132 of a patient's vasculature 130 and mechanically anchor the stent graft 150 to the vasculature 130, in addition to the anchoring function provided by the outward radial force of the proximal self-expanding stent member 160 against the inner luminal surface 132 of the patient's vasculature 130 when the stent graft 150 is in a deployed state. The second self-expanding member 202 of the proximal self-expanding stent member 160 may be secured to the proximal end 154 of the main body 152 of the stent graft 150 with one or more struts 168 and/or connector members 216 mechanically coupled to a proximal connector ring 164.
When loaded on the delivery catheter 100, the first and second self-expanding members 200, 202 of the proximal self-expanding stent member 160 may be radially constrained by releasable belts 104 and 106 which may be releasably held in a
constraining configuration by a release member, such as a release wire 120. FIG. 2 shows an embodiment of the proximal self-expanding stent member 160 where the first self-expanding member 200 is being radially constrained by a first releasable belt 104 and the second self-expanding member 202 is being radially constrained by a second releasable belt 106. The first releasable belt 104 may be released by a first release wire 120 and the second releasable belt 106 may be deployed by the second release wire 120. The first and second self-expanding members 200 and 202 of the proximal anchor member may only be released after the outer sheath 102 has been retracted, as shown in FIG. 2, in order to expose the stent graft 150.
The strut 168 structure of the proximal self-expanding stent member 160 and/or distal self-expanding stent member 170 may be formed from a cylindrical metal tube structure which is carved or bore by laser or other cutting device. Thereafter, the cut tube may be heat set into two separate forms or states such as an expanded state and non- expanded/contracted state. Fig. 3 shows an example of a non-expanded state. The proximal self-expanding stent member 160 and/or distal self-expanding stent member 170 may include one or more barbs 165. A barb 165 may be any outwardly directed
protuberance, typically terminating in a sharp point that is capable of at least partially penetrating a body passageway in which the stent graft 150 is deployed (typically the initial and medial layers of a blood vessel such as the abdominal aorta). The number of barbs 165, the length of each barb 165, each barb 165 angle, and the barb 165 orientation may vary from barb 165 to barb 165 within a single anchor member or between multiple anchor members (i.e., proximal self-expanding stent member 160 and/or distal self-expanding stent member 170) within a single stent graft 150. Although the various barbs 165 (and tuck pads 166, as will be discussed below) may be attached to or fixed on the struts 168, it may be preferred that they are integrally formed as part of the struts 168. When either the proximal self-expanding stent member 160 and/or distal self-expanding stent member 170 is deployed in the abdominal aorta, for example, typically in a location proximal to the aneurysm and any diseased tissue, barbs 165 may be designed to work in conjunction with the distally-oriented blood flow field. In this location, the barbs 165 may penetrate the tissue and prevent axial migration of the stent graft 150. As such, the barbs 165 may be oriented proximally with respect to the main body 152 section. However, the number, dimensions, configuration and orientation of barbs 165 may vary significantly, yet be within the scope of the present invention.
The staged deployment of the proximal self-expanding stent member 160 may also facilitate self-alignment of the stent graft 150. For instance, upon deployment of the proximal self-expanding stent member 160, the graft may be free to expand and enable distal fluid flow to flow through the stent graft 150 and create a "windsock" effect. That is, the distal fluid flow may apply a slight distal force generally upon the main body 152. This distal force may help to align at least the main body 152 and proximal self-expanding stent member 160 within the patient's vasculature 130, which may be particularly advantageous during deployment of the stent graft 150 within the angulated vasculature 130, for example.
In some embodiments of the stent graft 150, one or more struts 168 may include tuck pads 166. Additionally, the one or more struts 168 may have tuck pads 166
positioned such that the tuck pads 166 are generally aligned with a barb 165 extending from an adjacent strut 168, as shown in FIG. 1 1 . As such, during preparation of the stent graft 150 into its reduced diameter delivery configuration (or non-expanded/contracted
state), each barb 165 may be placed, for example, behind an adjacent strut 168 and/or tuck pad 166 in order to prevent the barbs 165 from radially extending and contacting the inside of a outer sheath 102 or delivery catheter 100 during delivery of the stent graft 150, as well as to prevent undesired contact of the barbs 165 with the inside luminal surface 132 of a patient's vasculature 130.
As illustrated in FIG. 3A, the struts 168 may have various circumferential
dimensions and/or cross sectional areas 169. Enlarged portions 180 of a strut 168 may also include varying radial lengths generally along a longitudinal axis of the strut 168. Enlarged portions 180 may be aligned with barbs 165 and/or located at a generally unstable portion of a strut 168. In some stent graft 150 embodiments, when the stent (i.e., proximal self-expanding member 169) is in a compressed state, enlarged portions 180 may abut each other and may have one or more flat sides which prevent slippage by each other. Adjacent enlarged portions 180 that abut each other and circumferentially interfere with each other may be axially coextensive. In a radially compressed state, for example, the one or more enlarged portions 180 may be compressed to a radial diameter that is no greater than the remaining part of the stent 168.
In some embodiments, one or more struts 168 may have a tapered section 300. For example, one or more struts 168 may have a tapered section 300 in order to evenly distribute strain induced at least when the stent is in a constrained state. The strut 168 may taper from a first end portion of the strut 168 to a smaller transverse cross section towards a middle portion of the strut 168. As shown in FIG. 7B, a strut 168 embodiment may taper from a proximal end 400 portion towards a respective middle portion 402 and taper to a reduced transverse cross section from a distal end portion 404 towards a respective middle portion 402. The strut 168 may taper over half or approximately half of the length of the strut 168. In addition, the strut 168 may taper generally over the entire length of the strut 168, such as from the apex or crown of the anchor member or stent to the middle of the strut or to the first discontinuity feature (i.e., an enlarged portion 180, barb 165, tuck pad 166 and the like). The struts 168 may taper in at least one transverse dimension of the strut 168. Additionally, the struts 168 may taper along a circumferential direction about the longitudinal axis of the struts 168 may have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent, such as the
proximal self-expanding stent member 160. The struts 168 may taper along a radial direction relative to the longitudinal axis of the anchor member or stent and the struts 168 may have a substantially constant thickness in a circumferential direction about the longitudinal axis of the anchor member or stent. The taper angle of a tapered section 300 of a strut 168 may be about 1 degree to about 3 degrees inclusive, about 1 .5 degree to about 2.5 degrees inclusive, or about 1 .75 degree to about 2.25 degrees inclusive. The strut 168 embodiments may taper continuously from each end portion to the respective middle portions, such as is shown by way of example in FIG. 9. The struts may include a stepped taper embodiment 302 which tapers in discrete steps rather than a smooth continuous taper from the distal and proximal end portions 404 and 400 of the respective middle portions 402 in either radial direction about the longitudinal axis. Such and embodiment is shown by way of example in FIGS. 7C. The struts may also taper in a circumferential direction about the longitudinal axis, as shown in FIG. 8. The tapered sections 300 of the struts 168 may extend from proximal and distal end portions 400 and 404 of the struts 168 to respective strut structures (i.e., enlarged portions 180) disposed in, for example, the middle portion 402 of the respective strut 168, as shown by way of example in FIG. 8.
FIG. 5 illustrates a portion of a stent 500 embodiment which may function as a proximal self-expanding stent member 160. The stent 500 may include a plurality of struts 168 extending axially between the proximal end 402 and distal end 404 thereof. The stent 500 may be oriented in either direction, depending on the application. Both the proximal and distal ends 400 and 404 may have a plurality of crowns adjoining adjacent struts 168. The distal end 404 may have a plurality of connecting members 216 configured to connect the stent 500 to the main body 152 or other structure. The stent 500 embodiment may have various features (i.e., tuck pads 166, etc.) and structures and is not limited to the strut 168 features and structures illustrated herein. For example, the stent 500 may have a body defined by a lattice structure or a helical structure.
Optional taper (or tapers) may be incorporated into one or more of the struts 168 of the various stent 500 embodiments, as well as the various connector members 216. In general, incorporating one or more tapers into one or more of the struts 168 in one or more stents 500 may provide greater space in the tapered section 300 to accommodate
alternative features such as barbs 165 and tuck pads 166. In addition, it may allow for a smaller deployment profile when the components are in a radially collapsed delivery configuration. When configuring the various stents 500 into this reduced diameter delivery profile (non-expanded/constrained state), the stents 500 may experience a large degree of bending strain that may be poorly distributed. Tapering certain stent 500 struts 168 in particular locations may help to distribute this strain more evenly throughout the stent 500 and/or strut 168 which may assist in preventing strain damage to the stent 500.
FIG. 5 illustrates a section of a stent 500, such as a proximal self-expanding stent member 160, in which the struts 168 taper from a proximal end 400 width to a minimum width about the middle portion 402 of the strut 168. An example transverse cross-section of the strut 168 taken along line 6AA-6AA, which is generally located in the proximal end 400 region of a strut 168, of FIG. 5 is shown in FIG. 6AA (which may or may not equal a width of strut 168 in the apex region or distal end 404). Another example transverse cross- section of the strut 168 taken along line 6A-6A, which is generally located in the minimum width, or near the middle portion 402 region of the strut 168, of FIG. 5 is shown in FIG. 6A. The optional taper, which may be expressed as the taper ratio, is the ratio of the maximum width (as shown, for example, in FIG. 6AA) to the minimum width (as shown in FIG. 6A) of a cross sectional area 169. The taper ratio may vary widely depending on, for example, the particular region of the strut 168 or connector member 216, the material used, and other factors. Taper ratios ranging from about 1 to about 10 or greater may be within the scope of the present invention. It may also be within the scope of the present invention for the struts 168 to have no taper (as shown by way of example in FIG. 7A).
FIGS. 6A-6EE, illustrate a variety of examples of varying transverse cross-sectional views taken at two different locations along a single strut 168. These figures illustrate examples of the different shapes and sizes a single cross sectional area 169 of a strut 168 may have. For instance, as described above, FIGS. 6A and 6AA show a pair of transverse cross section views of the strut 168 embodiment of FIG. 5 taken along the lines 6A-6A and 6AA-6AA which illustrates the rectangular shape of the cross sectional area 169 and the change in size of the cross sectional area 169 at two different locations along the strut 168. FIGS. 6B and 6BB illustrate another example embodiment of paired transverse cross section views of another strut 168 embodiment which illustrates the
trapezoidal shape of the cross sectional area 169 and the change in size of the cross sectional area 169 at two different locations along the strut 168. FIGS. 6C and 6CC illustrate another example embodiment of paired transverse cross section views of another strut 168 embodiment which illustrates the inverse trapezoidal shape of the cross sectional area 169 and the change in size of the cross sectional area 169 at two different locations along the strut 168. FIGS. 6D and 6DD illustrate another example embodiment of paired transverse cross section views of another strut 168 embodiment which illustrates the elliptical shape of the cross sectional area 169 and the change in size of the cross sectional area 169 at two different locations along the strut 168. FIGS. 6E and 6EE illustrate another example embodiment of paired transverse cross section views of another strut 168 embodiment which illustrates the circular shape of the cross sectional area 169 and the change in size of the cross sectional area 169 at two different locations along the strut 168. The transverse cross sectional area 169 of one or more locations along a strut 168 are not limited to the sizes and shapes disclosed herein, and may be any number of sizes and shapes that may be incorporated in a strut 168 and/or stent 500 configuration.
A proximal self-expanding stent member 160 may have, for example, one or more struts 168 having a proximal end 400 portion and/or distal end 404 portion which may be made from NiTi and an effective maximum strut 168 width ranging from about 0.016 to about 0.032 inch; particularly from about 0.022 inch and about 0.028 inch, and a minimum strut 168 width between about 0.010 inch and about 0.026 inch; particularly from about 0.012 inch and about 0.022 inch. Additional tapered strut 168 embodiments are described and shown herein in the figures which may be used in other anchor members (such as the proximal and distal self-expanding stent members 160 and 170), stent 500 embodiments or connector members 216 described herein, and may be incorporated in any number of components and made from any number of materials. For example, tapering of the struts 168 in any configuration described herein may improve the strain distribution at least between the proximal end 400 portions and distal end 404 portions of the struts 168.
Various types of taper features or configurations may be implemented in any number of struts 168 for achieving a variety of strut 168 characteristics. For example, one or more struts 168 may include a taper having an offset radii and/or combinations of elliptical and/or circular apex radii in order to further cause the desired behavior during
assembly into a reduced-diameter delivery configuration as well as effective delivery and performance in vivo. For example, the proximal end 400 portion, or apex, width may be the minimum width of the strut 168 which untapers towards the middle portion 402 of the strut 168, which may have the maximum width of the strut 168. The tapering from the proximal end 400 portion to the middle portion 402 of the strut 168 may be continuous, stepped in discrete steps 410 with straight untapered portions between each discrete step (as shown by way of example in FIG. 7C and 8) or a combination thereof. Furthermore, untapering of the strut 168 may be in the radial and/or circumferential direction along the longitudinal length of the strut 168.
The strut 168 may include an enlarged portion 180 located in about the middle portion 402 of one or more of the struts 168, as shown by way of example in FIG. 5. By way of further example, one or more enlarged portions 180 may be located along every other strut 168 of the stent 500. The one or more enlarged portion 180 may be located along a strut 168 in various locations, such as near or at the proximal end 400 portion, middle portion 402, and/or distal end 404 portion of the strut 168. Additionally, the one or more enlarged portions 180 may be located at offset locations relative to enlarged portions 180 (or other features) along neighboring struts 168.
In some cases, the one or more enlarged longitudinal sections or enlarged portions 180 may have an enlarged transverse dimension that is about 1 .5 times to about 3 times the nominal transverse dimension of the strut 168 in a direction of the enlargement.
Additionally, the enlarged portions 180 may have an undulating configuration of the nominal strut 168. Furthermore, the enlarged portion 180 may have an oval enlargement of the nominal strut. Each strut 168 of the stent 500 having an enlarged portion 168 along the length of the strut 168 may have only one enlarged portion 180. Alternatively, each strut 168 of the stent 500 having an enlarged portion 180 along the length of the strut 168 may have more than one enlarged portion 180. The enlarged portions 180 are not limited to what are described and shown herein, and may be sized, featured, shaped, and proportioned in any number of ways that may assist in assembly or use of the stent 500. Additionally, any number of materials may be used and may vary between struts 168, anchor members (such as the proximal and distal self-expanding strut members 160 and 170), and/or stents 500.
FIG. 10A shows an example portion of a cylindrical stent embodiment 500 in a constrained configuration including struts 168 having generally coaxially aligned enlarged portion 180 embodiments having circular or oval features. FIG. 10B shows an example portion of a cylindrical stent embodiment 500 in a constrained configuration having struts 168 with generally coaxially aligned enlarged portion 180 embodiments having square or rectangular features. FIG. 10C shows a portion of a cylindrical stent embodiment 500 in a constrained configuration including struts 168 having undulating deflected portions 182 which may be configured to physically separate adjacent struts 168 in a circumferential direction. One or more struts 168 of a stent embodiment 500 may have a stepped taper 302 feature generally along the length of the strut 168. For example, one or more struts 168 may have a stepped taper 302 from the proximal end 400 to the respective middle portion 402 of the strut 168 and/or a stepped taper 302 from the distal end 404 to the middle portion 402 of the strut 168, wherein the stepped taper 302 may be in either radial direction about the longitudinal axis of the strut 168, as shown by way of example in FIG. 7C, or the circumferential direction about the longitudinal axis, as shown by way of example in FIG. 8. The taper characteristics of a strut 168 may be continuous, stepped or any other shape configured to evenly distribute strain induced by the constraint of the constrained non- expanded stent 500.
FIG. 7A illustrates an example longitudinal section view taken along line 7A-7A of the strut 168 in FIG. 5 which shows a generally rectangular cross sectional area 169 having no radial tapering about the longitudinal axis. FIG. 7B illustrates another example of a longitudinal section view of a strut 168 which shows a generally tapered cross sectional area 169 due to radial tapering about the longitudinal axis of the strut 168. In FIG. 7B, the strut 168 tapers continuously from each end portion (the proximal and distal ends 400 and 404) to the middle portion 402 such that the middle portion 402 generally has the minimum strut 168 width in the radial direction. FIG. 7C shows another example strut 168
embodiment in longitudinal section including a radial stepped tapering 302 about the longitudinal axis of the strut 168. In FIG. 7C, the strut 168 generally tapers in steps continuously from each end portion (the proximal and distal ends 400 and 404) to the
middle portion 402 such that the middle portion 402 generally has the minimum strut 168 width in the radial direction.
FIG. 8 shows a portion of an embodiment of a stent 500 including struts 168 having a circumferential stepped taper 302 configuration about the longitudinal axis of the strut 168. The middle portion 402 of each strut 168 may also include an enlarged portion 180 extending, for example, in a circumferential direction. Portions of the stepped taper 302 of a strut 168 that may be directly adjacent an enlarged portion 180 may have the minimum strut 168 width in the circumferential direction. However, any number of combinations of tapering in any direction may be used.
FIG. 9 shows a stent embodiment 500 where the proximal self-expanding stent member 160 has a first self-expanding member 200 secured to a second self-expanding member 202 where the first self-expanding member 200 has alternating more proximally placed barbs 165 along the struts 168 with more distally placed barbs 165 along the struts 168. In addition, the stent embodiment 500 may have a continuous taper in the second self-expanding member 202, which is the portion of the proximal self-expanding stent member 160 adjacent the main body 152. Each strut 168 on the first self-expanding member 168 may have a barb 165 in a different location relative to a neighboring strut 168. The barbs 165 may be formed integrally with the struts 168, but may otherwise be manufactured, for example, as a separate component attached to the struts 168. In general, the struts 168 and the barbs 165 of the stent embodiments 500 and anchor members may be self-expanding, that is, upon release of a constraining force, the struts 168 may move radially apart and the barbs 165 may extend radially outward. Other configurations, such as balloon expansion, are also contemplated within the present invention.
In addition, stent embodiments 500 may include struts 168 including tuck pads 166, which may be positioned along a strut 168 such that the tuck pads 166 are axially aligned with a barb 165 positioned on a neighboring strut 168. Similar to the barbs 165 and enlarged portions 180, the number, dimensions, configurations and orientations of the tuck pads 166 may vary between struts 168, stent embodiments 500 and anchor members (such as the proximal and distal self-expanding stent members 160 and 170 described herein).
During preparation of a stent graft embodiment 150 (and therefore one or more proximal self-expanding stent members 160) into a reduced diameter delivery
configuration, one or more barbs 165 may be placed behind a corresponding strut 168 and/or tuck pad 166, if present, in order to prevent the barbs 165 from contacting the inside of a outer sheath 102 or delivery catheter 100 during delivery of the stent graft 150 and from undesired contact with the interior luminal surface 132 of the patient's
vasculature 130. As described in copending U.S. patent application Ser. No. 09/917,371 to Chobotov et al., now U.S. Pat. No. 6,761 ,733, and which is incorporated by reference herein in its entirety, a release belt may be disposed in one or more grooves (not shown) disposed on one or more struts 168 which may assist in retaining the proximal self- expanding stent member 160 in the reduced diameter delivery configuration.
For example, upon deployment of stent graft 150, and more particularly the proximal self-expanding stent member 160, (typically accomplished, at least in part, by release of one or more belts, such as the proximal releasable belts 104 and 106), the radial expansion of the proximal self-expanding stent member 160 results in a displacement of struts 168 so that the distance between them increases. Eventually, the displacement between the struts 168 become large enough to enable the barbs 165 to be released from behind the adjacent strut 168 and/or tuck pad 166 and engage the interior luminal surface 132 of the patient's vasculature 130. In general, the barbs 165 may release into a position suitable for engaging the interior luminal surface 132 of a patient's vasculature with a time constant that is generally an order of magnitude lower than the time constant associated with the radial expansion of the stent 500 embodiment or anchor member (such as the proximal self-expanding stent member 160). In other words, during the stent 500 or anchor member deployment process, the one or more barbs 165 may complete their deployment before the stent 500 or anchor member is fully expanded so that the barbs 165 may engage the interior luminal surface 132 of the vasculature 130 with maximum effectiveness.
Referring again to FIG. 9, the proximal self-expanding stent member 160 may include struts 168, any one of which may further comprise one or more barbs 165. In addition, optional tuck pads 166 may be positioned along a strut 168 such that the tuck pad 166 is coaxially aligned with a barb 165 on a neighboring strut 168 in order to shield
the neighboring barb 165 at least when the stent graft 150 is in its reduced diameter delivery configuration. Struts 168 and/or tuck pads 166 may also include a tuck slot 167 which may assist in retaining a barb 165 while the stent graft 150 (and consequently the proximal self-expanding stent member 160) is in its reduced diameter delivery
configuration. Upon deployment of a stent graft 150 embodiment, the one or more barbs 165 may be released from respective tuck slots 167 and thereafter placed in an
operational or deployed configuration for engaging a patient's vasculature 130.
FIG. 1 1 shows a portion of a cylindrical stent embodiment 500 in a generally constrained and flattened configuration having struts 168 with a coaxial enlarged portion 180 embodiments and undulating deflected portions 182. The undulating deflected portions 182 may have barbs 165 positioned at offset proximal and distal locations along neighboring struts 168 which may aid in efficiently compacting the struts 168 and barbs 165 in a constrained configuration for delivery into a patient's body. By alternating axial location of the barbs 165 and/or enlarged portions 180 along neighboring struts 168, the stent 500 may be optimally compressed. The undulating deflected portions 182 of a strut 168 may enable multiple lateral contact points within the stent 500. Such multiple contact points may aid in restraining or compacting the stent 500 in a constrained/non-expanded state. In some embodiments, one or more struts 168 may have enlarged longitudinal sections or enlarged portions 180 that may be disposed in a substantially longitudinal orientation between the proximal end and distal end of the stent 500 when the stent 500 is in the constrained state. Additionally, the one or more struts 168 may be disposed in an undulating pattern. FIG. 12 shows a transverse cross section view of the stent 500 portion of FIG. 1 1 taken along lines 12-12 of FIG. 1 1 . FIG. 12 illustrates an example of the varying circumferential cross sectional areas 169 of the struts 168 taken along a
transverse cross section of the strut 500.
As discussed above, some embodiments of a modular endovascular stent graft assembly may include a bifurcated graft member 600 with a proximal stent or anchor member 602 secured thereto. In some cases, the main body member 604 may be formed from a supple graft material, such as ePTFE, having a main fluid flow lumen 606 therein. FIG. 13 illustrates such an embodiment. Referring to this figure, the main graft portion 604
may include an ipsilateral leg 608 with an ipsilateral fluid flow lumen 610 in communication with the main fluid flow lumen 606, a contralateral leg 612 with a contralateral fluid flow lumen 614 in communication with the main fluid flow lumen 606 and a network of inflatable channels 616 disposed on the main graft member 604. For some embodiments, the main graft or main body member 604 may have an axial length of about 5 cm to about 10 cm, more specifically, about 6 cm to about 8 cm in order to span an aneurysm 622 of a patient's aorta 618 without engaging the patient's iliac arteries 620 directly with the legs 608 and 612 of the main graft member 604 (see FIG. 14).
The inflatable channels of the network of inflatable channels 616 may be disposed on any portion of the main graft or main body member 604 including the ipsilateral and contralateral legs 608 and 612. The network of inflatable channels 616 may be configured to accept a hardenable fill material to provide structural rigidity to the main body 604 member when the network of inflatable channels 616 are in an inflated state and the inflation material has been cured or hardened. Radiopaque inflation material may be used to facilitate monitoring of the fill process and subsequent engagement of graft extensions. The network of inflatable channels 616 may also include at least one inflatable cuff 624 disposed on a proximal portion of the main body member which may be configured to seal against an inside surface of a patient's vessel, such as the aorta.
The proximal anchor member 626, which may have a substantially tubular or cylindrical configuration, may be disposed at a proximal end 628 of the main body member 604 and secured to the main body member 604 in any suitable manner including stitching, adhesive bonding, welding, and the like. The proximal anchor member 626 may also be secured to the main body 604 with a resilient connector ring (not shown) which may be embedded in a proximal end or portion 628 the main body 604. The proximal anchor member 626 may have a self-expanding proximal stent portion 630 secured to a self- expanding distal stent portion 632. Each of these stent portions 630 and 632 may include an undulating elongate stent element that may be disposed in a somewhat serpentine or sinusoidal configuration, as shown above with regard to stent members 160 and 170. Each of the stent portions 630 and 632 of the proximal anchor member 626 of the stent graft 600 in FIG. 13 may share any or all of the features, dimensions or materials of stent
members 160 and 170 discussed above. For example, the proximal and distal stent portions 630 and 632 of the proximal anchor member 626 may include tapered struts 634 that extend between crown portions 636 of each respective stent portion 630 or 632. Such tapered struts 634 may have any or all of the features, dimensions, and materials of the struts discussed above and include a tapered strut configuration that allows for the strain imposed on the strut structure to be evenly distributed through the structure of the stent portion or portions 630 and 632.
In some cases, the proximal stent portion 630 may be secured to the distal stent portion 632 with one or more struts or strut segments 638 disposed between the respective proximal and distal stent sections 630 and 632. Some embodiments of such interconnecting struts 638 may have a cross sectional area that is substantially the same as or greater than a cross sectional area of proximal stent portions 630 or distal stent portions 632 adjacent the strut 638. Such configurations may be useful in avoiding points of concentrated stress in the proximal anchor member 602 or struts 638 which couple components thereof. For some embodiments, the proximal stent portion 630 of the proximal anchor member 602 may further include a plurality of barbs 640 having sharp tissue engaging tips 642 that are configured to extend in a radial outward direction in a deployed expanded state (see FIG. 15). For some embodiments, each stent portion 630 and 632 of the proximal anchor member 602 may include about 5 crowns 636 to about 8 crowns 636 at either end of the respective section 630 or 632 and may be made from a superelastic alloy such as superelastic NiTi alloy.
At least one tubular ipsilateral graft extension 644 having a fluid flow lumen 646 disposed therein may be deployed with the fluid flow lumen 646 of the graft extension 644 sealed to and in fluid communication with the fluid flow lumen 610 of the ipsilateral leg 608 of the main body member 604. In addition, at least one tubular contralateral graft extension 648 having a fluid flow lumen 650 disposed therein may be deployed with the fluid flow lumen 650 of the graft extension 648 sealed to and in fluid communication with the fluid flow lumen 614 of the contralateral leg 612 of the main body member 604. For some embodiments, the graft extensions 644 and 648 may include an interposed self- expanding stent 652 disposed between at least one outer layer and at least one inner layer
of supple layers of graft material. The interposed stent disposed between the outer layer and inner layer of graft material may be formed from an elongate resilient element helically wound with a plurality of longitudinally spaced turns into an open tubular configuration. For some embodiments, the interposed stent 652 may include a superelastic alloy such as superelastic NiTi alloy. In addition, the graft material of each graft extension 644 and 648 may further include at least one axial zone of low permeability for some embodiments.
For some embodiments, an outside surface of the graft extension 648 may be sealed to an inside surface of the contralateral leg 612 of the main body 604 when the graft extension 648 is in a deployed state. For some embodiments, the axial length of the ipsilateral and contralateral legs 608 and 612 may be sufficient to provide adequate surface area contact with outer surfaces of graft extensions 644 and 648 to provide sufficient friction to hold the graft extensions 644 and 648 in place. For some
embodiments, the ipsilateral and contralateral legs 608 and 612 may have an axial length of at least about 2 cm. For some embodiments, the ipsilateral and contralateral legs 608 and 612 may have an axial length of about 2 cm to about 6 cm, more specifically, about 3 cm to about 5 cm.
For the bifurcated stent graft embodiment 600 discussed above or any other suitable stent graft embodiment discussed herein that includes a proximal self-expanding anchor member 602, it may be desirable in some cases to constrain each of the proximal and distal stent portions 630 and 632 separately so that each of the proximal and distal stent portions 630 and 632 of the proximal anchor member 602 can be deployed from a radially constrained state independent of each other. FIG. 14 shows the stent graft 600 having an 8 crown distal stent portion 632 with marker elements 654 disposed at a distal end 656 of the distal stent portion 632. Other than this variation in the proximal anchor configuration, the stent graft of FIG. 14 may have the same features, dimensions and materials as those of the stent graft 600 shown in FIG. 13.
The stent graft 600 of FIG. 14 is shown in a partially deployed state within an abdominal aorta 618 of a patient with the proximal end 628 of the main body 604 disposed just below and in a non-interfering relationship with the renal arteries 658 which extend from and are in communication with the patient's aorta. The main body 604 of the stent
graft 600 also extends substantially across the aneurysm 622 of the aorta 618, however, this relationship may vary depending on the size of the graft 600 used and the morphology of the aneurysm 632. The proximal stent portion 630 of the proximal anchor member 602 is still constrained by a releasable member or belt 660 such that it has an outer dimension or profile suitable for delivery within a catheter assembly within the patient's vasculature. The distal stent portion 632, however, has been released from a constrained state and has expanded radially such that the distal end 656 of the distal stent portion 632 has expanded outwardly in approximation to the inner surface 662 of the patient's aorta 618.
In such cases, a proximal anchor member 602 configured to allow the distal end 656 of the distal stent portion 632 to so expand may be desirable. For example, the markers 654 disposed at the distal end 656 of the distal stent portion 632 are substantially open and are close to or in contact with the inner wall 662 of the patient's aorta 68 providing good visualization of the position of the partially deployed stent graft 600 under fluoroscopy. This configuration may allow the physician deploying the stent graft 600 to visualize the position of the stent graft 600 and accurately predict what the final position of the stent graft 600 will be after complete deployment. However, such a configuration may also allow the physician to adjust the position of the stent graft 600 prior to full deployment of the proximal anchor member 602. In other words, the stent graft 600 and markers 654 at the distal end 656 of the distal stent portion 632 are sufficiently expanded so that the physician can easily see how the stent graft 600 will be positioned when fully deployed before the physician has deployed the proximal stent portion 630 in which case the barbs 640 or other tissue engaging members of the proximal stent portion 630 engage the tissue of the inner wall 662 of the patient's aorta 618.
We have found that in some instances, in order to configure an anchor member 602 such that the distal end 656 of the distal stent portion 632 opens or radially expands sufficiently upon release from a constrained state, that certain design parameters or criteria may be desirable. In particular, such a stent portion 632 may benefit from a configuration that produces a good distal opening force or maximum opening force in an outward radial direction. In order to produce a generous opening force in an outward radial direction, the section of the struts 634 and crowns 636 of the proximal and distal stent portions 630 and 632 may be increased, however, it may also be desirable to adjust
the tapering profile of the struts 634 in order to maintain a substantially even distribution of strain throughout the structure of the stent portions 630 and 632. For some embodiments, a useful outward opening force may include about 0.5 to about 0.75 Ibf of force for a stent embodiment that is about 14 mm to about 16 mm in outer diameter in a relaxed
unconstrained state.
In cases such as the stent graft embodiment 600 of FIG. 13 wherein the proximal anchor member 602 includes both a proximal stent portion 630 and a distal stent portion 632, it may be useful to vary the axial lengths of the respective proximal and distal portions 630 and 632 of the anchor member 602. Such an unsymmetric arrangement may be beneficial in cases such as the partial deployment sequence step shown in FIG. 14 wherein the constraint on the distal stent portion 632 has been released so as to allow radial expansion of the distal portion 632 but the proximal stent portion 630 remains constrained.
FIG. 15 illustrates an embodiment of the proximal anchor member 602 having a 5 crown proximal stent portion 630 and a five crown distal stent portion 632. An attachment ring 664 is secured to each crown 636 of the distal end 656 of the distal stent portion 632. Such attachment rings 664 may be secured to the proximal end 628 of main body 604 by stitching the ring 664 to the flexible material of the main body portion 604 with suture or any other suitable material. Such attachment rings 664 may also be secured to the main body 604 by any other suitable method including any of the attachment methods and devices discussed above. A cutaway portion 668 of the proximal anchor member 602 is shown at the ends of arrows 665 to illustrate an element of the proximal anchor member 602 for further discussion. The cutaway portion 668 includes a distal crown 670 and respective stent struts 634 attached thereto from the distal stent portion 632 and a proximal crown 672 and respective stent struts 634 attached thereto from the proximal stent portion 630. The proximal end of the distal stent portion 632 is secured to the distal end 676 of the proximal stent portion 630 by strut segments 638.
FIG. 16 illustrates the cutaway portion 668 of the proximal anchor member 602 of FIG. 15 with an adjacent arrow 678 that indicates the axial length of the proximal stent portion 630 and an arrow 680 that indicates the axial length of the proximal stent portion 630 together with the distal stent portion 632 or, in other words, the axial length of the
proximal anchor member 602 as a whole. For some embodiments, it has been determined that one or more of the design parameters discussed above may be optimized by use of a proximal anchor member 602 having a proximal stent portion 630 and a distal stent portion 632 wherein the axial length of the proximal anchor member 602 as a whole (L stent) divided by the axial length of the proximal stent portion 630 (L proximai) is a ratio of about 1 .75 to about 2.5, more specifically, about 1 .75 to about 2.1 , and even more specifically, about 1 .75 to about 1 .9. Such a configuration may be useful for a multi-element stent or proximal anchor member 602 in order to maximize opening force and minimize peak strain within the proximal anchor member 602.
It has also been discovered that for such proximal anchor member embodiments
600 as shown in FIG. 16 including unsymmetric axial lengths of the proximal stent portion 630 and distal stent portion 632, that it may also be useful to include unsymmetric taper lengths. FIG. 17 illustrates the cutaway portion 668 of the proximal anchor member 602 of FIG. 15 with an arrow 682 that indicates the axial length of the tapered portion 684 of the strut 634 that tapers from the proximal end 674 of the distal stent portion 632 towards the distal end 656 of the distal stent portion 632. Such a tapered portion 684 extends from the crown 686 of the distal stent portion 632 at a proximal end thereof to an axial position of minimum strut cross section 688 between the proximal crown 686 and distal crown 670 of the distal stent portion 632. Distal of the position of minimum section 688 on the strut 634, the strut 634 may begin to flare and increase in section towards the distal crown 670. Thus, the point of minimum section 688 on the strut 634 represents the endpoint of the tapered portions 684 of the strut 634 which begin at each respective crown 670 and 686 of the distal stent portion 632. For some stent embodiments 602, a strut taper configuration wherein the axial length of the proximal anchor member as a whole 602 or Lstent divided by the axial length of the tapered strut 634 from the crown 686 of the distal stent portion 632 at a proximal end 674 thereof to an axial position of minimum strut cross section 688 between the proximal crown 686 and distal crown 670 of the distal stent portion 632 (Ltaper) is about 3.0 to about 4.5, may be particularly useful in order to maximize opening force and reduce or minimize peak strains within the structure of the proximal anchor member 602. It should also be noted that such unsymmetric taper lengths may also be used for multi-
element stents or proximal anchor members 602 having stent portions 630 and 632 of equal axial length.
Another design parameter that may be useful when maximizing opening force and minimizing peak strain within a proximal anchor member 602 is selection of the inner crown radius of the crowns 636 at each end of the respective proximal and distal stent portions 630 and 632. FIGS. 18 and 19 illustrate an inner crown radius R of a distal crown 670 of the distal stent portion 632 of the proximal anchor member 602. For some embodiments, it may be useful to have an inner crown radius R of about 0.001 inches to about 0.005 inches, more specifically, about 0.001 inches to about 0.004 inches. It should be noted that such inner crown radii dimensions R may also be used for single element stents or proximal anchor members 160 and 170, particularly in embodiments where it is desirable to maximize opening force and minimize peak strains within the proximal anchor member.
For some particular stent graft embodiments 600 having a bifurcated main body 604 and a multi-element proximal anchor member 602, the proximal anchor member 602 may be configured to open to a maximum diameter of about 29 mm to about 31 mm, more specifically, about 30 mm, the proximal anchor member may have an overall axial length Lstent of about 35 mm to about 37 mm, more specifically, about 36 mm, an opening force of about 0.5 Ibf to about 0.7 Ibf, more specifically, about 0.6 Ibf, and a ratio of the axial length 680 of the anchor member 602 Lstent divided by the axial length 678 of the proximal stent portion 630 Lpr0ximai of about 2.0 to about 2.2, more specifically, about 2.1 . Such an embodiment 600 may also have a distal stent portion 632 with a strut taper configuration wherein the length 680 of the proximal anchor member 602 as a whole Lstent divided by the length 682 of the tapered strut 639 from the crown 686 of the distal stent portion 632 at a proximal end thereof to an axial position of minimum strut cross section 688 between the proximal crown 686 and distal crown 670 of the distal stent portion 632 (Ltaper) is about 3.0 to about 3.2, more specifically, about 3.1 . Many other embodiments following the design parameters discussed above may also be used in order to maximize opening force and minimize peak strain within the proximal anchor member 602. As discussed above, these design parameters may also be used singly or in any combination in order to achieve the desired results in either single element stents 160 and 170 or multi-element stents 600
having a proximal stent portion 630, distal stent portion 632 or any other number of stent portions.
While preferred embodiments of the invention have been shown and described herein, it will be understood that such embodiments are provided by way of example only. Numerous variations, changes and substitutions will occur to those skilled in the art without departing from the spirit of the invention. Accordingly, it is intended that the appended claims cover all such variations as fall within the spirit and scope of the invention.
The number of barbs, enlarged portions or tapers per strut, the length of each barb, enlarged portions or tapers, each of the barb angles or tapered angle described above, and the barb, enlarged portion or tapered orientation may vary from barb to barb, enlarged portion to enlarged portion, strut to strut within a single stent or between multiple stents within a single graft.
The entirety of each patent, patent application, publication and document
referenced herein hereby is incorporated by reference. Citation of the above patents, patent applications, publications and documents is not an admission that any of the foregoing is pertinent prior art, nor does it constitute any admission as to the contents or date of these publications or documents.
Modifications may be made to the foregoing without departing from the basic aspects of the invention. Although embodiments of the invention have been described in substantial detail with reference to one or more specific embodiments, those of ordinary skill in the art will recognize that changes may be made to the embodiments specifically disclosed in this application, yet these modifications and improvements are within the scope and spirit of the invention.
Embodiments illustratively described herein suitably may be practiced in the absence of any element(s) not specifically disclosed herein. Thus, for example, in each instance herein any of the terms "comprising," "consisting essentially of," and "consisting of may be replaced with either of the other two terms. The terms and expressions which have been employed are used as terms of description and not of limitation and use of such terms and expressions do not exclude any equivalents of the features shown and described or portions thereof and various modifications are possible within the scope of the invention claimed. The term "a" or "an" can refer to one of or a plurality of the elements it
modifies (e.g., "a reagent" can mean one or more reagents) unless it is contextually clear either one of the elements or more than one of the elements is described. Thus, it should be understood that although embodiments have been specifically disclosed by
representative embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to by those skilled in the art, and such modifications and variations are considered within the scope of this invention.
Certain embodiments of the invention are set forth in the claim(s) that follow(s).
Claims
1 . A self-expanding cylindrical stent which has a constrained state and a relaxed expanded state, comprising:
a longitudinal axis;
a proximal end;
a distal end;
a plurality of resilient struts configured to exert an outward radial force in the constrained state, at least one of the resilient struts including a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state.
2. The stent of claim 1 wherein all resilient struts include a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state.
3. The stent of claim 2 wherein at least some of the enlarged longitudinal sections are in axial alignment with each other.
4. The stent of claim 2 wherein the enlarged longitudinal sections of the struts are enlarged in one transverse dimension of the struts.
5. The stent of claim 4 wherein the enlarged longitudinal sections are enlarged along a circumferential direction about the longitudinal axis of the stent and the struts have a substantially constant thickness in a radial direction relative to the longitudinal axis of the stent.
6. The stent of claim 1 wherein the enlarged longitudinal section has an enlarged transverse dimension that is about 1 .5 times to about 3 times the nominal transverse dimension of the strut in a direction of the enlargement.
7. The stent of claim 1 wherein the enlarged longitudinal section comprises an undulating configuration of the nominal strut.
8. The stent of claim 1 wherein the enlarged longitudinal section comprises an oval enlargement of the nominal strut.
9. The stent of claim 1 wherein each strut of the stent that comprises an enlarged longitudinal section comprises only one enlarged longitudinal section.
10. The stent of claim 1 wherein one or more struts of the stent that comprise an enlarged longitudinal section comprise a plurality of enlarged longitudinal sections.
1 1 . The stent of claim 1 wherein the struts having enlarged longitudinal sections are disposed in a substantially longitudinal orientation between the proximal end and distal end of the stent when the stent is in the constrained state.
12. The stent of claim 2 wherein the struts are disposed in an undulating pattern.
13. The stent of claim 1 further comprising a superelastic alloy.
14. The stent of claim 13 wherein the superelastic alloy comprises NiTi alloy.
15. An endovascular stent graft, comprising:
a main body portion including at least one tubular portion made from at least one layer of flexible material; and
a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state, comprising:
a longitudinal axis;
a proximal end;
a distal end;
a plurality of resilient struts configured to exert an outward radial force in the constrained state, at least one of the resilient struts including a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state.
16. A method of loading a delivery system with a stent graft, comprising:
providing an endovascular stent graft, comprising:
a main body portion including at least one tubular portion made from at least one layer of flexible material, and a self-expanding cylindrical stent which has a constrained state and a relaxed expanded state, including:
a longitudinal axis,
a proximal end,
a distal end,
a plurality of resilient struts configured to exert an outward radial force in the constrained state, at least one of the resilient struts including a longitudinal section which is enlarged in a circumferential orientation relative to a longitudinal axis of the stent and configured to separate and stabilize the at least one strut relative to the position of adjacent struts while the stent is in a constrained state; constraining the self-expanding cylindrical stent of the stent graft about a bushing of the delivery system such that the enlarged longitudinal section of the at least one resilient strut stabilizes the position of the at least one strut relative to the position of adjacent struts in the constrained state; and
releasably securing the stent in the constrained stabilized state.
17. A self-expanding cylindrical stent which has a constrained state and a relaxed expanded state, comprising:
a longitudinal axis;
a proximal end;
a distal end;
a plurality of resilient struts configured to exert an outward radial force in the constrained state with at least one strut comprising a stepped tapered section which tapers in discrete steps from an end portion of said strut to a smaller transverse cross section towards a middle portion of said strut.
18. The stent of claim 17 wherein with the tapered portion is configured to evenly distribute strain induced by the constraint of the constrained state.
19. An endovascular stent graft, comprising:
a main body portion including at least one tubular portion made from at least one layer of flexible material; and
a self-expanding anchor member which includes
a constrained state,
a relaxed expanded state,
a proximal stent portion,
a distal stent portion with a proximal end of the distal stent portion secured to a distal end of the proximal stent portion and a distal end of the distal stent portion secured to a proximal end of the main body portion, and wherein the axial length of the self- expanding anchor member as a whole divided by the axial length of the proximal stent portion is about 1 .75 to about 2.5.
20. The endovascular stent graft of claim 19 wherein the axial length of the self- expanding anchor member as a whole divided by the axial length of the proximal stent portion is about 1 .75 to about 2.1 .
21 . the endovascular stent graft of claim 19 wherein an axial length of the proximal anchor member as a whole divided by an axial length of a tapered strut from a distal crown of the distal stent portion at a proximal end thereof to an axial position of minimum strut cross section between a proximal crown and the distal crown of the distal stent portion is a ratio of about 3.0 to about 4.5.
22. The endovascular stent graft of claim 19 wherein the main body portion comprises a bifurcated main body portion.
23. The endovascular stent graft of claim 19 wherein the self-expanding anchor member comprises a substantially cylindrical configuration.
24. The endovascular stent graft of claim 19 wherein the self-expanding anchor member comprises a superelastic alloy.
25. The endovascular stent graft of claim 24 wherein the superelastic alloy of the self-expanding anchor member comprises NiTi.
26. A self-expanding anchor member, comprising:
a constrained state, a relaxed expanded state,
a proximal stent portion,
a distal stent portion with a proximal end of the distal stent portion secured to a distal end of the proximal stent portion, and wherein the axial length of the self-expanding anchor member as a whole divided by the axial length of the proximal stent portion is about 1 .75 to about 2.5.
27. The self-expanding anchor member of claim 26 wherein the axial length of the self-expanding anchor member as a whole divided by the axial length of the proximal stent portion is about 1 .75 to about 2.1 .
28. The self-expanding anchor member of claim 26 wherein an axial length of the proximal anchor member as a whole divided by an axial length of a tapered strut from a distal crown of the distal stent portion at a proximal end thereof to an axial position of minimum strut cross section between a proximal crown and the distal crown of the distal stent portion is a ratio of about 3.0 to about 4.5.
29. The self-expanding anchor member of claim 26 wherein the main body portion comprises a bifurcated main body portion.
30. The self-expanding anchor member of claim 26 wherein the self-expanding anchor member comprises a substantially cylindrical configuration.
31 . The self-expanding anchor member of claim 26 wherein the self-expanding anchor member comprises a superelastic alloy.
32. The self-expanding anchor member of claim 31 wherein the superelastic alloy of the self-expanding anchor member comprises NiTi.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13772199.9A EP2833830A4 (en) | 2012-04-04 | 2013-03-29 | Durable stent graft with tapered struts and stable delivery methods and devices |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261620362P | 2012-04-04 | 2012-04-04 | |
US61/620,362 | 2012-04-04 | ||
US13/799,207 | 2013-03-13 | ||
US13/799,207 US8992595B2 (en) | 2012-04-04 | 2013-03-13 | Durable stent graft with tapered struts and stable delivery methods and devices |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013151896A1 true WO2013151896A1 (en) | 2013-10-10 |
Family
ID=49292934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/034654 WO2013151896A1 (en) | 2012-04-04 | 2013-03-29 | Durable stent graft with tapered struts and stable delivery methods and devices |
Country Status (3)
Country | Link |
---|---|
US (3) | US8992595B2 (en) |
EP (1) | EP2833830A4 (en) |
WO (1) | WO2013151896A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015138402A1 (en) | 2014-03-10 | 2015-09-17 | Trivascular, Inc. | Inflatable occlusion wire-balloon for aortic applications |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
EP2194921B1 (en) | 2007-10-04 | 2018-08-29 | TriVascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
PT3263070T (en) | 2008-06-06 | 2020-01-07 | Edwards Lifesciences Corp | Low profile transcatheter heart valve |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US20140031917A1 (en) * | 2012-07-25 | 2014-01-30 | Medtronic Vascular, Inc. | Matched End Stiffness Stent and Method of Manufacture |
US9381103B2 (en) * | 2014-10-06 | 2016-07-05 | Abbott Cardiovascular Systems Inc. | Stent with elongating struts |
JP6672286B2 (en) | 2014-10-23 | 2020-03-25 | トリバスキュラー・インコーポレイテッドTriVascular, INC. | Stent graft delivery system with access conduit |
US10166126B2 (en) | 2014-12-08 | 2019-01-01 | Boston Scientific Scimed, Inc. | Inflatable balloon stent |
CN112426253A (en) | 2015-05-27 | 2021-03-02 | 特里瓦斯库拉尔公司 | Balloon assisted endoluminal prosthesis deployment |
CN107847323B (en) | 2015-06-01 | 2020-04-24 | 爱德华兹生命科学公司 | Heart valve repair device configured for percutaneous delivery |
EP3328326A4 (en) | 2015-07-30 | 2019-03-20 | TriVascular, Inc. | Endoluminal prosthesis deployment devices and methods |
WO2017117068A1 (en) * | 2015-12-31 | 2017-07-06 | Endologix, Inc. | Systems and methods with fenestrated graft and filling structure |
US10052185B2 (en) * | 2016-02-12 | 2018-08-21 | Covidien Lp | Vascular device marker attachment |
WO2018126238A1 (en) * | 2016-12-30 | 2018-07-05 | Bvw Holding Ag | Stents with improved fixation |
JP7351292B2 (en) * | 2018-03-30 | 2023-09-27 | 日本ゼオン株式会社 | A stent delivery system including a stent for luminal interorgan bypass and a stent for luminal interorgan bypass |
US20200268533A1 (en) * | 2019-02-21 | 2020-08-27 | Cook Medical Technologies Llc | Hybrid stent designs |
US11786388B2 (en) | 2021-03-12 | 2023-10-17 | Cook Medical Technologies Llc | Endovascular delivery systems with radial orientation mechanisms |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1611867A2 (en) * | 2000-09-23 | 2006-01-04 | Boston Scientific Scimed, Inc. | Intravascular stent |
US20090082847A1 (en) * | 2007-09-26 | 2009-03-26 | Boston Scientific Corporation | System and method of securing stent barbs |
EP2158880A1 (en) * | 2008-08-26 | 2010-03-03 | Cordis Corporation | Intravascular stent having improved design for loading and deploying |
US20120016457A1 (en) * | 2001-12-20 | 2012-01-19 | Trivascular2, Inc. | Barbed radially expandable stent with slotted struts |
US20120041543A1 (en) * | 2007-06-29 | 2012-02-16 | Abbott Cardiovascular Systems Inc. | Stent having circumferentially deformable stents |
Family Cites Families (1014)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3076737A (en) | 1957-11-15 | 1963-02-05 | Fred T Roberts & Company | Corrugated annularly reinforced hose and method for its manufacture |
US3540431A (en) | 1968-04-04 | 1970-11-17 | Kazi Mobin Uddin | Collapsible filter for fluid flowing in closed passageway |
US3631854A (en) | 1969-05-19 | 1972-01-04 | Robert Howard Fryer | Inflatable medical assemblies |
US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
CA962021A (en) | 1970-05-21 | 1975-02-04 | Robert W. Gore | Porous products and process therefor |
US3669586A (en) | 1970-06-17 | 1972-06-13 | Crushproof Tubing Co | Apparatus for making flexible tubing with annular corrugations |
JPS4942773Y1 (en) | 1970-08-19 | 1974-11-22 | ||
US3818511A (en) | 1972-11-17 | 1974-06-25 | Medical Prod Corp | Medical prosthesis for ducts or conduits |
US3814137A (en) | 1973-01-26 | 1974-06-04 | Baxter Laboratories Inc | Injection site for flow conduits containing biological fluids |
US4096227A (en) | 1973-07-03 | 1978-06-20 | W. L. Gore & Associates, Inc. | Process for producing filled porous PTFE products |
US3991767A (en) | 1973-11-02 | 1976-11-16 | Cutter Laboratories, Inc. | Tubular unit with vessel engaging cuff structure |
US3902198A (en) | 1974-05-20 | 1975-09-02 | Gore & Ass | Method of replacing a body part with expanded porous polytetrafluoroethylene |
US6436135B1 (en) | 1974-10-24 | 2002-08-20 | David Goldfarb | Prosthetic vascular graft |
US4374669A (en) | 1975-05-09 | 1983-02-22 | Mac Gregor David C | Cardiovascular prosthetic devices and implants with porous systems |
US4208745A (en) | 1976-01-21 | 1980-06-24 | Sumitomo Electric Industries, Ltd. | Vascular prostheses composed of polytetrafluoroethylene and process for their production |
DE2714810A1 (en) | 1976-04-05 | 1977-10-13 | Anvar | PROCESS FOR MANUFACTURING ORGAN DENTALS PRODUCED ACCORDING TO THE PROCESS |
JPS603842B2 (en) | 1976-09-03 | 1985-01-31 | 住友電気工業株式会社 | Asymmetric pore diameter thin film material and its manufacturing method |
US4110392A (en) | 1976-12-17 | 1978-08-29 | W. L. Gore & Associates, Inc. | Production of porous sintered PTFE products |
US4140126A (en) | 1977-02-18 | 1979-02-20 | Choudhury M Hasan | Method for performing aneurysm repair |
JPS5413694A (en) | 1977-07-01 | 1979-02-01 | Sumitomo Electric Industries | Composite blood vessel prosthesis and method of producing same |
US4183102A (en) | 1977-09-08 | 1980-01-15 | Jacques Guiset | Inflatable prosthetic device for lining a body duct |
CA1147087A (en) | 1977-12-21 | 1983-05-24 | David Goldfarb | Graphite impregnated prosthetic vascular graft materials |
DE2806030C2 (en) | 1978-02-14 | 1984-02-02 | B. Braun Melsungen Ag, 3508 Melsungen | Process for the production of a tubular blood vessel prosthesis |
SE424045B (en) | 1979-01-12 | 1982-06-28 | Tesi Ab | CATHETER |
US4214587A (en) | 1979-02-12 | 1980-07-29 | Sakura Chester Y Jr | Anastomosis device and method |
US4330126A (en) * | 1979-08-30 | 1982-05-18 | Brunswick Corporation | High flex golf shaft having reverse tapered butt section |
US4385093A (en) | 1980-11-06 | 1983-05-24 | W. L. Gore & Associates, Inc. | Multi-component, highly porous, high strength PTFE article and method for manufacturing same |
US4478665A (en) | 1980-11-06 | 1984-10-23 | W. L. Gore & Associates, Inc. | Method for manufacturing highly porous, high strength PTFE articles |
US4416028A (en) | 1981-01-22 | 1983-11-22 | Ingvar Eriksson | Blood vessel prosthesis |
US4604762A (en) | 1981-02-13 | 1986-08-12 | Thoratec Laboratories Corporation | Arterial graft prosthesis |
SE445884B (en) | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
GB2121286B (en) | 1982-06-02 | 1985-11-06 | Ethicon Inc | Improvements in synthetic vascular grafts, and methods of manufacturing such grafts |
US4482516A (en) | 1982-09-10 | 1984-11-13 | W. L. Gore & Associates, Inc. | Process for producing a high strength porous polytetrafluoroethylene product having a coarse microstructure |
JPS59109534A (en) | 1982-12-14 | 1984-06-25 | Nitto Electric Ind Co Ltd | Porous polytetrafluoroethylene object |
US4512338A (en) | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4503569A (en) | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4647416A (en) | 1983-08-03 | 1987-03-03 | Shiley Incorporated | Method of preparing a vascular graft prosthesis |
US4550447A (en) | 1983-08-03 | 1985-11-05 | Shiley Incorporated | Vascular graft prosthesis |
US4592754A (en) | 1983-09-09 | 1986-06-03 | Gupte Pradeep M | Surgical prosthetic vessel graft and catheter combination and method |
US4665906A (en) | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US5190546A (en) | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US5104399A (en) | 1986-12-10 | 1992-04-14 | Endovascular Technologies, Inc. | Artificial graft and implantation method |
US5749920A (en) | 1983-12-09 | 1998-05-12 | Endovascular Technologies, Inc. | Multicapsule intraluminal grafting system and method |
US5275622A (en) | 1983-12-09 | 1994-01-04 | Harrison Medical Technologies, Inc. | Endovascular grafting apparatus, system and method and devices for use therewith |
US6221102B1 (en) | 1983-12-09 | 2001-04-24 | Endovascular Technologies, Inc. | Intraluminal grafting system |
US5693083A (en) | 1983-12-09 | 1997-12-02 | Endovascular Technologies, Inc. | Thoracic graft and delivery catheter |
US4787899A (en) | 1983-12-09 | 1988-11-29 | Lazarus Harrison M | Intraluminal graft device, system and method |
US7166125B1 (en) | 1988-03-09 | 2007-01-23 | Endovascular Technologies, Inc. | Intraluminal grafting system |
US5669936A (en) | 1983-12-09 | 1997-09-23 | Endovascular Technologies, Inc. | Endovascular grafting system and method for use therewith |
US5108424A (en) | 1984-01-30 | 1992-04-28 | Meadox Medicals, Inc. | Collagen-impregnated dacron graft |
US4617932A (en) | 1984-04-25 | 1986-10-21 | Elliot Kornberg | Device and method for performing an intraluminal abdominal aortic aneurysm repair |
US4562596A (en) | 1984-04-25 | 1986-01-07 | Elliot Kornberg | Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair |
SU1217402A1 (en) | 1984-05-22 | 1986-03-15 | Харьковский научно-исследовательский институт общей и неотложной хирургии | Blood vessel prosthesis |
SU1342511A1 (en) | 1984-08-01 | 1987-10-07 | Всесоюзный научный центр хирургии АМН СССР | Method of intravascular setting of prosthesis |
US4580568A (en) | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4655769A (en) | 1984-10-24 | 1987-04-07 | Zachariades Anagnostis E | Ultra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states |
US4577631A (en) | 1984-11-16 | 1986-03-25 | Kreamer Jeffry W | Aneurysm repair apparatus and method |
SU1237201A1 (en) | 1985-03-04 | 1986-06-15 | Всесоюзный научный центр хирургии | Intravascular frame |
SU1237202A1 (en) | 1985-03-04 | 1986-06-15 | Всесоюзный научный центр хирургии | Prosthesis of tubular organ |
US4871365A (en) | 1985-04-25 | 1989-10-03 | American Cyanamid Company | Partially absorbable prosthetic tubular article having an external support |
SU1273077A1 (en) | 1985-06-06 | 1986-11-30 | Ростовский-На-Дону Ордена Дружбы Народов Медицинский Институт | Method of treatment of urethra strictures |
SU1586718A1 (en) | 1985-08-20 | 1990-08-23 | И. К. Рапопорт, А. А. Сажина, О. А. Рапопорт и Л. А. Рапопорт | Arrangement for introducing agents to organ cavity |
US4705517A (en) | 1985-09-03 | 1987-11-10 | Becton, Dickinson And Company | Percutaneously deliverable intravascular occlusion prosthesis |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4740207A (en) | 1986-09-10 | 1988-04-26 | Kreamer Jeffry W | Intralumenal graft |
SU1482714A2 (en) | 1986-10-15 | 1989-05-30 | Харьковский научно-исследовательский институт общей и неотложной хирургии | Device for setting prosthesis into blood vessel |
JPH0696023B2 (en) | 1986-11-10 | 1994-11-30 | 宇部日東化成株式会社 | Artificial blood vessel and method for producing the same |
US4743480A (en) | 1986-11-13 | 1988-05-10 | W. L. Gore & Associates, Inc. | Apparatus and method for extruding and expanding polytetrafluoroethylene tubing and the products produced thereby |
SU1389778A2 (en) | 1986-11-26 | 1988-04-23 | Харьковский научно-исследовательский институт общей и неотложной хирургии | Arrangement for fitting a prosthesis into blood vessel |
SU1457921A1 (en) | 1987-03-10 | 1989-02-15 | Харьковский научно-исследовательский институт общей и неотложной хирургии | Self-fixing prosthesis of blood vessel |
US5041126A (en) | 1987-03-13 | 1991-08-20 | Cook Incorporated | Endovascular stent and delivery system |
SU1560134A1 (en) | 1987-06-01 | 1990-04-30 | С. А. Попов | Device for application of anastomosis |
US5059211A (en) | 1987-06-25 | 1991-10-22 | Duke University | Absorbable vascular stent |
US4816028A (en) | 1987-07-01 | 1989-03-28 | Indu Kapadia | Woven vascular graft |
US4877661A (en) | 1987-10-19 | 1989-10-31 | W. L. Gore & Associates, Inc. | Rapidly recoverable PTFE and process therefore |
US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US4830003A (en) | 1988-06-17 | 1989-05-16 | Wolff Rodney G | Compressive stent and delivery system |
RU1768154C (en) | 1988-06-22 | 1992-10-15 | Всесоюзный научный центр хирургии АМН СССР | Prosthetic appliance for hollow organ |
SU1650127A1 (en) | 1988-06-27 | 1991-05-23 | С.А.Попов | Prosthesis of tubular organ |
DE68922497T2 (en) | 1988-08-24 | 1995-09-14 | Marvin J Slepian | ENDOLUMINAL SEAL WITH BISDEGRADABLE POLYMERS. |
US5226913A (en) | 1988-09-01 | 1993-07-13 | Corvita Corporation | Method of making a radially expandable prosthesis |
US5019090A (en) | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
US4856516A (en) | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
US4902423A (en) | 1989-02-02 | 1990-02-20 | W. L. Gore & Associates, Inc. | Highly air permeable expanded polytetrafluoroethylene membranes and process for making them |
US5098625A (en) | 1989-03-14 | 1992-03-24 | Yeu Ming Tai Chemical Industrial Co., Ltd. | Process for forming an expanded porous tetrafluoroethylene polymer |
US4985296A (en) | 1989-03-16 | 1991-01-15 | W. L. Gore & Associates, Inc. | Polytetrafluoroethylene film |
US4957669A (en) | 1989-04-06 | 1990-09-18 | Shiley, Inc. | Method for producing tubing useful as a tapered vascular graft prosthesis |
US4994077A (en) | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
SU1732964A1 (en) | 1989-04-25 | 1992-05-15 | Витебский медицинский институт | Trachea prothesis |
US4932938A (en) | 1989-05-05 | 1990-06-12 | Medical Engineering Corporation | Urethral indwelling catheter with incontinence control |
US4994071A (en) | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US4955899A (en) | 1989-05-26 | 1990-09-11 | Impra, Inc. | Longitudinally compliant vascular graft |
US5104400A (en) | 1989-05-26 | 1992-04-14 | Impra, Inc. | Blood vessel patch |
US5152782A (en) | 1989-05-26 | 1992-10-06 | Impra, Inc. | Non-porous coated ptfe graft |
US5100422A (en) | 1989-05-26 | 1992-03-31 | Impra, Inc. | Blood vessel patch |
US5609626A (en) | 1989-05-31 | 1997-03-11 | Baxter International Inc. | Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts |
US5171262A (en) | 1989-06-15 | 1992-12-15 | Cordis Corporation | Non-woven endoprosthesis |
JP2814574B2 (en) | 1989-06-15 | 1998-10-22 | 住友電気工業株式会社 | Polytetrafluoroethylene porous body and method for producing the same |
US5207695A (en) | 1989-06-19 | 1993-05-04 | Trout Iii Hugh H | Aortic graft, implantation device, and method for repairing aortic aneurysm |
WO1991000792A1 (en) | 1989-07-06 | 1991-01-24 | Ramset Fasteners (Aust.) Pty. Limited | Aligning members |
US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
CA2026604A1 (en) | 1989-10-02 | 1991-04-03 | Rodney G. Wolff | Articulated stent |
EP0425714A1 (en) | 1989-10-28 | 1991-05-08 | Metalpraecis Berchem + Schaberg Gesellschaft Für Metallformgebung Mbh | Process for manufacturing an implantable joint prosthesis |
GB8927282D0 (en) | 1989-12-01 | 1990-01-31 | Univ Strathclyde | Vascular surgical devices |
ATE120377T1 (en) | 1990-02-08 | 1995-04-15 | Howmedica | INFLATABLE DILATATOR. |
US6004346A (en) | 1990-02-28 | 1999-12-21 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
US5052998A (en) | 1990-04-04 | 1991-10-01 | Zimmon David S | Indwelling stent and method of use |
US5344426A (en) | 1990-04-25 | 1994-09-06 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
US5158548A (en) | 1990-04-25 | 1992-10-27 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
US5560986A (en) | 1990-04-27 | 1996-10-01 | W. L. Gore & Associates, Inc. | Porous polytetrafluoroethylene sheet composition |
US5123917A (en) | 1990-04-27 | 1992-06-23 | Lee Peter Y | Expandable intraluminal vascular graft |
DK124690D0 (en) | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION |
US5578071A (en) | 1990-06-11 | 1996-11-26 | Parodi; Juan C. | Aortic graft |
US5360443A (en) | 1990-06-11 | 1994-11-01 | Barone Hector D | Aortic graft for repairing an abdominal aortic aneurysm |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5405379A (en) | 1990-07-26 | 1995-04-11 | Lane; Rodney J. | Self expanding vascular endoprosthesis for aneurysms |
US5202352A (en) | 1990-08-08 | 1993-04-13 | Takeda Chemical Industries, Ltd. | Intravascular embolizing agent containing angiogenesis-inhibiting substance |
US5122154A (en) | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
US5139480A (en) | 1990-08-22 | 1992-08-18 | Biotech Laboratories, Inc. | Necking stents |
US5415634A (en) | 1990-08-23 | 1995-05-16 | Devices For Vascular Intervention, Inc. | Catheter having helical inflation lumen |
AR246020A1 (en) | 1990-10-03 | 1994-03-30 | Hector Daniel Barone Juan Carl | A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms. |
DE9117152U1 (en) | 1990-10-09 | 1996-07-11 | Cook Inc | Stent |
RU1812980C (en) | 1990-11-06 | 1993-04-30 | Сергей Владимирович Щукин | Intravascular frame |
US5217483A (en) | 1990-11-28 | 1993-06-08 | Numed, Inc. | Intravascular radially expandable stent |
US5755782A (en) | 1991-01-24 | 1998-05-26 | Autogenics | Stents for autologous tissue heart valve |
US5163955A (en) | 1991-01-24 | 1992-11-17 | Autogenics | Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment |
CA2060067A1 (en) | 1991-01-28 | 1992-07-29 | Lilip Lau | Stent delivery system |
US5156620A (en) | 1991-02-04 | 1992-10-20 | Pigott John P | Intraluminal graft/stent and balloon catheter for insertion thereof |
US5135536A (en) | 1991-02-05 | 1992-08-04 | Cordis Corporation | Endovascular stent and method |
DE4104702C2 (en) | 1991-02-15 | 1996-01-18 | Malte Neuss | Implants for organ pathways in spiral form |
US5116365A (en) | 1991-02-22 | 1992-05-26 | Cordis Corporation | Stent apparatus and method for making |
US5282847A (en) | 1991-02-28 | 1994-02-01 | Medtronic, Inc. | Prosthetic vascular grafts with a pleated structure |
US5628783A (en) | 1991-04-11 | 1997-05-13 | Endovascular Technologies, Inc. | Bifurcated multicapsule intraluminal grafting system and method |
CA2065634C (en) | 1991-04-11 | 1997-06-03 | Alec A. Piplani | Endovascular graft having bifurcation and apparatus and method for deploying the same |
US5197978B1 (en) | 1991-04-26 | 1996-05-28 | Advanced Coronary Tech | Removable heat-recoverable tissue supporting device |
US5350398A (en) | 1991-05-13 | 1994-09-27 | Dusan Pavcnik | Self-expanding filter for percutaneous insertion |
US5304200A (en) | 1991-05-29 | 1994-04-19 | Cordis Corporation | Welded radially expandable endoprosthesis and the like |
CA2110499C (en) | 1991-06-14 | 1998-06-23 | Stanislaw L. Zukowski | Surface modified porous expanded polytetrafluoroethylene and process for making |
US5591172A (en) | 1991-06-14 | 1997-01-07 | Ams Medinvent S.A. | Transluminal implantation device |
US5314472A (en) | 1991-10-01 | 1994-05-24 | Cook Incorporated | Vascular stent |
NL9101159A (en) | 1991-07-03 | 1993-02-01 | Industrial Res Bv | FORMATTABLE EXPANDABLE RING, CYLINDER OR SLEEVE. |
RU2029527C1 (en) | 1991-09-02 | 1995-02-27 | Самохвалов Игорь Маркелович | Blood vessel prosthesis |
US5320100A (en) | 1991-09-16 | 1994-06-14 | Atrium Medical Corporation | Implantable prosthetic device having integral patency diagnostic indicia |
US5197976A (en) | 1991-09-16 | 1993-03-30 | Atrium Medical Corporation | Manually separable multi-lumen vascular graft |
US5192310A (en) | 1991-09-16 | 1993-03-09 | Atrium Medical Corporation | Self-sealing implantable vascular graft |
US5411550A (en) | 1991-09-16 | 1995-05-02 | Atrium Medical Corporation | Implantable prosthetic device for the delivery of a bioactive material |
US5443498A (en) | 1991-10-01 | 1995-08-22 | Cook Incorporated | Vascular stent and method of making and implanting a vacsular stent |
US5500013A (en) | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
US5151105A (en) | 1991-10-07 | 1992-09-29 | Kwan Gett Clifford | Collapsible vessel sleeve implant |
US5366504A (en) | 1992-05-20 | 1994-11-22 | Boston Scientific Corporation | Tubular medical prosthesis |
US5662713A (en) | 1991-10-09 | 1997-09-02 | Boston Scientific Corporation | Medical stents for body lumens exhibiting peristaltic motion |
US5290305A (en) | 1991-10-11 | 1994-03-01 | Kanji Inoue | Appliance collapsible for insertion into human organs and capable of resilient restoration |
US5387235A (en) | 1991-10-25 | 1995-02-07 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm |
US5693084A (en) | 1991-10-25 | 1997-12-02 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm |
US5720776A (en) | 1991-10-25 | 1998-02-24 | Cook Incorporated | Barb and expandable transluminal graft prosthesis for repair of aneurysm |
AU669338B2 (en) | 1991-10-25 | 1996-06-06 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting |
US5456713A (en) | 1991-10-25 | 1995-10-10 | Cook Incorporated | Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting |
CA2380683C (en) | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5167614A (en) | 1991-10-29 | 1992-12-01 | Medical Engineering Corporation | Prostatic stent |
FR2683449A1 (en) | 1991-11-08 | 1993-05-14 | Cardon Alain | ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION. |
US5524633A (en) | 1991-11-25 | 1996-06-11 | Advanced Surgical, Inc. | Self-deploying isolation bag |
US5334164A (en) | 1992-01-03 | 1994-08-02 | United States Surgical Corporation | Variable interior dimension cannula assembly |
US5316023A (en) | 1992-01-08 | 1994-05-31 | Expandable Grafts Partnership | Method for bilateral intra-aortic bypass |
DK6192A (en) | 1992-01-20 | 1993-07-21 | Engineers & Doctors As | SEGMENTALLY EXPANDABLE TUBULAR ENDOLUMINAL PROSTHESIS |
US5250059A (en) | 1992-01-22 | 1993-10-05 | Devices For Vascular Intervention, Inc. | Atherectomy catheter having flexible nose cone |
US5649950A (en) | 1992-01-22 | 1997-07-22 | C. R. Bard | System for the percutaneous transluminal front-end loading delivery and retrieval of a prosthetic occluder |
US5405377A (en) | 1992-02-21 | 1995-04-11 | Endotech Ltd. | Intraluminal stent |
US5683448A (en) | 1992-02-21 | 1997-11-04 | Boston Scientific Technology, Inc. | Intraluminal stent and graft |
FR2688401B1 (en) | 1992-03-12 | 1998-02-27 | Thierry Richard | EXPANDABLE STENT FOR HUMAN OR ANIMAL TUBULAR MEMBER, AND IMPLEMENTATION TOOL. |
DE69325649T2 (en) | 1992-03-13 | 1999-11-18 | Atrium Medical Corp | OBJECTS OF EXPANDED FLUOROPOLYMER (e.g. POLYTETRAFLUORETHYLENE) WITH CONTROLLED POROSITY AND ITS PRODUCTION |
US5282823A (en) | 1992-03-19 | 1994-02-01 | Medtronic, Inc. | Intravascular radially expandable stent |
JPH07505316A (en) | 1992-03-31 | 1995-06-15 | ボストン サイエンティフィック コーポレーション | medical wire |
US5201757A (en) | 1992-04-03 | 1993-04-13 | Schneider (Usa) Inc. | Medial region deployment of radially self-expanding stents |
US5354329A (en) | 1992-04-17 | 1994-10-11 | Whalen Biomedical, Inc. | Vascular prosthesis having enhanced compatibility and compliance characteristics |
US5817102A (en) | 1992-05-08 | 1998-10-06 | Schneider (Usa) Inc. | Apparatus for delivering and deploying a stent |
US5405378A (en) | 1992-05-20 | 1995-04-11 | Strecker; Ernst P. | Device with a prosthesis implantable in the body of a patient |
US5365996A (en) | 1992-06-10 | 1994-11-22 | Amei Technologies Inc. | Method and apparatus for making customized fixation devices |
US5383928A (en) | 1992-06-10 | 1995-01-24 | Emory University | Stent sheath for local drug delivery |
US5344451A (en) | 1992-06-24 | 1994-09-06 | Dayton Michael P | Synthetic reconstructive implant device |
US5721283A (en) | 1992-06-25 | 1998-02-24 | E. I. Du Pont De Nemours And Company | Porous polytetrafluoroethylene and preparation |
JPH07509633A (en) | 1992-08-06 | 1995-10-26 | ウイリアム、クック、ユーロプ、アクティーゼルスカブ | Prosthetic device for supporting the lumen of a blood vessel or hollow organ |
EP0586717B1 (en) | 1992-08-13 | 2001-12-12 | Terumo Kabushiki Kaisha | Endotracheal tube and the method of manufacturing it |
US5374473A (en) | 1992-08-19 | 1994-12-20 | W. L. Gore & Associates, Inc. | Dense polytetrafluoroethylene articles |
US5382261A (en) | 1992-09-01 | 1995-01-17 | Expandable Grafts Partnership | Method and apparatus for occluding vessels |
US5562725A (en) | 1992-09-14 | 1996-10-08 | Meadox Medicals Inc. | Radially self-expanding implantable intraluminal device |
US5321109A (en) | 1992-11-17 | 1994-06-14 | Impra, Inc. | Uniformly expanded PTFE film |
US5391147A (en) | 1992-12-01 | 1995-02-21 | Cardiac Pathways Corporation | Steerable catheter with adjustable bend location and/or radius and method |
CA2109980A1 (en) | 1992-12-01 | 1994-06-02 | Mir A. Imran | Steerable catheter with adjustable bend location and/or radius and method |
US5716395A (en) | 1992-12-11 | 1998-02-10 | W.L. Gore & Associates, Inc. | Prosthetic vascular graft |
BE1006440A3 (en) | 1992-12-21 | 1994-08-30 | Dereume Jean Pierre Georges Em | Luminal endoprosthesis AND METHOD OF PREPARATION. |
US5443458A (en) | 1992-12-22 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method of manufacture |
WO1994015549A1 (en) | 1992-12-30 | 1994-07-21 | Schneider (Usa) Inc. | Apparatus for deploying body implantable stents |
US5466509A (en) | 1993-01-15 | 1995-11-14 | Impra, Inc. | Textured, porous, expanded PTFE |
DE69424569T2 (en) | 1993-01-25 | 2001-01-18 | Daikin Ind Ltd | Porous film made of polytetrafluoroethylene |
US5370691A (en) | 1993-01-26 | 1994-12-06 | Target Therapeutics, Inc. | Intravascular inflatable stent |
IL108455A (en) | 1993-01-27 | 1997-04-15 | Instent Inc | Vascular and coronary stents |
US5453235A (en) | 1993-01-29 | 1995-09-26 | Impra, Inc. | Method of forming dual porosity FTFE tubes by extrusion of concentric preforms |
US5658960A (en) | 1993-02-23 | 1997-08-19 | W.L. Gore & Associates, Inc. | Polytetrafluoroethylene molding resin and processes |
US5334201A (en) | 1993-03-12 | 1994-08-02 | Cowan Kevin P | Permanent stent made of a cross linkable material |
JP3345786B2 (en) | 1993-03-17 | 2002-11-18 | ジャパンゴアテックス株式会社 | Flexible tube and method of manufacturing the same |
US5354310A (en) | 1993-03-22 | 1994-10-11 | Cordis Corporation | Expandable temporary graft |
NL9300500A (en) | 1993-03-22 | 1994-10-17 | Industrial Res Bv | Expandable hollow sleeve for locally supporting and / or strengthening a body vessel, as well as a method for manufacturing it. |
WO1994023786A1 (en) | 1993-04-13 | 1994-10-27 | Boston Scientific Corporation | Prosthesis delivery system |
AU689094B2 (en) | 1993-04-22 | 1998-03-26 | C.R. Bard Inc. | Non-migrating vascular prosthesis and minimally invasive placement system therefor |
US5843167A (en) | 1993-04-22 | 1998-12-01 | C. R. Bard, Inc. | Method and apparatus for recapture of hooked endoprosthesis |
US5441515A (en) | 1993-04-23 | 1995-08-15 | Advanced Cardiovascular Systems, Inc. | Ratcheting stent |
EP0621015B1 (en) | 1993-04-23 | 1998-03-18 | Schneider (Europe) Ag | Stent with a covering layer of elastic material and method for applying the layer on the stent |
US5370682A (en) | 1993-04-26 | 1994-12-06 | Meadox Medicals, Inc. | Solid woven tubular prosthesis |
CA2126315A1 (en) | 1993-05-11 | 1994-11-12 | Gene Samson | Temporary inflatable intravascular prothesis |
US5480423A (en) | 1993-05-20 | 1996-01-02 | Boston Scientific Corporation | Prosthesis delivery |
DK0627201T3 (en) | 1993-06-02 | 1999-04-26 | Schneider Europ Gmbh | Device for releasing a self-expanding endoprosthesis |
US5464449A (en) | 1993-07-08 | 1995-11-07 | Thomas J. Fogarty | Internal graft prosthesis and delivery system |
GR930100328A (en) | 1993-07-30 | 1995-03-31 | Grigorios Skalkeas | Vascular graft for the replacement of the aortic arch and the superior part of the abdominal aorta. |
CA2125258C (en) | 1993-08-05 | 1998-12-22 | Dinah B Quiachon | Multicapsule intraluminal grafting system and method |
US6027779A (en) | 1993-08-18 | 2000-02-22 | W. L. Gore & Associates, Inc. | Thin-wall polytetrafluoroethylene tube |
US5735892A (en) | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US6025044A (en) | 1993-08-18 | 2000-02-15 | W. L. Gore & Associates, Inc. | Thin-wall polytetrafluoroethylene tube |
US6159565A (en) | 1993-08-18 | 2000-12-12 | W. L. Gore & Associates, Inc. | Thin-wall intraluminal graft |
EP0714270B1 (en) | 1993-08-18 | 2002-09-04 | W.L. Gore & Associates, Inc. | A tubular intraluminally insertable graft |
AU6943794A (en) | 1993-08-18 | 1995-03-14 | W.L. Gore & Associates, Inc. | A thin-wall, seamless, porous polytetrafluoroethylene tube |
DE69332644T2 (en) | 1993-08-20 | 2003-09-25 | Kanji Inoue | IMPLANT AND METHOD FOR FOLDING IT UP |
WO1995008966A1 (en) | 1993-09-30 | 1995-04-06 | White Geoffrey H | Intraluminal graft |
US6685736B1 (en) | 1993-09-30 | 2004-02-03 | Endogad Research Pty Limited | Intraluminal graft |
AU7621794A (en) | 1993-10-01 | 1995-05-01 | Imperial College Of Science, Technology And Medicine | Vascular prostheses |
AU8012394A (en) | 1993-10-01 | 1995-05-01 | Emory University | Self-expanding intraluminal composite prosthesis |
DE4334140C2 (en) | 1993-10-07 | 1996-04-18 | Angiomed Ag | Stent and device with stent |
US5609624A (en) | 1993-10-08 | 1997-03-11 | Impra, Inc. | Reinforced vascular graft and method of making same |
WO1995010989A1 (en) | 1993-10-19 | 1995-04-27 | Scimed Life Systems, Inc. | Intravascular stent pump |
US5639278A (en) | 1993-10-21 | 1997-06-17 | Corvita Corporation | Expandable supportive bifurcated endoluminal grafts |
US5855598A (en) | 1993-10-21 | 1999-01-05 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
US5723004A (en) | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
US5632772A (en) | 1993-10-21 | 1997-05-27 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
US5445646A (en) | 1993-10-22 | 1995-08-29 | Scimed Lifesystems, Inc. | Single layer hydraulic sheath stent delivery apparatus and method |
US5989280A (en) | 1993-10-22 | 1999-11-23 | Scimed Lifesystems, Inc | Stent delivery apparatus and method |
US5389106A (en) | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
DE69419877T2 (en) | 1993-11-04 | 1999-12-16 | Bard Inc C R | Fixed vascular prosthesis |
WO1995013033A1 (en) | 1993-11-08 | 1995-05-18 | Lazarus Harrison M | Intraluminal vascular graft and method |
US5527353A (en) | 1993-12-02 | 1996-06-18 | Meadox Medicals, Inc. | Implantable tubular prosthesis |
DE4341367C1 (en) | 1993-12-04 | 1995-06-14 | Harald Dr Med Dr Med Eufinger | Process for the production of endoprostheses |
DE9319267U1 (en) | 1993-12-15 | 1994-02-24 | Vorwerk Dierk Dr | Aortic endoprosthesis |
US5789047A (en) | 1993-12-21 | 1998-08-04 | Japan Gore-Tex, Inc | Flexible, multilayered tube |
JP2703510B2 (en) | 1993-12-28 | 1998-01-26 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Expandable stent and method of manufacturing the same |
IT1269443B (en) | 1994-01-19 | 1997-04-01 | Stefano Nazari | VASCULAR PROSTHESIS FOR THE REPLACEMENT OR INTERNAL COATING OF MEDIUM AND LARGE DIAMETER BLOOD VESSELS AND DEVICE FOR ITS APPLICATION WITHOUT INTERRUPTION OF BLOOD FLOW |
EP0741547B1 (en) | 1994-01-26 | 2005-04-20 | Kyphon Inc. | Improved inflatable device for use in surgical protocol relating to fixation of bone |
US5476506A (en) | 1994-02-08 | 1995-12-19 | Ethicon, Inc. | Bi-directional crimped graft |
US6051020A (en) | 1994-02-09 | 2000-04-18 | Boston Scientific Technology, Inc. | Bifurcated endoluminal prosthesis |
US6165213A (en) | 1994-02-09 | 2000-12-26 | Boston Scientific Technology, Inc. | System and method for assembling an endoluminal prosthesis |
US5609627A (en) | 1994-02-09 | 1997-03-11 | Boston Scientific Technology, Inc. | Method for delivering a bifurcated endoluminal prosthesis |
US6039749A (en) | 1994-02-10 | 2000-03-21 | Endovascular Systems, Inc. | Method and apparatus for deploying non-circular stents and graftstent complexes |
US5507769A (en) | 1994-10-18 | 1996-04-16 | Stentco, Inc. | Method and apparatus for forming an endoluminal bifurcated graft |
WO1995022359A1 (en) | 1994-02-17 | 1995-08-24 | W.L. Gore & Associates, Inc. | A carvable ptfe implant material |
SI0669114T1 (en) | 1994-02-25 | 1999-02-28 | Robert E. Fischell | Stent having a multiplicity of closed circular structures |
US5423851A (en) | 1994-03-06 | 1995-06-13 | Samuels; Shaun L. W. | Method and apparatus for affixing an endoluminal device to the walls of tubular structures within the body |
US5653746A (en) | 1994-03-08 | 1997-08-05 | Meadox Medicals, Inc. | Radially expandable tubular prosthesis |
US5549663A (en) | 1994-03-09 | 1996-08-27 | Cordis Corporation | Endoprosthesis having graft member and exposed welded end junctions, method and procedure |
US6530765B1 (en) | 1994-03-10 | 2003-03-11 | Meadox Medicals, Inc. | Apparatus for manufacturing expanded polytetrafluoroethylene products |
US5505887A (en) | 1994-03-10 | 1996-04-09 | Meadox Medicals, Inc. | Extrusion process for manufacturing PTFE products |
US5556413A (en) | 1994-03-11 | 1996-09-17 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US6461381B2 (en) | 1994-03-17 | 2002-10-08 | Medinol, Ltd. | Flexible expandable stent |
US5733303A (en) | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
US6464722B2 (en) | 1994-03-17 | 2002-10-15 | Medinol, Ltd. | Flexible expandable stent |
US5449373A (en) | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
US6001123A (en) | 1994-04-01 | 1999-12-14 | Gore Enterprise Holdings Inc. | Folding self-expandable intravascular stent-graft |
DE69532049T2 (en) | 1994-04-01 | 2004-07-08 | Prograft Medical, Inc., Palo Alto | Self-expanding stent or stent graft and method for its preparation |
US6165210A (en) | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
DE69534640T2 (en) | 1994-04-29 | 2006-08-10 | Scimed Life Systems, Inc., Maple Grove | Stent with collagen |
US5554181A (en) | 1994-05-04 | 1996-09-10 | Regents Of The University Of Minnesota | Stent |
CA2189662C (en) | 1994-05-06 | 2004-12-14 | William M. Colone | Radially expandable polytetrafluoroethylene |
US5824044A (en) | 1994-05-12 | 1998-10-20 | Endovascular Technologies, Inc. | Bifurcated multicapsule intraluminal grafting system |
DE4418336A1 (en) | 1994-05-26 | 1995-11-30 | Angiomed Ag | Stent for widening and holding open receptacles |
DK63894A (en) | 1994-06-06 | 1996-01-08 | Meadox Medicals Inc | Stent catheter and method for making such a stent catheter |
US5683451A (en) | 1994-06-08 | 1997-11-04 | Cardiovascular Concepts, Inc. | Apparatus and methods for deployment release of intraluminal prostheses |
US5824041A (en) | 1994-06-08 | 1998-10-20 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
DE69518435T3 (en) | 1994-06-08 | 2004-07-22 | CardioVascular Concepts, Inc., Portola Valley | A branching graft manufacturing system |
DE69530842T2 (en) | 1994-06-13 | 2004-01-22 | Endomed, Inc., Phoenix | EXPANDABLE ENDOVASCULAR TRANSPLANT AND METHOD FOR THE PRODUCTION THEREOF |
US5522881A (en) | 1994-06-28 | 1996-06-04 | Meadox Medicals, Inc. | Implantable tubular prosthesis having integral cuffs |
US5554185A (en) | 1994-07-18 | 1996-09-10 | Block; Peter C. | Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same |
CA2192457C (en) | 1994-07-27 | 2002-02-19 | Thane L. Kranzler | High strength porous ptfe sheet material |
US5556426A (en) | 1994-08-02 | 1996-09-17 | Meadox Medicals, Inc. | PTFE implantable tubular prostheses with external coil support |
US5571172A (en) | 1994-08-15 | 1996-11-05 | Origin Medsystems, Inc. | Method and apparatus for endoscopic grafting |
US5972023A (en) | 1994-08-15 | 1999-10-26 | Eva Corporation | Implantation device for an aortic graft method of treating aortic aneurysm |
US5575817A (en) | 1994-08-19 | 1996-11-19 | Martin; Eric C. | Aorto femoral bifurcation graft and method of implantation |
US6331188B1 (en) | 1994-08-31 | 2001-12-18 | Gore Enterprise Holdings, Inc. | Exterior supported self-expanding stent-graft |
CN1145600A (en) | 1994-09-02 | 1997-03-19 | W·L·戈尔及同仁股份有限公司 | Porous polyetetrafluoroethylene compsn. |
US5843170A (en) | 1994-09-02 | 1998-12-01 | Ahn; Sam Seunghae | Apparatus and method for performing aneurysm repair |
US5527355A (en) | 1994-09-02 | 1996-06-18 | Ahn; Sam S. | Apparatus and method for performing aneurysm repair |
US5707378A (en) | 1994-09-02 | 1998-01-13 | Sam S. Ahn | Apparatus and method for performing aneurysm repair |
US6015429A (en) | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US5512360A (en) | 1994-09-20 | 1996-04-30 | W. L. Gore & Associates, Inc. | PTFE reinforced compliant adhesive and method of fabricating same |
US5649977A (en) | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
US5562727A (en) | 1994-10-07 | 1996-10-08 | Aeroquip Corporation | Intraluminal graft and method for insertion thereof |
US5782789A (en) | 1994-10-19 | 1998-07-21 | Atrium Medical Corporation | Macrochannel phosthetic/delivery patch |
US5836965A (en) | 1994-10-19 | 1998-11-17 | Jendersee; Brad | Stent delivery and deployment method |
CA2203122A1 (en) | 1994-10-20 | 1996-05-02 | Mordechay Beyar | Cystoscope delivery system |
US5836964A (en) | 1996-10-30 | 1998-11-17 | Medinol Ltd. | Stent fabrication method |
US5545135A (en) | 1994-10-31 | 1996-08-13 | Boston Scientific Corporation | Perfusion balloon stent |
US5534024A (en) | 1994-11-04 | 1996-07-09 | Aeroquip Corporation | Intraluminal stenting graft |
US5549662A (en) | 1994-11-07 | 1996-08-27 | Scimed Life Systems, Inc. | Expandable stent using sliding members |
EP0793512A1 (en) | 1994-11-07 | 1997-09-10 | University Of Medicine And Dentistry Of New Jersey | Synthetic collagen orthopaedic structures such as grafts, tendons and other structures |
DE69532966T2 (en) | 1994-11-09 | 2004-10-21 | Endotex Interventional Sys Inc | COMBINATION OF DELIVERY CATHETER AND IMPLANT FOR AN ANEURYSMA |
US6254978B1 (en) | 1994-11-14 | 2001-07-03 | W. L. Gore & Associates, Inc. | Ultra-thin integral composite membrane |
AU3783195A (en) | 1994-11-15 | 1996-05-23 | Advanced Cardiovascular Systems Inc. | Intraluminal stent for attaching a graft |
US5507770A (en) | 1994-11-23 | 1996-04-16 | Aeroquip Corporation | Intraluminal grafting stent and method for implanting same in a blood vessel |
CA2301351C (en) | 1994-11-28 | 2002-01-22 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for direct laser cutting of metal stents |
US5630829A (en) | 1994-12-09 | 1997-05-20 | Intervascular, Inc. | High hoop strength intraluminal stent |
IT1273855B (en) | 1994-12-16 | 1997-07-11 | Xtrode Srl | PROSTHESIS FOR VENOUS CAVITY |
NL9500147A (en) | 1995-01-26 | 1996-09-02 | Industrial Res Bv | A method of manufacturing a sheath-shaped stent from foil material and a stent obtained using this method. |
US5755770A (en) | 1995-01-31 | 1998-05-26 | Boston Scientific Corporatiion | Endovascular aortic graft |
US5575818A (en) | 1995-02-14 | 1996-11-19 | Corvita Corporation | Endovascular stent with locking ring |
US5522883A (en) | 1995-02-17 | 1996-06-04 | Meadox Medicals, Inc. | Endoprosthesis stent/graft deployment system |
US5662675A (en) | 1995-02-24 | 1997-09-02 | Intervascular, Inc. | Delivery catheter assembly |
US5683449A (en) | 1995-02-24 | 1997-11-04 | Marcade; Jean Paul | Modular bifurcated intraluminal grafts and methods for delivering and assembling same |
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US6818014B2 (en) | 1995-03-01 | 2004-11-16 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
EP1163889B1 (en) | 1995-03-01 | 2008-05-14 | Boston Scientific Scimed, Inc. | Improved longitudinally flexible expandable stent |
US5556414A (en) | 1995-03-08 | 1996-09-17 | Wayne State University | Composite intraluminal graft |
EP0813397A4 (en) | 1995-03-10 | 1999-10-06 | Cardiovascular Concepts Inc | Tubular endoluminar prosthesis having oblique ends |
US6451047B2 (en) | 1995-03-10 | 2002-09-17 | Impra, Inc. | Encapsulated intraluminal stent-graft and methods of making same |
US5476589A (en) | 1995-03-10 | 1995-12-19 | W. L. Gore & Associates, Inc. | Porpous PTFE film and a manufacturing method therefor |
US6579314B1 (en) | 1995-03-10 | 2003-06-17 | C.R. Bard, Inc. | Covered stent with encapsulated ends |
WO1996028115A1 (en) | 1995-03-10 | 1996-09-19 | Impra, Inc. | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery |
US6053943A (en) | 1995-12-08 | 2000-04-25 | Impra, Inc. | Endoluminal graft with integral structural support and method for making same |
US6124523A (en) | 1995-03-10 | 2000-09-26 | Impra, Inc. | Encapsulated stent |
US6264684B1 (en) | 1995-03-10 | 2001-07-24 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Helically supported graft |
US5591197A (en) | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
CA2171896C (en) | 1995-03-17 | 2007-05-15 | Scott C. Anderson | Multi-anchor stent |
US5709713A (en) | 1995-03-31 | 1998-01-20 | Cardiovascular Concepts, Inc. | Radially expansible vascular prosthesis having reversible and other locking structures |
US5693089A (en) | 1995-04-12 | 1997-12-02 | Inoue; Kanji | Method of collapsing an implantable appliance |
US5641373A (en) | 1995-04-17 | 1997-06-24 | Baxter International Inc. | Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft |
US5609628A (en) | 1995-04-20 | 1997-03-11 | Keranen; Victor J. | Intravascular graft and catheter |
US5667523A (en) | 1995-04-28 | 1997-09-16 | Impra, Inc. | Dual supported intraluminal graft |
US5552100A (en) | 1995-05-02 | 1996-09-03 | Baxter International Inc. | Method for manufacturing porous fluoropolymer films |
US5628786A (en) | 1995-05-12 | 1997-05-13 | Impra, Inc. | Radially expandable vascular graft with resistance to longitudinal compression and method of making same |
WO1996036297A1 (en) | 1995-05-19 | 1996-11-21 | Kanji Inoue | Transplantation instrument, method of bending same and method of transplanting same |
DE69635659T2 (en) | 1995-06-01 | 2006-07-06 | Meadox Medicals, Inc. | IMPLANTABLE INTRALUMINARY PROSTHESIS |
DE69629679T3 (en) | 1995-06-07 | 2011-07-07 | Edwards Lifesciences Corp., Calif. | REINFORCED VIDEO IMPLANT WITH AN OUTSTANDING SUPPORTED TAPE |
US7550005B2 (en) | 1995-06-07 | 2009-06-23 | Cook Incorporated | Coated implantable medical device |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
EP0830108B1 (en) | 1995-06-08 | 2003-09-17 | Ave Galway Limited | Endovascular stent |
US5728131A (en) | 1995-06-12 | 1998-03-17 | Endotex Interventional Systems, Inc. | Coupling device and method of use |
US5833707A (en) | 1995-07-05 | 1998-11-10 | Advanced Cardiovascular Systems, Inc. | Removable stent and method of deployment |
EP0840577B1 (en) | 1995-07-07 | 2005-08-24 | W.L. GORE & ASSOCIATES, INC. | Interior liner for tubes, pipes and blood conduits |
US5554180A (en) | 1995-07-07 | 1996-09-10 | Aeroquip Corporation | Intraluminal stenting graft |
US5785679A (en) | 1995-07-19 | 1998-07-28 | Endotex Interventional Systems, Inc. | Methods and apparatus for treating aneurysms and arterio-venous fistulas |
US5713948A (en) | 1995-07-19 | 1998-02-03 | Uflacker; Renan | Adjustable and retrievable graft and graft delivery system for stent-graft system |
US5766203A (en) | 1995-07-20 | 1998-06-16 | Intelliwire, Inc. | Sheath with expandable distal extremity and balloon catheters and stents for use therewith and method |
FR2737404B1 (en) | 1995-08-03 | 1997-09-19 | Braun Celsa Sa | PROSTHESIS IMPLANTABLE IN A HUMAN OR ANIMAL CONDUCT, SUCH AS A WALL Expander, OR ANEURISM PROSTHESIS |
US5814405A (en) | 1995-08-04 | 1998-09-29 | W. L. Gore & Associates, Inc. | Strong, air permeable membranes of polytetrafluoroethylene |
US5797951A (en) | 1995-08-09 | 1998-08-25 | Mueller; Edward Gene | Expandable support member |
US5697968A (en) | 1995-08-10 | 1997-12-16 | Aeroquip Corporation | Check valve for intraluminal graft |
DE69533289T2 (en) | 1995-08-24 | 2005-08-18 | Bard Peripheral Vascular, Inc., Tempe | ARRANGEMENT PROCESS OF A COVERED, ENDOLUMINARY STENT |
AU6905696A (en) | 1995-09-01 | 1997-03-27 | Emory University | Endovascular support device and method of use |
WO1999037242A1 (en) | 1998-01-26 | 1999-07-29 | Anson Medical Limited | Reinforced graft |
US5769882A (en) | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
DK171865B1 (en) | 1995-09-11 | 1997-07-21 | Cook William Europ | Expandable endovascular stent |
WO1997010778A1 (en) | 1995-09-18 | 1997-03-27 | W.L. Gore & Associates, Inc. | A delivery system for intraluminal vascular grafts |
US5868704A (en) | 1995-09-18 | 1999-02-09 | W. L. Gore & Associates, Inc. | Balloon catheter device |
US5562697A (en) | 1995-09-18 | 1996-10-08 | William Cook, Europe A/S | Self-expanding stent assembly and methods for the manufacture thereof |
US6193745B1 (en) | 1995-10-03 | 2001-02-27 | Medtronic, Inc. | Modular intraluminal prosteheses construction and methods |
US5824037A (en) | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
US6099558A (en) | 1995-10-10 | 2000-08-08 | Edwards Lifesciences Corp. | Intraluminal grafting of a bifuricated artery |
US5776161A (en) | 1995-10-16 | 1998-07-07 | Instent, Inc. | Medical stents, apparatus and method for making same |
US6287336B1 (en) | 1995-10-16 | 2001-09-11 | Medtronic, Inc. | Variable flexibility stent |
US5591195A (en) | 1995-10-30 | 1997-01-07 | Taheri; Syde | Apparatus and method for engrafting a blood vessel |
US6287315B1 (en) | 1995-10-30 | 2001-09-11 | World Medical Manufacturing Corporation | Apparatus for delivering an endoluminal prosthesis |
US5628788A (en) | 1995-11-07 | 1997-05-13 | Corvita Corporation | Self-expanding endoluminal stent-graft |
US6929659B2 (en) | 1995-11-07 | 2005-08-16 | Scimed Life Systems, Inc. | Method of preventing the dislodgment of a stent-graft |
EP0775470B1 (en) | 1995-11-14 | 1999-03-24 | Schneider (Europe) GmbH | Stent delivery device |
US5788626A (en) | 1995-11-21 | 1998-08-04 | Schneider (Usa) Inc | Method of making a stent-graft covered with expanded polytetrafluoroethylene |
US5665117A (en) | 1995-11-27 | 1997-09-09 | Rhodes; Valentine J. | Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use |
US6576009B2 (en) | 1995-12-01 | 2003-06-10 | Medtronic Ave, Inc. | Bifurcated intraluminal prostheses construction and methods |
US5824040A (en) | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses and therapies for highly variable body lumens |
JP3734509B2 (en) | 1995-12-08 | 2006-01-11 | バード・ペリフェラル・バスキュラー・インコーポレーテッド | Intravascular graft with monolithic support and method for manufacturing the same |
EP0950385A3 (en) | 1995-12-14 | 1999-10-27 | Prograft Medical, Inc. | Stent-graft deployment apparatus and method |
US6042605A (en) | 1995-12-14 | 2000-03-28 | Gore Enterprose Holdings, Inc. | Kink resistant stent-graft |
US5725547A (en) | 1996-01-04 | 1998-03-10 | Chuter; Timothy A. M. | Corrugated stent |
US6203569B1 (en) | 1996-01-04 | 2001-03-20 | Bandula Wijay | Flexible stent |
US5843158A (en) | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
EP0955954B1 (en) | 1996-01-05 | 2005-03-16 | Medtronic, Inc. | Expansible endoluminal prostheses |
US6878161B2 (en) | 1996-01-05 | 2005-04-12 | Medtronic Vascular, Inc. | Stent graft loading and deployment device and method |
US5749894A (en) | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
US5800512A (en) | 1996-01-22 | 1998-09-01 | Meadox Medicals, Inc. | PTFE vascular graft |
US6428571B1 (en) | 1996-01-22 | 2002-08-06 | Scimed Life Systems, Inc. | Self-sealing PTFE vascular graft and manufacturing methods |
US6258116B1 (en) | 1996-01-26 | 2001-07-10 | Cordis Corporation | Bifurcated axially flexible stent |
US6436104B2 (en) | 1996-01-26 | 2002-08-20 | Cordis Corporation | Bifurcated axially flexible stent |
US5895406A (en) | 1996-01-26 | 1999-04-20 | Cordis Corporation | Axially flexible stent |
US5747128A (en) | 1996-01-29 | 1998-05-05 | W. L. Gore & Associates, Inc. | Radially supported polytetrafluoroethylene vascular graft |
US5871537A (en) | 1996-02-13 | 1999-02-16 | Scimed Life Systems, Inc. | Endovascular apparatus |
US5843117A (en) | 1996-02-14 | 1998-12-01 | Inflow Dynamics Inc. | Implantable vascular and endoluminal stents and process of fabricating the same |
US5749921A (en) | 1996-02-20 | 1998-05-12 | Medtronic, Inc. | Apparatus and methods for compression of endoluminal prostheses |
CA2192520A1 (en) | 1996-03-05 | 1997-09-05 | Ian M. Penn | Expandable stent and method for delivery of same |
EP1477133B9 (en) | 1996-03-05 | 2007-11-21 | Evysio Medical Devices Ulc | Expandable stent |
US5607478A (en) | 1996-03-14 | 1997-03-04 | Meadox Medicals Inc. | Yarn wrapped PTFE tubular prosthesis |
US5843160A (en) | 1996-04-01 | 1998-12-01 | Rhodes; Valentine J. | Prostheses for aneurysmal and/or occlusive disease at a bifurcation in a vessel, duct, or lumen |
US5824042A (en) | 1996-04-05 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
US6413269B1 (en) | 2000-07-06 | 2002-07-02 | Endocare, Inc. | Stent delivery system |
DE19614160A1 (en) | 1996-04-10 | 1997-10-16 | Variomed Ag | Stent for transluminal implantation in hollow organs |
US20010029349A1 (en) | 1996-04-12 | 2001-10-11 | Boris Leschinsky | Method and apparatus for treating aneurysms |
BE1010183A3 (en) | 1996-04-25 | 1998-02-03 | Dereume Jean Pierre Georges Em | Luminal endoprosthesis FOR BRANCHING CHANNELS OF A HUMAN OR ANIMAL BODY AND MANUFACTURING METHOD THEREOF. |
US6241760B1 (en) | 1996-04-26 | 2001-06-05 | G. David Jang | Intravascular stent |
JP4636634B2 (en) | 1996-04-26 | 2011-02-23 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Intravascular stent |
US6036640A (en) | 1996-04-29 | 2000-03-14 | Medtronic, Inc. | Device and method for repositioning the heart during surgery |
US5718159A (en) | 1996-04-30 | 1998-02-17 | Schneider (Usa) Inc. | Process for manufacturing three-dimensional braided covered stent |
FR2748198B1 (en) | 1996-05-02 | 1998-08-21 | Braun Celsa Sa | PROSTHESIS IN PARTICULAR FOR THE TREATMENT OF ANNEVRISMS OVERFLOWING ON ILIAC VESSELS |
FR2748199B1 (en) | 1996-05-02 | 1998-10-09 | Braun Celsa Sa | TRANSCUTANEOUS SURGICAL ANASTOMOSABLE VASCULAR PROSTHESIS |
US6440165B1 (en) | 1996-05-03 | 2002-08-27 | Medinol, Ltd. | Bifurcated stent with improved side branch aperture and method of making same |
UA58485C2 (en) | 1996-05-03 | 2003-08-15 | Медінол Лтд. | Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants) |
US6251133B1 (en) | 1996-05-03 | 2001-06-26 | Medinol Ltd. | Bifurcated stent with improved side branch aperture and method of making same |
JP3273735B2 (en) | 1996-05-17 | 2002-04-15 | 日東電工株式会社 | Polytetrafluoroethylene porous membrane and method for producing the same, sheet-like polytetrafluoroethylene molded article, and filter medium for air filter |
NL1003178C2 (en) | 1996-05-21 | 1997-11-25 | Cordis Europ | Tubular prosthesis made of curable material. |
US5709701A (en) | 1996-05-30 | 1998-01-20 | Parodi; Juan C. | Apparatus for implanting a prothesis within a body passageway |
US5697971A (en) | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
DE19624642B4 (en) | 1996-06-20 | 2006-03-16 | Vascutek Ltd., Inchinnan | Vascular prosthesis and associated application device |
ATE288233T1 (en) | 1996-06-20 | 2005-02-15 | Vascutek Ltd | REPAIR OF BODY VESSELS USING PROSTHESES |
US5928279A (en) | 1996-07-03 | 1999-07-27 | Baxter International Inc. | Stented, radially expandable, tubular PTFE grafts |
US6060534A (en) | 1996-07-11 | 2000-05-09 | Scimed Life Systems, Inc. | Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
US6077295A (en) | 1996-07-15 | 2000-06-20 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent delivery system |
GB9614950D0 (en) | 1996-07-16 | 1996-09-04 | Anson Medical Ltd | A ductus stent and delivery catheter |
US5676697A (en) | 1996-07-29 | 1997-10-14 | Cardiovascular Dynamics, Inc. | Two-piece, bifurcated intraluminal graft for repair of aneurysm |
US5922020A (en) | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
AU3904197A (en) | 1996-08-09 | 1998-03-06 | John K. Edoga | Endoluminal graft replacement of abdominal aortic aneurysms |
US6325819B1 (en) | 1996-08-19 | 2001-12-04 | Cook Incorporated | Endovascular prosthetic device, an endovascular graft prothesis with such a device, and a method for repairing an abdominal aortic aneurysm |
DE19633901A1 (en) | 1996-08-22 | 1998-02-26 | Thomas Prof Dr Med Ischinger | Vascular support in the form of a tube section-like support structure |
US6391032B2 (en) | 1996-08-23 | 2002-05-21 | Scimed Life Systems, Inc. | Stent delivery system having stent securement means |
US6007543A (en) | 1996-08-23 | 1999-12-28 | Scimed Life Systems, Inc. | Stent delivery system with stent securement means |
US5776183A (en) | 1996-08-23 | 1998-07-07 | Kanesaka; Nozomu | Expandable stent |
US5980530A (en) | 1996-08-23 | 1999-11-09 | Scimed Life Systems Inc | Stent delivery system |
US5941249A (en) | 1996-09-05 | 1999-08-24 | Maynard; Ronald S. | Distributed activator for a two-dimensional shape memory alloy |
US5968068A (en) | 1996-09-12 | 1999-10-19 | Baxter International Inc. | Endovascular delivery system |
US6306165B1 (en) | 1996-09-13 | 2001-10-23 | Meadox Medicals | ePTFE small caliber vascular grafts with significant patency enhancement via a surface coating which contains covalently bonded heparin |
EP1011524A4 (en) | 1996-09-20 | 2001-04-25 | Medical Inc Converge | Radially expanding prostheses and systems for their deployment |
US5954764A (en) | 1996-09-20 | 1999-09-21 | Parodi; Juan Carlos | Device for concurrently placing an endovascular expander with an endovascular prosthesis |
US6174326B1 (en) | 1996-09-25 | 2001-01-16 | Terumo Kabushiki Kaisha | Radiopaque, antithrombogenic stent and method for its production |
WO1998012990A1 (en) | 1996-09-26 | 1998-04-02 | Scimed Life Systems, Inc. | Support structure/membrane composite medical device |
US5824046A (en) | 1996-09-27 | 1998-10-20 | Scimed Life Systems, Inc. | Covered stent |
US5755776A (en) | 1996-10-04 | 1998-05-26 | Al-Saadon; Khalid | Permanent expandable intraluminal tubular stent |
US6000601A (en) | 1996-10-22 | 1999-12-14 | Boston Scientific Corporation | Welding method |
ATE539702T1 (en) | 1996-11-04 | 2012-01-15 | Advanced Stent Tech Inc | DEVICE FOR EXPANDING A STENT AND METHOD FOR DEPLOYING IT |
US5976178A (en) | 1996-11-07 | 1999-11-02 | Vascular Science Inc. | Medical grafting methods |
US6036702A (en) | 1997-04-23 | 2000-03-14 | Vascular Science Inc. | Medical grafting connectors and fasteners |
US5833651A (en) | 1996-11-08 | 1998-11-10 | Medtronic, Inc. | Therapeutic intraluminal stents |
WO1998020810A1 (en) | 1996-11-12 | 1998-05-22 | Medtronic, Inc. | Flexible, radially expansible luminal prostheses |
AU7178698A (en) | 1996-11-15 | 1998-06-03 | Advanced Bio Surfaces, Inc. | Biomaterial system for in situ tissue repair |
US6395017B1 (en) | 1996-11-15 | 2002-05-28 | C. R. Bard, Inc. | Endoprosthesis delivery catheter with sequential stage control |
US5925074A (en) | 1996-12-03 | 1999-07-20 | Atrium Medical Corporation | Vascular endoprosthesis and method |
US6416537B1 (en) | 1996-12-03 | 2002-07-09 | Atrium Medical Corporation | Multi-stage prosthesis |
US6315791B1 (en) | 1996-12-03 | 2001-11-13 | Atrium Medical Corporation | Self-expanding prothesis |
AU743779B2 (en) | 1996-12-10 | 2002-02-07 | Cook Biotech, Inc. | Tubular grafts from purified submucosa |
US6096052A (en) | 1998-07-08 | 2000-08-01 | Ovion, Inc. | Occluding device and method of use |
US7073504B2 (en) | 1996-12-18 | 2006-07-11 | Ams Research Corporation | Contraceptive system and method of use |
US5776142A (en) | 1996-12-19 | 1998-07-07 | Medtronic, Inc. | Controllable stent delivery system and method |
US6551350B1 (en) | 1996-12-23 | 2003-04-22 | Gore Enterprise Holdings, Inc. | Kink resistant bifurcated prosthesis |
US6015431A (en) | 1996-12-23 | 2000-01-18 | Prograft Medical, Inc. | Endolumenal stent-graft with leak-resistant seal |
US6352561B1 (en) | 1996-12-23 | 2002-03-05 | W. L. Gore & Associates | Implant deployment apparatus |
US6494904B1 (en) | 1996-12-27 | 2002-12-17 | Ramus Medical Technologies | Method and apparatus for forming vascular prostheses |
US6117168A (en) | 1996-12-31 | 2000-09-12 | Scimed Life Systems, Inc. | Multilayer liquid absorption and deformation devices |
US5925061A (en) | 1997-01-13 | 1999-07-20 | Gore Enterprise Holdings, Inc. | Low profile vascular stent |
US5827310A (en) | 1997-01-14 | 1998-10-27 | Endovascular Systems, Inc. | Apparatus for forming custom length grafts after endoluminal insertion |
BE1010858A4 (en) | 1997-01-16 | 1999-02-02 | Medicorp R & D Benelux Sa | Luminal endoprosthesis FOR BRANCHING. |
US5961545A (en) | 1997-01-17 | 1999-10-05 | Meadox Medicals, Inc. | EPTFE graft-stent composite device |
US5843166A (en) | 1997-01-17 | 1998-12-01 | Meadox Medicals, Inc. | Composite graft-stent having pockets for accomodating movement |
US5858556A (en) | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
US5957974A (en) | 1997-01-23 | 1999-09-28 | Schneider (Usa) Inc | Stent graft with braided polymeric sleeve |
US6152956A (en) | 1997-01-28 | 2000-11-28 | Pierce; George E. | Prosthesis for endovascular repair of abdominal aortic aneurysms |
WO1998032399A1 (en) | 1997-01-29 | 1998-07-30 | Endovascular Technologies, Inc. | Bell-bottom modular stent-graft |
DE19703482A1 (en) | 1997-01-31 | 1998-08-06 | Ernst Peter Prof Dr M Strecker | Stent |
US6203735B1 (en) | 1997-02-03 | 2001-03-20 | Impra, Inc. | Method of making expanded polytetrafluoroethylene products |
US5827321A (en) | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US6090128A (en) | 1997-02-20 | 2000-07-18 | Endologix, Inc. | Bifurcated vascular graft deployment device |
US6500532B1 (en) | 1999-08-13 | 2002-12-31 | Bruce G. Ruefer | Expanded PTFE multilayer composite sheet |
ATE287679T1 (en) | 1997-03-05 | 2005-02-15 | Boston Scient Ltd | COMPLIANT MULTI-LAYER STENT DEVICE |
US6152944A (en) | 1997-03-05 | 2000-11-28 | Scimed Life Systems, Inc. | Catheter with removable balloon protector and stent delivery system with removable stent protector |
US5830229A (en) | 1997-03-07 | 1998-11-03 | Micro Therapeutics Inc. | Hoop stent |
JP2001514568A (en) | 1997-03-14 | 2001-09-11 | ベルナール ジョセフ スポエルストラ,ハリー | Device for endovascular repair of vascular segments |
US5810872A (en) | 1997-03-14 | 1998-09-22 | Kanesaka; Nozomu | Flexible stent |
US5853419A (en) | 1997-03-17 | 1998-12-29 | Surface Genesis, Inc. | Stent |
US6048360A (en) | 1997-03-18 | 2000-04-11 | Endotex Interventional Systems, Inc. | Methods of making and using coiled sheet graft for single and bifurcated lumens |
US6302908B1 (en) | 1997-03-24 | 2001-10-16 | Juan Carlos Parodi | Arterial graft device and method of positioning the same |
GR970100134A (en) | 1997-04-10 | 1998-12-31 | Bifurcated inravascular implant for the intravascular treatment of aneurysms of the abdominal aorta and implanting technique | |
US6240616B1 (en) | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US6143016A (en) | 1997-04-21 | 2000-11-07 | Advanced Cardiovascular Systems, Inc. | Sheath and method of use for a stent delivery system |
US6451049B2 (en) | 1998-04-29 | 2002-09-17 | Sorin Biomedica Cardio, S.P.A. | Stents for angioplasty |
US5957929A (en) | 1997-05-02 | 1999-09-28 | Micro Therapeutics, Inc. | Expandable stent apparatus and method |
US5741327A (en) | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US6245102B1 (en) | 1997-05-07 | 2001-06-12 | Iowa-India Investments Company Ltd. | Stent, stent graft and stent valve |
US6162245A (en) | 1997-05-07 | 2000-12-19 | Iowa-India Investments Company Limited | Stent valve and stent graft |
FR2762989B1 (en) | 1997-05-12 | 1999-09-03 | Braun Celsa Sa | SYSTEM FOR REPAIRING AN ANATOMIC DUCT BY A PROGRESSIVE OPENING IMPLANT |
DE19720115C2 (en) | 1997-05-14 | 1999-05-20 | Jomed Implantate Gmbh | Stent graft |
CA2308396A1 (en) | 1997-05-14 | 1998-11-19 | Novo Rps Ulc | Expandable stent and method for production of same |
US6143015A (en) | 1997-05-19 | 2000-11-07 | Cardio Medical Solutions, Inc. | Device and method for partially occluding blood vessels using flow-through balloon |
US5836966A (en) | 1997-05-22 | 1998-11-17 | Scimed Life Systems, Inc. | Variable expansion force stent |
US5906641A (en) | 1997-05-27 | 1999-05-25 | Schneider (Usa) Inc | Bifurcated stent graft |
CA2424551A1 (en) | 1997-05-27 | 1998-11-27 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
US6168616B1 (en) | 1997-06-02 | 2001-01-02 | Global Vascular Concepts | Manually expandable stent |
ES2238759T3 (en) | 1997-06-05 | 2005-09-01 | Adiana, Inc. | APPARATUS FOR THE OCLUSION OF THE UTERINE TRUMPS. |
US5746691A (en) | 1997-06-06 | 1998-05-05 | Global Therapeutics, Inc. | Method for polishing surgical stents |
US6007575A (en) | 1997-06-06 | 1999-12-28 | Samuels; Shaun Laurence Wilkie | Inflatable intraluminal stent and method for affixing same within the human body |
US6045498A (en) | 1997-06-12 | 2000-04-04 | Uromedica, Inc. | Method for adjustably restricting a body lumen |
US5843175A (en) | 1997-06-13 | 1998-12-01 | Global Therapeutics, Inc. | Enhanced flexibility surgical stent |
EP0884029B1 (en) | 1997-06-13 | 2004-12-22 | Gary J. Becker | Expandable intraluminal endoprosthesis |
US6102938A (en) | 1997-06-17 | 2000-08-15 | Medtronic Inc. | Endoluminal prosthetic bifurcation shunt |
GB9713624D0 (en) | 1997-06-28 | 1997-09-03 | Anson Medical Ltd | Expandable device |
US6071292A (en) | 1997-06-28 | 2000-06-06 | Transvascular, Inc. | Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures |
US5944750A (en) | 1997-06-30 | 1999-08-31 | Eva Corporation | Method and apparatus for the surgical repair of aneurysms |
ATE258032T1 (en) | 1997-06-30 | 2004-02-15 | Medex Holding Gmbh | INTRALUMINAL IMPLANT |
US5904713A (en) | 1997-07-14 | 1999-05-18 | Datascope Investment Corp. | Invertible bifurcated stent/graft and method of deployment |
US5906619A (en) | 1997-07-24 | 1999-05-25 | Medtronic, Inc. | Disposable delivery device for endoluminal prostheses |
JPH1142284A (en) | 1997-07-25 | 1999-02-16 | Ube Ind Ltd | Artificial blood vessel with stent |
US6070589A (en) | 1997-08-01 | 2000-06-06 | Teramed, Inc. | Methods for deploying bypass graft stents |
US6361544B1 (en) | 1997-08-13 | 2002-03-26 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
JPH1177787A (en) | 1997-09-02 | 1999-03-23 | Daikin Ind Ltd | Production of highly conductive polytetrafluoroethylene sheet and highly conductive polytetrafluoroethylene wide and long sheet |
US6063114A (en) | 1997-09-04 | 2000-05-16 | Kensey Nash Corporation | Connector system for vessels, ducts, lumens or hollow organs and methods of use |
US6306164B1 (en) | 1997-09-05 | 2001-10-23 | C. R. Bard, Inc. | Short body endoprosthesis |
US5968090A (en) | 1997-09-08 | 1999-10-19 | United States Surgical Corp. | Endovascular graft and method |
DE29716117U1 (en) | 1997-09-09 | 1999-01-14 | Micro Science Medical Ag | Stent |
US6206910B1 (en) | 1997-09-11 | 2001-03-27 | Wake Forest University | Compliant intraluminal stents |
US5984955A (en) | 1997-09-11 | 1999-11-16 | Wisselink; Willem | System and method for endoluminal grafting of bifurcated or branched vessels |
JP4292710B2 (en) | 1997-09-24 | 2009-07-08 | エム イー ディ インスチィチュート インク | Radially expandable stent |
US5948016A (en) | 1997-09-25 | 1999-09-07 | Jang; G. David | Intravascular stent with non-parallel slots |
US6042606A (en) | 1997-09-29 | 2000-03-28 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
US5972027A (en) | 1997-09-30 | 1999-10-26 | Scimed Life Systems, Inc | Porous stent drug delivery system |
US5984956A (en) | 1997-10-06 | 1999-11-16 | Heartstent Corporation | Transmyocardial implant |
US6013091A (en) | 1997-10-09 | 2000-01-11 | Scimed Life Systems, Inc. | Stent configurations |
US6132457A (en) | 1997-10-22 | 2000-10-17 | Triad Vascular Systems, Inc. | Endovascular graft having longitudinally displaceable sections |
US6309414B1 (en) | 1997-11-04 | 2001-10-30 | Sorin Biomedica Cardio S.P.A. | Angioplasty stents |
AU1170199A (en) | 1997-11-07 | 1999-05-31 | Ave Connaught | Balloon catheter for repairing bifurcated vessels |
US6030414A (en) | 1997-11-13 | 2000-02-29 | Taheri; Syde A. | Variable stent and method for treatment of arterial disease |
US5931865A (en) | 1997-11-24 | 1999-08-03 | Gore Enterprise Holdings, Inc. | Multiple-layered leak resistant tube |
US6331191B1 (en) | 1997-11-25 | 2001-12-18 | Trivascular Inc. | Layered endovascular graft |
AUPP083597A0 (en) | 1997-12-10 | 1998-01-08 | William A Cook Australia Pty Ltd | Endoluminal aortic stents |
US6235051B1 (en) | 1997-12-16 | 2001-05-22 | Timothy P. Murphy | Method of stent-graft system delivery |
US6248116B1 (en) | 1997-12-16 | 2001-06-19 | B. Braun Celsa | Medical treatment of a diseased anatomical duct |
US6503271B2 (en) | 1998-01-09 | 2003-01-07 | Cordis Corporation | Intravascular device with improved radiopacity |
US6190406B1 (en) * | 1998-01-09 | 2001-02-20 | Nitinal Development Corporation | Intravascular stent having tapered struts |
US6074398A (en) | 1998-01-13 | 2000-06-13 | Datascope Investment Corp. | Reduced diameter stent/graft deployment catheter |
US7520890B2 (en) | 1998-01-26 | 2009-04-21 | Phillips Peter W | Reinforced graft and method of deployment |
US5873907A (en) | 1998-01-27 | 1999-02-23 | Endotex Interventional Systems, Inc. | Electrolytic stent delivery system and methods of use |
CA2318829C (en) | 1998-02-02 | 2007-11-13 | Impra, Inc. | Encapsulated intraluminal stent-graft and methods of making same |
US6533807B2 (en) * | 1998-02-05 | 2003-03-18 | Medtronic, Inc. | Radially-expandable stent and delivery system |
US6395019B2 (en) | 1998-02-09 | 2002-05-28 | Trivascular, Inc. | Endovascular graft |
US6102918A (en) | 1998-02-18 | 2000-08-15 | Montefiore Hospital And Medical Center | Collapsible low-profile vascular graft implantation instrument and method for use thereof |
FR2775182B1 (en) | 1998-02-25 | 2000-07-28 | Legona Anstalt | DEVICE FORMING INTRACORPOREAL ENDOLUMINAL ANDOPROTHESIS, IN PARTICULAR AORTIC ABDOMINAL |
US6488701B1 (en) | 1998-03-31 | 2002-12-03 | Medtronic Ave, Inc. | Stent-graft assembly with thin-walled graft component and method of manufacture |
DK174814B1 (en) | 1998-02-25 | 2003-12-01 | Cook William Europ | stent device |
US6015432A (en) | 1998-02-25 | 2000-01-18 | Cordis Corporation | Wire reinforced vascular prosthesis |
US6280467B1 (en) | 1998-02-26 | 2001-08-28 | World Medical Manufacturing Corporation | Delivery system for deployment and endovascular assembly of a multi-stage stented graft |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6077296A (en) | 1998-03-04 | 2000-06-20 | Endologix, Inc. | Endoluminal vascular prosthesis |
US6019778A (en) | 1998-03-13 | 2000-02-01 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US6425898B1 (en) | 1998-03-13 | 2002-07-30 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US6224609B1 (en) | 1998-03-16 | 2001-05-01 | Teramed Inc. | Bifurcated prosthetic graft |
US6129756A (en) | 1998-03-16 | 2000-10-10 | Teramed, Inc. | Biluminal endovascular graft system |
EP0943300A1 (en) | 1998-03-17 | 1999-09-22 | Medicorp S.A. | Reversible action endoprosthesis delivery device. |
US6132461A (en) | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
US5980570A (en) | 1998-03-27 | 1999-11-09 | Sulzer Carbomedics Inc. | System and method for implanting an expandable medical device into a body |
US6558415B2 (en) | 1998-03-27 | 2003-05-06 | Intratherapeutics, Inc. | Stent |
US6656215B1 (en) | 2000-11-16 | 2003-12-02 | Cordis Corporation | Stent graft having an improved means for attaching a stent to a graft |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US6290731B1 (en) | 1998-03-30 | 2001-09-18 | Cordis Corporation | Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm |
US6520983B1 (en) | 1998-03-31 | 2003-02-18 | Scimed Life Systems, Inc. | Stent delivery system |
US6103172A (en) | 1998-04-07 | 2000-08-15 | Pall Corporation | Method of preparaing a porous polytetrafluoroethylene membranne |
US6524336B1 (en) | 1998-04-09 | 2003-02-25 | Cook Incorporated | Endovascular graft |
US6364856B1 (en) | 1998-04-14 | 2002-04-02 | Boston Scientific Corporation | Medical device with sponge coating for controlled drug release |
US6436133B1 (en) | 1998-04-15 | 2002-08-20 | Joseph G. Furst | Expandable graft |
US6146389A (en) | 1998-04-23 | 2000-11-14 | Boston Scientific Corporation | Stent deployment device and method for deploying a stent |
US6494907B1 (en) | 1998-04-28 | 2002-12-17 | Intratherapeutics, Inc. | Braided stent |
US6497722B1 (en) | 1998-05-04 | 2002-12-24 | Jomed Gmbh | Methods and apparatus for in-vivo tailored stents indicated for use in tortuous anatomy |
WO1999056663A2 (en) | 1998-05-05 | 1999-11-11 | Scimed Life Systems, Inc. | Stent with smooth ends |
US5989287A (en) | 1998-05-06 | 1999-11-23 | Av Healing Llc | Vascular graft assemblies and methods for implanting same |
US6093203A (en) | 1998-05-13 | 2000-07-25 | Uflacker; Renan | Stent or graft support structure for treating bifurcated vessels having different diameter portions and methods of use and implantation |
CA2332801A1 (en) | 1998-05-15 | 1999-11-25 | Shelhigh, Inc. | Intra vascular implant and method of manufacture thereof |
US6447501B1 (en) | 1998-05-15 | 2002-09-10 | X Technologies Inc. | Enhanced stent delivery system |
US6132458A (en) | 1998-05-15 | 2000-10-17 | American Medical Systems, Inc. | Method and device for loading a stent |
DE19822157B4 (en) | 1998-05-16 | 2013-01-10 | Abbott Laboratories Vascular Enterprises Ltd. | Radially expandable stent for implantation in a body vessel |
US7452371B2 (en) | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
JP4399585B2 (en) | 1998-06-02 | 2010-01-20 | クック インコーポレイティド | Multi-sided medical device |
US6074341A (en) | 1998-06-09 | 2000-06-13 | Timm Medical Technologies, Inc. | Vessel occlusive apparatus and method |
US6036725A (en) | 1998-06-10 | 2000-03-14 | General Science And Technology | Expandable endovascular support device |
EP1087729B1 (en) | 1998-06-19 | 2006-10-11 | Endologix, Inc. | Self expanding bifurcated endovascular prosthesis |
US20020007193A1 (en) | 1998-07-01 | 2002-01-17 | Howard Tanner | Method and apparatus for the surgical repair of aneurysms |
US6261319B1 (en) | 1998-07-08 | 2001-07-17 | Scimed Life Systems, Inc. | Stent |
US6143021A (en) | 1998-07-10 | 2000-11-07 | American Medical Systems, Inc. | Stent placement instrument and method of assembly |
US6264662B1 (en) | 1998-07-21 | 2001-07-24 | Sulzer Vascutek Ltd. | Insertion aid for a bifurcated prosthesis |
US6325824B2 (en) | 1998-07-22 | 2001-12-04 | Advanced Cardiovascular Systems, Inc. | Crush resistant stent |
US5911754A (en) | 1998-07-24 | 1999-06-15 | Uni-Cath Inc. | Flexible stent with effective strut and connector patterns |
EP1029584A4 (en) | 1998-08-11 | 2005-11-16 | Daicel Chem | Cellulose acetate semipermeable membrane and method for producing the same |
US6156064A (en) | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
US6159239A (en) | 1998-08-14 | 2000-12-12 | Prodesco, Inc. | Woven stent/graft structure |
US6312461B1 (en) | 1998-08-21 | 2001-11-06 | John D. Unsworth | Shape memory tubular stent |
US6143022A (en) | 1998-08-24 | 2000-11-07 | Medtronic Ave, Inc. | Stent-graft assembly with dual configuration graft component and method of manufacture |
US6117117A (en) | 1998-08-24 | 2000-09-12 | Advanced Cardiovascular Systems, Inc. | Bifurcated catheter assembly |
US6238432B1 (en) | 1998-08-25 | 2001-05-29 | Juan Carlos Parodi | Stent graft device for treating abdominal aortic aneurysms |
US6514281B1 (en) | 1998-09-04 | 2003-02-04 | Scimed Life Systems, Inc. | System for delivering bifurcation stents |
US6500204B1 (en) | 1998-09-08 | 2002-12-31 | Kabushikikaisha Igaki Iryo Sekkei | Stent for vessels |
US6193744B1 (en) | 1998-09-10 | 2001-02-27 | Scimed Life Systems, Inc. | Stent configurations |
US6290728B1 (en) | 1998-09-10 | 2001-09-18 | Percardia, Inc. | Designs for left ventricular conduit |
US6261304B1 (en) | 1998-09-10 | 2001-07-17 | Percardia, Inc. | Delivery methods for left ventricular conduit |
US6196230B1 (en) | 1998-09-10 | 2001-03-06 | Percardia, Inc. | Stent delivery system and method of use |
US6248112B1 (en) | 1998-09-30 | 2001-06-19 | C. R. Bard, Inc. | Implant delivery system |
EP1726271B1 (en) | 1998-09-30 | 2012-07-25 | Bard Peripheral Vascular, Inc. | Selective adherence of stentgraft coverings, mandrel and method of making stent-graft device |
US6547814B2 (en) | 1998-09-30 | 2003-04-15 | Impra, Inc. | Selective adherence of stent-graft coverings |
US6368345B1 (en) | 1998-09-30 | 2002-04-09 | Edwards Lifesciences Corporation | Methods and apparatus for intraluminal placement of a bifurcated intraluminal garafat |
AUPQ302999A0 (en) | 1999-09-23 | 1999-10-21 | Endogad Research Pty Limited | Pre-shaped intraluminal graft |
US6358276B1 (en) | 1998-09-30 | 2002-03-19 | Impra, Inc. | Fluid containing endoluminal stent |
US6203550B1 (en) | 1998-09-30 | 2001-03-20 | Medtronic, Inc. | Disposable delivery device for endoluminal prostheses |
US6273909B1 (en) | 1998-10-05 | 2001-08-14 | Teramed Inc. | Endovascular graft system |
US6019779A (en) | 1998-10-09 | 2000-02-01 | Intratherapeutics Inc. | Multi-filar coil medical stent |
US6168619B1 (en) | 1998-10-16 | 2001-01-02 | Quanam Medical Corporation | Intravascular stent having a coaxial polymer member and end sleeves |
US6042597A (en) | 1998-10-23 | 2000-03-28 | Scimed Life Systems, Inc. | Helical stent design |
US6214036B1 (en) | 1998-11-09 | 2001-04-10 | Cordis Corporation | Stent which is easily recaptured and repositioned within the body |
US6540780B1 (en) | 1998-11-23 | 2003-04-01 | Medtronic, Inc. | Porous synthetic vascular grafts with oriented ingrowth channels |
US6336937B1 (en) | 1998-12-09 | 2002-01-08 | Gore Enterprise Holdings, Inc. | Multi-stage expandable stent-graft |
AU1474700A (en) | 1998-12-11 | 2000-06-26 | Endologix, Inc. | Endoluminal vascular prosthesis |
US6733523B2 (en) | 1998-12-11 | 2004-05-11 | Endologix, Inc. | Implantable vascular graft |
US6187036B1 (en) | 1998-12-11 | 2001-02-13 | Endologix, Inc. | Endoluminal vascular prosthesis |
US6660030B2 (en) | 1998-12-11 | 2003-12-09 | Endologix, Inc. | Bifurcation graft deployment catheter |
US6197049B1 (en) | 1999-02-17 | 2001-03-06 | Endologix, Inc. | Articulating bifurcation graft |
DE29822381U1 (en) | 1998-12-16 | 1999-03-18 | Fumedica Intertrade Ag | Device for inserting an aortic endoprosthesis |
US6363938B2 (en) | 1998-12-22 | 2002-04-02 | Angiotrax, Inc. | Methods and apparatus for perfusing tissue and/or stimulating revascularization and tissue growth |
US6652554B1 (en) | 1999-01-04 | 2003-11-25 | Mark H. Wholey | Instrument for thromboembolic protection |
EP1020166A1 (en) | 1999-01-12 | 2000-07-19 | Orbus Medical Technologies, Inc. | Expandable intraluminal endoprosthesis |
US6530950B1 (en) | 1999-01-12 | 2003-03-11 | Quanam Medical Corporation | Intraluminal stent having coaxial polymer member |
US6022359A (en) | 1999-01-13 | 2000-02-08 | Frantzen; John J. | Stent delivery system featuring a flexible balloon |
US6187034B1 (en) | 1999-01-13 | 2001-02-13 | John J. Frantzen | Segmented stent for flexible stent delivery system |
US6350277B1 (en) | 1999-01-15 | 2002-02-26 | Scimed Life Systems, Inc. | Stents with temporary retaining bands |
CA2360587A1 (en) | 1999-01-15 | 2000-07-20 | Darin C. Gittings | Methods and devices for forming vascular anastomoses |
EP1121066B1 (en) | 1999-01-22 | 2006-05-17 | Gore Enterprise Holdings, Inc. | Covered endoprosthesis |
AU768071B2 (en) | 1999-01-22 | 2003-12-04 | W.L. Gore & Associates, Inc. | Low profile stent and graft combination |
US6517571B1 (en) | 1999-01-22 | 2003-02-11 | Gore Enterprise Holdings, Inc. | Vascular graft with improved flow surfaces |
US6673102B1 (en) | 1999-01-22 | 2004-01-06 | Gore Enterprises Holdings, Inc. | Covered endoprosthesis and delivery system |
US6395208B1 (en) | 1999-01-25 | 2002-05-28 | Atrium Medical Corporation | Method of making an expandable fluoropolymer device |
DE60021173T2 (en) | 1999-01-27 | 2006-04-27 | Boston Scientific Ltd., St Michael | BIFURKATIONSSTENTEINFÜHRSYSTEM |
ATE514729T1 (en) | 1999-02-01 | 2011-07-15 | Eidgenoess Tech Hochschule | BIOMATERIALS ADDED BY NUCLEOPHILIC REACTION ON CONJUGATE UNSATURATED GROUPS |
IL144695A0 (en) | 1999-02-01 | 2002-06-30 | Univ Texas | Woven bifurcated and trifurcated stents and methods for making the same |
US6398803B1 (en) | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
US6558414B2 (en) | 1999-02-02 | 2003-05-06 | Impra, Inc. | Partial encapsulation of stents using strips and bands |
US6187054B1 (en) | 1999-02-04 | 2001-02-13 | Endomed Inc. | Method of making large diameter vascular prosteheses and a vascular prosthesis made by said method |
US6162246A (en) | 1999-02-16 | 2000-12-19 | Barone; Hector Daniel | Aortic graft and method of treating abdominal aortic aneurysms |
US6077298A (en) | 1999-02-20 | 2000-06-20 | Tu; Lily Chen | Expandable/retractable stent and methods thereof |
US6200339B1 (en) | 1999-02-23 | 2001-03-13 | Datascope Investment Corp. | Endovascular split-tube bifurcated graft prosthesis and an implantation method for such a prosthesis |
EP1156758B1 (en) | 1999-02-26 | 2008-10-15 | LeMaitre Vascular, Inc. | Coiled stent |
GB9904722D0 (en) | 1999-03-03 | 1999-04-21 | Murch Clifford R | A tubular intraluminal graft |
US20030225453A1 (en) | 1999-03-03 | 2003-12-04 | Trivascular, Inc. | Inflatable intraluminal graft |
US5976155A (en) | 1999-03-05 | 1999-11-02 | Advanced Cardiovascular Systems, Inc. | System for removably securing a stent on a catheter assembly and method of use |
US6261316B1 (en) | 1999-03-11 | 2001-07-17 | Endologix, Inc. | Single puncture bifurcation graft deployment system |
US6273910B1 (en) | 1999-03-11 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Stent with varying strut geometry |
US6203779B1 (en) | 1999-03-19 | 2001-03-20 | Charlie Ricci | Methods for treating endoleaks during endovascular repair of abdominal aortic aneurysms |
US6303100B1 (en) | 1999-03-19 | 2001-10-16 | Micro Therapeutics, Inc. | Methods for inhibiting the formation of potential endoleaks associated with endovascular repair of abdominal aortic aneurysms |
US6331186B1 (en) | 1999-03-22 | 2001-12-18 | Scimed Life Systems, Inc. | End sleeve coating for stent delivery |
US6258099B1 (en) | 1999-03-31 | 2001-07-10 | Scimed Life Systems, Inc. | Stent security balloon/balloon catheter |
US6312457B1 (en) | 1999-04-01 | 2001-11-06 | Boston Scientific Corporation | Intraluminal lining |
US6425855B2 (en) | 1999-04-06 | 2002-07-30 | Cordis Corporation | Method for making a multi-laminate stent having superelastic articulated sections |
US6325825B1 (en) | 1999-04-08 | 2001-12-04 | Cordis Corporation | Stent with variable wall thickness |
US6273911B1 (en) | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6368347B1 (en) | 1999-04-23 | 2002-04-09 | Sulzer Vascutek Ltd. | Expanded polytetrafluoroethylene vascular graft with coating |
US6287335B1 (en) | 1999-04-26 | 2001-09-11 | William J. Drasler | Intravascular folded tubular endoprosthesis |
US6328762B1 (en) | 1999-04-27 | 2001-12-11 | Sulzer Biologics, Inc. | Prosthetic grafts |
US6245101B1 (en) | 1999-05-03 | 2001-06-12 | William J. Drasler | Intravascular hinge stent |
US6146415A (en) | 1999-05-07 | 2000-11-14 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US6726712B1 (en) | 1999-05-14 | 2004-04-27 | Boston Scientific Scimed | Prosthesis deployment device with translucent distal end |
US6673103B1 (en) | 1999-05-20 | 2004-01-06 | Scimed Life Systems, Inc. | Mesh and stent for increased flexibility |
WO2000071058A1 (en) | 1999-05-20 | 2000-11-30 | Boston Scientific Limited | Stent delivery system with nested stabilizer and method of loading and using same |
ES2238287T3 (en) | 1999-05-26 | 2005-09-01 | Bard Peripheral Vascular, Inc. | VASCULAR INJERT OF EXPANDED POLYETRAFLUORETILENE WITH IMPROVED CICATRIZATION RESPONSE. |
US6368346B1 (en) | 1999-06-03 | 2002-04-09 | American Medical Systems, Inc. | Bioresorbable stent |
US6280457B1 (en) | 1999-06-04 | 2001-08-28 | Scimed Life Systems, Inc. | Polymer covered vaso-occlusive devices and methods of producing such devices |
US6168617B1 (en) | 1999-06-14 | 2001-01-02 | Scimed Life Systems, Inc. | Stent delivery system |
US6398802B1 (en) | 1999-06-21 | 2002-06-04 | Scimed Life Systems, Inc. | Low profile delivery system for stent and graft deployment |
US6287329B1 (en) | 1999-06-28 | 2001-09-11 | Nitinol Development Corporation | Stent keeper for a self-expanding stent delivery system |
US6652570B2 (en) | 1999-07-02 | 2003-11-25 | Scimed Life Systems, Inc. | Composite vascular graft |
US6409754B1 (en) | 1999-07-02 | 2002-06-25 | Scimed Life Systems, Inc. | Flexible segmented stent |
US6364904B1 (en) | 1999-07-02 | 2002-04-02 | Scimed Life Systems, Inc. | Helically formed stent/graft assembly |
DK1113764T3 (en) | 1999-07-16 | 2004-01-26 | Cook Inc | Stent suitable for entanglement-free unfolding |
AU6000200A (en) | 1999-07-16 | 2001-02-05 | Biocompatibles Limited | Braided stent |
US6554857B1 (en) | 1999-07-20 | 2003-04-29 | Medtronic, Inc | Transmural concentric multilayer ingrowth matrix within well-defined porosity |
US6569193B1 (en) | 1999-07-22 | 2003-05-27 | Advanced Cardiovascular Systems, Inc. | Tapered self-expanding stent |
US6402779B1 (en) | 1999-07-26 | 2002-06-11 | Endomed, Inc. | Balloon-assisted intraluminal stent graft |
US6485507B1 (en) | 1999-07-28 | 2002-11-26 | Scimed Life Systems | Multi-property nitinol by heat treatment |
DE19936207A1 (en) | 1999-08-02 | 2001-02-15 | Angiomed Ag | Catheter and introducer with separator |
EP1207819B1 (en) | 1999-08-06 | 2009-03-04 | Cook Biotech, Inc. | Tubular graft construct |
FR2797389B1 (en) | 1999-08-09 | 2001-11-30 | Novatech Inc | BIFURCED AORTIC PROSTHESIS |
AU7095300A (en) | 1999-09-01 | 2001-03-26 | Scimed Life Systems, Inc. | Tubular stent-graft composite device and method of manufacture |
US6293968B1 (en) | 1999-09-02 | 2001-09-25 | Syde A. Taheri | Inflatable intraluminal vascular stent |
US6379381B1 (en) | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
US6409757B1 (en) | 1999-09-15 | 2002-06-25 | Eva Corporation | Method and apparatus for supporting a graft assembly |
US6312462B1 (en) | 1999-09-22 | 2001-11-06 | Impra, Inc. | Prosthesis for abdominal aortic aneurysm repair |
US6183481B1 (en) | 1999-09-22 | 2001-02-06 | Endomed Inc. | Delivery system for self-expanding stents and grafts |
AUPQ302899A0 (en) | 1999-09-23 | 1999-10-21 | Endogad Research Pty Limited | Implants for the use in the treatment of aneurysmal disease |
US6270525B1 (en) | 1999-09-23 | 2001-08-07 | Cordis Corporation | Precursor stent gasket for receiving bilateral grafts having controlled contralateral guidewire access |
US20020123790A1 (en) | 1999-09-28 | 2002-09-05 | White Geoffrey Hamilton | Enhanced engagement member for anchoring prosthetic devices in body lumen |
US6533806B1 (en) | 1999-10-01 | 2003-03-18 | Scimed Life Systems, Inc. | Balloon yielded delivery system and endovascular graft design for easy deployment |
US6383213B2 (en) | 1999-10-05 | 2002-05-07 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US20020198585A1 (en) | 1999-10-05 | 2002-12-26 | Willem Wisselink | System and method for edoluminal grafting of bifurcated or branched vessels |
WO2001028454A2 (en) | 1999-10-05 | 2001-04-26 | Amjad Ahmad | Intra vascular stent |
DE60021917D1 (en) | 1999-10-08 | 2005-09-15 | Gen Hospital Corp | Perkutane stentprothese |
WO2001026584A1 (en) | 1999-10-14 | 2001-04-19 | United Stenting, Inc. | Stents with multilayered struts |
US6319279B1 (en) | 1999-10-15 | 2001-11-20 | Edwards Lifesciences Corp. | Laminated self-sealing vascular access graft |
US6409753B1 (en) | 1999-10-26 | 2002-06-25 | Scimed Life Systems, Inc. | Flexible stent |
US6325823B1 (en) | 1999-10-29 | 2001-12-04 | Revasc Corporation | Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use |
US6428569B1 (en) | 1999-11-09 | 2002-08-06 | Scimed Life Systems Inc. | Micro structure stent configurations |
US7758624B2 (en) | 2000-11-13 | 2010-07-20 | C. R. Bard, Inc. | Implant delivery device |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
WO2001035715A2 (en) | 1999-11-18 | 2001-05-25 | Petrus Besselink | Method for placing bifurcated stents |
US7011673B2 (en) | 1999-11-22 | 2006-03-14 | Fischell Robert E | Stent delivery system with a fixed guide wire |
US20020055768A1 (en) | 1999-11-24 | 2002-05-09 | Kathy Hess | Method of manufacturing a thin-layered, endovascular, polymer-covered stent device |
US6280466B1 (en) | 1999-12-03 | 2001-08-28 | Teramed Inc. | Endovascular graft system |
US6673107B1 (en) | 1999-12-06 | 2004-01-06 | Advanced Cardiovascular Systems, Inc. | Bifurcated stent and method of making |
WO2001041675A1 (en) | 1999-12-07 | 2001-06-14 | Edwards Lifesciences Corporation | Novel enhanced flexible expandable stents |
US6251136B1 (en) | 1999-12-08 | 2001-06-26 | Advanced Cardiovascular Systems, Inc. | Method of layering a three-coated stent using pharmacological and polymeric agents |
US6254593B1 (en) | 1999-12-10 | 2001-07-03 | Advanced Cardiovascular Systems, Inc. | Bifurcated stent delivery system having retractable sheath |
US6702849B1 (en) | 1999-12-13 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers |
US6443979B1 (en) | 1999-12-20 | 2002-09-03 | Advanced Cardiovascular Systems, Inc. | Expandable stent delivery sheath and method of use |
US6428506B1 (en) | 1999-12-22 | 2002-08-06 | Advanced Cardiovascular Systems, Inc. | Medical device formed of ultrahigh molecular weight polyethylene |
US6663667B2 (en) | 1999-12-29 | 2003-12-16 | Edwards Lifesciences Corporation | Towel graft means for enhancing tissue ingrowth in vascular grafts |
US6471721B1 (en) | 1999-12-30 | 2002-10-29 | Advanced Cardiovascular Systems, Inc. | Vascular stent having increased radiopacity and method for making same |
US6312458B1 (en) | 2000-01-19 | 2001-11-06 | Scimed Life Systems, Inc. | Tubular structure/stent/stent securement member |
US6355063B1 (en) | 2000-01-20 | 2002-03-12 | Impra, Inc. | Expanded PTFE drug delivery graft |
US6409756B1 (en) | 2000-01-24 | 2002-06-25 | Edward G. Murphy | Endovascular aortic graft |
US6245100B1 (en) | 2000-02-01 | 2001-06-12 | Cordis Corporation | Method for making a self-expanding stent-graft |
US6296661B1 (en) | 2000-02-01 | 2001-10-02 | Luis A. Davila | Self-expanding stent-graft |
US6602280B2 (en) | 2000-02-02 | 2003-08-05 | Trivascular, Inc. | Delivery system and method for expandable intracorporeal device |
AU2001238038B2 (en) | 2000-02-03 | 2005-08-25 | Cook Biotech, Inc. | Implantable vascular device |
SE0000363A0 (en) | 2000-02-04 | 2001-08-05 | Zoucas Kirurgkonsult Ab | Coated medical device |
NL1014559C2 (en) | 2000-02-11 | 2001-08-14 | Surgical Innovations Vof | Umbrella stent. |
US6344044B1 (en) | 2000-02-11 | 2002-02-05 | Edwards Lifesciences Corp. | Apparatus and methods for delivery of intraluminal prosthesis |
US6423090B1 (en) | 2000-02-11 | 2002-07-23 | Advanced Cardiovascular Systems, Inc. | Stent pattern with staged expansion |
GB0003387D0 (en) | 2000-02-14 | 2000-04-05 | Angiomed Ag | Stent matrix |
US6432129B2 (en) | 2000-02-22 | 2002-08-13 | Scimed Life Systems, Inc. | Stent delivery system |
US6391050B1 (en) | 2000-02-29 | 2002-05-21 | Scimed Life Systems, Inc. | Self-expanding stent delivery system |
US6527753B2 (en) | 2000-02-29 | 2003-03-04 | Olympus Optical Co., Ltd. | Endoscopic treatment system |
US6319278B1 (en) | 2000-03-03 | 2001-11-20 | Stephen F. Quinn | Low profile device for the treatment of vascular abnormalities |
PT1259192E (en) | 2000-03-03 | 2004-04-30 | Cook Inc | ENDOVASCULAR DEVICE WITH A ENDOPROTESE |
US6929658B1 (en) | 2000-03-09 | 2005-08-16 | Design & Performance-Cyprus Limited | Stent with cover connectors |
EP1263348B1 (en) | 2000-03-09 | 2006-02-08 | Design & Performance - Cyprus Limited | Intraluminal prosthesis |
US6613082B2 (en) | 2000-03-13 | 2003-09-02 | Jun Yang | Stent having cover with drug delivery capability |
US6379382B1 (en) | 2000-03-13 | 2002-04-30 | Jun Yang | Stent having cover with drug delivery capability |
DK1263349T3 (en) | 2000-03-14 | 2009-10-19 | Cook Inc | Endovascular stent graft |
DE60141466D1 (en) | 2000-03-30 | 2010-04-15 | Teramed Corp | BRANCHED TRANSPLANT |
US20020049490A1 (en) | 2000-04-11 | 2002-04-25 | Pollock David T. | Single-piece endoprosthesis with high expansion ratios |
WO2001076675A2 (en) | 2000-04-11 | 2001-10-18 | Scimed Life Systems, Inc. | Reinforced retention structures |
US6517573B1 (en) * | 2000-04-11 | 2003-02-11 | Endovascular Technologies, Inc. | Hook for attaching to a corporeal lumen and method of manufacturing |
GB2369575A (en) | 2000-04-20 | 2002-06-05 | Salviac Ltd | An embolic protection system |
US6361556B1 (en) | 2000-04-27 | 2002-03-26 | Endovascular Tech Inc | System and method for endovascular aneurysm repair in conjuction with vascular stabilization |
US6520984B1 (en) | 2000-04-28 | 2003-02-18 | Cardiovasc, Inc. | Stent graft assembly and method |
US6451050B1 (en) | 2000-04-28 | 2002-09-17 | Cardiovasc, Inc. | Stent graft and method |
US7226474B2 (en) | 2000-05-01 | 2007-06-05 | Endovascular Technologies, Inc. | Modular graft component junctions |
US7666221B2 (en) | 2000-05-01 | 2010-02-23 | Endovascular Technologies, Inc. | Lock modular graft component junctions |
US7686842B2 (en) | 2000-05-04 | 2010-03-30 | Oregon Health Sciences University | Endovascular stent graft |
US6454796B1 (en) | 2000-05-05 | 2002-09-24 | Endovascular Technologies, Inc. | Vascular graft |
JP4754714B2 (en) | 2000-06-01 | 2011-08-24 | テルモ株式会社 | Intraluminal indwelling |
US6478807B1 (en) | 2000-06-08 | 2002-11-12 | Advanced Cardiovascular Systems, Inc. | Pre-formed expandable member having grooves |
US20020077693A1 (en) | 2000-12-19 | 2002-06-20 | Barclay Bruce J. | Covered, coiled drug delivery stent and method |
ES2228912T3 (en) | 2000-07-14 | 2005-04-16 | Cook Incorporated | DEVICE FOR MEDICAL USE WITH BRAIDED AND COIL. |
US6475166B1 (en) | 2000-08-18 | 2002-11-05 | Endovascular Technologies, Inc. | Guidewire placement system for delivery of an aneurysm graft limb |
ES2257436T3 (en) | 2000-08-23 | 2006-08-01 | Thoratec Corporation | VASCULATOR IMPLANTS COVERED AND USE PROCEDURES. |
DE10044043A1 (en) | 2000-08-30 | 2002-03-14 | Biotronik Mess & Therapieg | Repositionable stent |
US6478815B1 (en) | 2000-09-18 | 2002-11-12 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US6945989B1 (en) | 2000-09-18 | 2005-09-20 | Endotex Interventional Systems, Inc. | Apparatus for delivering endoluminal prostheses and methods of making and using them |
US20030050684A1 (en) | 2001-09-10 | 2003-03-13 | Abrams Robert M. | Internal restraint for delivery of self-expanding stents |
US8070792B2 (en) | 2000-09-22 | 2011-12-06 | Boston Scientific Scimed, Inc. | Stent |
US20020072792A1 (en) | 2000-09-22 | 2002-06-13 | Robert Burgermeister | Stent with optimal strength and radiopacity characteristics |
CA2421830C (en) | 2000-09-25 | 2010-04-27 | Boston Scientific Limited | Intravascular stent apparatus |
CA2421804C (en) | 2000-09-25 | 2009-05-12 | Boston Scientific Limited | Intravascular stent apparatus |
US6695833B1 (en) | 2000-09-27 | 2004-02-24 | Nellix, Inc. | Vascular stent-graft apparatus and forming method |
US6254632B1 (en) | 2000-09-28 | 2001-07-03 | Advanced Cardiovascular Systems, Inc. | Implantable medical device having protruding surface structures for drug delivery and cover attachment |
US6863685B2 (en) | 2001-03-29 | 2005-03-08 | Cordis Corporation | Radiopacity intraluminal medical device |
EP1322258A2 (en) | 2000-10-05 | 2003-07-02 | Boston Scientific Limited | Stent delivery system with membrane |
US6730119B1 (en) | 2000-10-06 | 2004-05-04 | Board Of Regents Of The University Of Texas System | Percutaneous implantation of partially covered stents in aneurysmally dilated arterial segments with subsequent embolization and obliteration of the aneurysm cavity |
AU2002213465A1 (en) | 2000-10-10 | 2002-04-22 | Prodesco, Inc. | Bifurcated fabric sleeve stent graft with junction region strengthening elements |
JP2004515271A (en) | 2000-10-11 | 2004-05-27 | マイクロ・セラピューティクス・インコーポレーテッド | How to treat aneurysms |
US6485508B1 (en) | 2000-10-13 | 2002-11-26 | Mcguinness Colm P. | Low profile stent |
US6663664B1 (en) | 2000-10-26 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with time variable radial force |
US6428566B1 (en) | 2000-10-31 | 2002-08-06 | Advanced Cardiovascular Systems, Inc. | Flexible hoop and link sheath for a stent delivery system |
US6918927B2 (en) | 2000-10-31 | 2005-07-19 | Cook Incorporated | Coated implantable medical device |
EP1343435A4 (en) | 2000-10-31 | 2006-05-24 | Prodesco | Graft having region for biological seal formation |
US6602272B2 (en) | 2000-11-02 | 2003-08-05 | Advanced Cardiovascular Systems, Inc. | Devices configured from heat shaped, strain hardened nickel-titanium |
US6770086B1 (en) | 2000-11-02 | 2004-08-03 | Scimed Life Systems, Inc. | Stent covering formed of porous polytetraflouroethylene |
US6506211B1 (en) | 2000-11-13 | 2003-01-14 | Scimed Life Systems, Inc. | Stent designs |
US6843802B1 (en) | 2000-11-16 | 2005-01-18 | Cordis Corporation | Delivery apparatus for a self expanding retractable stent |
US6607553B1 (en) | 2000-11-17 | 2003-08-19 | B. Braun Medical, Inc. | Method for deploying a thermo-mechanically expandable stent |
CA2428836A1 (en) | 2000-11-17 | 2002-05-23 | Evysio Medical Devices Ulc | Endovascular prosthesis |
MXPA03004395A (en) | 2000-11-22 | 2004-04-20 | Bard Peripheral Vascular Inc | High density microwall expanded polytetrafluoroethylene tubular structure. |
US6494909B2 (en) | 2000-12-01 | 2002-12-17 | Prodesco, Inc. | Endovascular valve |
DE10061936A1 (en) | 2000-12-13 | 2002-07-04 | Valentin Kramer | Object from ePTFE and method of manufacturing the same |
US7083642B2 (en) | 2000-12-22 | 2006-08-01 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
US6939375B2 (en) | 2000-12-22 | 2005-09-06 | Avantac Vascular Corporation | Apparatus and methods for controlled substance delivery from implanted prostheses |
US6663662B2 (en) | 2000-12-28 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Diffusion barrier layer for implantable devices |
US20020123791A1 (en) | 2000-12-28 | 2002-09-05 | Harrison William J. | Stent design with increased vessel coverage |
US20020169497A1 (en) | 2001-01-02 | 2002-11-14 | Petra Wholey | Endovascular stent system and method of providing aneurysm embolization |
US6709449B2 (en) | 2001-01-12 | 2004-03-23 | Mayo Foundation For Medical Education And Research | Stent treatment apparatus and method |
AU2002236790B2 (en) | 2001-01-19 | 2006-08-17 | Boston Scientific Limited | Introducer for deployment of branched prosthesis |
US6899727B2 (en) | 2001-01-22 | 2005-05-31 | Gore Enterprise Holdings, Inc. | Deployment system for intraluminal devices |
US6699274B2 (en) | 2001-01-22 | 2004-03-02 | Scimed Life Systems, Inc. | Stent delivery system and method of manufacturing same |
US6548013B2 (en) | 2001-01-24 | 2003-04-15 | Scimed Life Systems, Inc. | Processing of particulate Ni-Ti alloy to achieve desired shape and properties |
US6752829B2 (en) | 2001-01-30 | 2004-06-22 | Scimed Life Systems, Inc. | Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same |
US6736839B2 (en) | 2001-02-01 | 2004-05-18 | Charles Cummings | Medical device delivery system |
DE10105160B4 (en) | 2001-02-06 | 2005-09-01 | Osypka, Peter, Dr.-Ing. | Implantable vascular support |
US6743210B2 (en) | 2001-02-15 | 2004-06-01 | Scimed Life Systems, Inc. | Stent delivery catheter positioning device |
US20020120321A1 (en) | 2001-02-26 | 2002-08-29 | Gunderson Richard C. | Stent retention mechanism |
US7799064B2 (en) | 2001-02-26 | 2010-09-21 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
US6695877B2 (en) | 2001-02-26 | 2004-02-24 | Scimed Life Systems | Bifurcated stent |
JP4863424B2 (en) | 2001-02-27 | 2012-01-25 | 株式会社 京都医療設計 | Stent holding member and stent supply system |
US6740114B2 (en) | 2001-03-01 | 2004-05-25 | Cordis Corporation | Flexible stent |
US6679911B2 (en) | 2001-03-01 | 2004-01-20 | Cordis Corporation | Flexible stent |
US6790227B2 (en) | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US6998060B2 (en) | 2001-03-01 | 2006-02-14 | Cordis Corporation | Flexible stent and method of manufacture |
US6589274B2 (en) | 2001-03-23 | 2003-07-08 | Medtronic Ave, Inc. | Stent delivery catheter and method of making same |
US6918925B2 (en) | 2001-03-23 | 2005-07-19 | Hassan Tehrani | Branched aortic arch stent graft and method of deployment |
US6547813B2 (en) | 2001-03-23 | 2003-04-15 | Medtronic Ave, Inc. | Stent delivery catheter with folded sleeve and method of making same |
US6613077B2 (en) | 2001-03-27 | 2003-09-02 | Scimed Life Systems, Inc. | Stent with controlled expansion |
DK1245202T3 (en) | 2001-03-27 | 2004-08-30 | Cook William Europ | Aortic device |
US20020143387A1 (en) | 2001-03-27 | 2002-10-03 | Soetikno Roy M. | Stent repositioning and removal |
KR20030094304A (en) | 2001-03-28 | 2003-12-11 | 쿡 인코포레이티드 | Modular stent graft assembly and use thereof |
US6602269B2 (en) | 2001-03-30 | 2003-08-05 | Scimed Life Systems | Embolic devices capable of in-situ reinforcement |
KR100457630B1 (en) | 2001-04-04 | 2004-11-18 | (주) 태웅메디칼 | Flexible self-expandable stent and methods for making the stent for lumen |
US6602283B2 (en) | 2001-04-06 | 2003-08-05 | Scimed Life Systems, Inc. | Stent design |
US20030009212A1 (en) | 2001-07-06 | 2003-01-09 | Andrew Kerr | Axially-connected stent/graft assembly |
US6733521B2 (en) | 2001-04-11 | 2004-05-11 | Trivascular, Inc. | Delivery system and method for endovascular graft |
US7175651B2 (en) | 2001-07-06 | 2007-02-13 | Andrew Kerr | Stent/graft assembly |
US20040138734A1 (en) | 2001-04-11 | 2004-07-15 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US6761733B2 (en) | 2001-04-11 | 2004-07-13 | Trivascular, Inc. | Delivery system and method for bifurcated endovascular graft |
US20020161376A1 (en) | 2001-04-27 | 2002-10-31 | Barry James J. | Method and system for delivery of coated implants |
DE10121210B4 (en) | 2001-04-30 | 2005-11-17 | Universitätsklinikum Freiburg | Anchoring element for the intraluminal anchoring of a heart valve replacement and method for its production |
US6613083B2 (en) | 2001-05-02 | 2003-09-02 | Eckhard Alt | Stent device and method |
US6656506B1 (en) | 2001-05-09 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Microparticle coated medical device |
US6716238B2 (en) | 2001-05-10 | 2004-04-06 | Scimed Life Systems, Inc. | Stent with detachable tethers and method of using same |
US6663663B2 (en) | 2001-05-14 | 2003-12-16 | M.I. Tech Co., Ltd. | Stent |
SE0101887L (en) | 2001-05-30 | 2002-12-01 | Jan Otto Solem | Vascular instrument and method |
US6926732B2 (en) | 2001-06-01 | 2005-08-09 | Ams Research Corporation | Stent delivery device and method |
US7128755B2 (en) | 2001-06-01 | 2006-10-31 | Texas Stent Technologies, Inc. | Expandable biodegradable polymeric stents for combined mechanical support and pharmacological or radiation therapy |
US6821291B2 (en) | 2001-06-01 | 2004-11-23 | Ams Research Corporation | Retrievable stent and method of use thereof |
KR100393548B1 (en) | 2001-06-05 | 2003-08-02 | 주식회사 엠아이텍 | Stent |
US6562067B2 (en) | 2001-06-08 | 2003-05-13 | Cordis Corporation | Stent with interlocking elements |
US7510571B2 (en) | 2001-06-11 | 2009-03-31 | Boston Scientific, Scimed, Inc. | Pleated composite ePTFE/textile hybrid covering |
ATE303170T1 (en) | 2001-06-11 | 2005-09-15 | Boston Scient Ltd | COMPOSITE EPTFE/TEXTIL PROSTHESIS |
US6818013B2 (en) | 2001-06-14 | 2004-11-16 | Cordis Corporation | Intravascular stent device |
US6673106B2 (en) | 2001-06-14 | 2004-01-06 | Cordis Neurovascular, Inc. | Intravascular stent device |
WO2002102277A2 (en) | 2001-06-18 | 2002-12-27 | Eva Corporation | Prosthetic graft assembly and method of use |
US8197535B2 (en) | 2001-06-19 | 2012-06-12 | Cordis Corporation | Low profile improved radiopacity intraluminal medical device |
US6605110B2 (en) | 2001-06-29 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Stent with enhanced bendability and flexibility |
US6702847B2 (en) | 2001-06-29 | 2004-03-09 | Scimed Life Systems, Inc. | Endoluminal device with indicator member for remote detection of endoleaks and/or changes in device morphology |
US6994722B2 (en) | 2001-07-03 | 2006-02-07 | Scimed Life Systems, Inc. | Implant having improved fixation to a body lumen and method for implanting the same |
US6716239B2 (en) | 2001-07-03 | 2004-04-06 | Scimed Life Systems, Inc. | ePTFE graft with axial elongation properties |
US6858035B2 (en) | 2001-07-05 | 2005-02-22 | Converge Medical, Inc. | Distal anastomosis system |
US6626920B2 (en) | 2001-07-05 | 2003-09-30 | Converge Medical, Inc. | Distal anastomosis system |
EP1273314A1 (en) | 2001-07-06 | 2003-01-08 | Terumo Kabushiki Kaisha | Stent |
US20030014075A1 (en) | 2001-07-16 | 2003-01-16 | Microvention, Inc. | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation |
WO2003013821A1 (en) | 2001-08-03 | 2003-02-20 | Coltec Industrial Products Llc | Method of manufacturing a pfte preform compression moulding |
US7022135B2 (en) | 2001-08-17 | 2006-04-04 | Medtronic, Inc. | Film with highly porous vascular graft prostheses |
US20030040803A1 (en) | 2001-08-23 | 2003-02-27 | Rioux Robert F. | Maintaining an open passageway through a body lumen |
US6796999B2 (en) | 2001-09-06 | 2004-09-28 | Medinol Ltd. | Self articulating stent |
IES20010828A2 (en) | 2001-09-12 | 2003-03-19 | Medtronic Inc | Medical device for intraluminal endovascular stenting |
US20030097170A1 (en) | 2001-09-25 | 2003-05-22 | Curative Ag | Implantation device for an aorta in an aortic arch |
US6827737B2 (en) | 2001-09-25 | 2004-12-07 | Scimed Life Systems, Inc. | EPTFE covering for endovascular prostheses and method of manufacture |
US6666817B2 (en) | 2001-10-05 | 2003-12-23 | Scimed Life Systems, Inc. | Expandable surgical implants and methods of using them |
US7033389B2 (en) | 2001-10-16 | 2006-04-25 | Scimed Life Systems, Inc. | Tubular prosthesis for external agent delivery |
US7192441B2 (en) | 2001-10-16 | 2007-03-20 | Scimed Life Systems, Inc. | Aortic artery aneurysm endovascular prosthesis |
AUPR847201A0 (en) | 2001-10-26 | 2001-11-15 | Cook Incorporated | Endoluminal graft |
AUPR847301A0 (en) | 2001-10-26 | 2001-11-15 | Cook Incorporated | Endoluminal prostheses for curved lumens |
US6719784B2 (en) | 2001-11-21 | 2004-04-13 | Scimed Life Systems, Inc. | Counter rotational layering of ePTFE to improve mechanical properties of a prosthesis |
US20060292206A1 (en) | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
US7128754B2 (en) | 2001-11-28 | 2006-10-31 | Aptus Endosystems, Inc. | Catheter-based fastener implantation apparatus and methods |
CN100512777C (en) | 2001-12-05 | 2009-07-15 | 斯恩蒂斯有限公司 | Intervertebral disk prosthesis or nucleus replacement prosthesis |
US6793666B2 (en) | 2001-12-18 | 2004-09-21 | Scimed Life Systems, Inc. | Distal protection mechanically attached filter cartridge |
AUPR961701A0 (en) | 2001-12-19 | 2002-01-24 | Cook Incorporated | Improving graft adhesion |
US7125464B2 (en) | 2001-12-20 | 2006-10-24 | Boston Scientific Santa Rosa Corp. | Method for manufacturing an endovascular graft section |
US6641606B2 (en) | 2001-12-20 | 2003-11-04 | Cleveland Clinic Foundation | Delivery system and method for deploying an endovascular prosthesis |
US6776604B1 (en) | 2001-12-20 | 2004-08-17 | Trivascular, Inc. | Method and apparatus for shape forming endovascular graft material |
US7147660B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Advanced endovascular graft |
US7014653B2 (en) | 2001-12-20 | 2006-03-21 | Cleveland Clinic Foundation | Furcated endovascular prosthesis |
US6682537B2 (en) | 2001-12-20 | 2004-01-27 | The Cleveland Clinic Foundation | Apparatus and method for capturing a wire in a blood vessel |
US7090693B1 (en) | 2001-12-20 | 2006-08-15 | Boston Scientific Santa Rosa Corp. | Endovascular graft joint and method for manufacture |
US6939374B2 (en) | 2001-12-21 | 2005-09-06 | Scimed Life Systems, Inc. | Stents, stenting systems, and related methods for agent delivery |
US6866805B2 (en) | 2001-12-27 | 2005-03-15 | Advanced Cardiovascular Systems, Inc. | Hybrid intravascular stent |
US20030212449A1 (en) | 2001-12-28 | 2003-11-13 | Cox Daniel L. | Hybrid stent |
US7163553B2 (en) | 2001-12-28 | 2007-01-16 | Advanced Cardiovascular Systems, Inc. | Intravascular stent and method of use |
US20030135256A1 (en) | 2002-01-14 | 2003-07-17 | Gallagher Brendan P. | Stent delivery system |
US7708771B2 (en) * | 2002-02-26 | 2010-05-04 | Endovascular Technologies, Inc. | Endovascular graft device and methods for attaching components thereof |
US7789903B2 (en) | 2002-04-04 | 2010-09-07 | Boston Scientific Scimed, Inc. | Stent-graft with adjustable length |
SI1499729T1 (en) | 2002-04-18 | 2011-11-30 | Yeda Res & Dev | Derivatives of the nf-kappab inducing enzyme, their preparation and use |
US20030204244A1 (en) | 2002-04-26 | 2003-10-30 | Stiger Mark L. | Aneurysm exclusion stent |
US7105031B2 (en) | 2002-04-26 | 2006-09-12 | Medtronic Vascular, Inc. | Balloon-tipped, multi-lumen catheter for endoluminal repair of endoluminal leaks in aortic or aorto-iliac endoluminal grafts |
US7351256B2 (en) | 2002-05-10 | 2008-04-01 | Cordis Corporation | Frame based unidirectional flow prosthetic implant |
US7189256B2 (en) | 2002-05-10 | 2007-03-13 | Scimed Life Systems, Inc. | Endoluminal device and system and method for detecting a change in pressure differential across an endoluminal device |
AU2003225291A1 (en) | 2002-05-10 | 2003-11-11 | Cordis Corporation | Method of making a medical device having a thin wall tubular membrane over a structural frame |
JP4624779B2 (en) | 2002-05-16 | 2011-02-02 | クック インコーポレイテッド | Flexible “kaeshi” that locks the prosthesis |
US20030220683A1 (en) | 2002-05-22 | 2003-11-27 | Zarouhi Minasian | Endoluminal device having barb assembly and method of using same |
EP1517651B1 (en) | 2002-06-28 | 2010-05-26 | Cook Incorporated | Thoracic aortic aneurysm stent graft |
WO2004028399A2 (en) | 2002-06-28 | 2004-04-08 | Cook Incorporated | Thoracic deployment device |
US7314484B2 (en) | 2002-07-02 | 2008-01-01 | The Foundry, Inc. | Methods and devices for treating aneurysms |
US6696666B2 (en) | 2002-07-03 | 2004-02-24 | Scimed Life Systems, Inc. | Tubular cutting process and system |
US6746890B2 (en) | 2002-07-17 | 2004-06-08 | Tini Alloy Company | Three dimensional thin film devices and methods of fabrication |
US20040093068A1 (en) | 2002-07-24 | 2004-05-13 | Bergen Lee C. | Abdominal stent graft and delivery system |
US20040034407A1 (en) | 2002-08-16 | 2004-02-19 | John Sherry | Covered stents with degradable barbs |
US7550004B2 (en) | 2002-08-20 | 2009-06-23 | Cook Biotech Incorporated | Endoluminal device with extracellular matrix material and methods |
US7175652B2 (en) | 2002-08-20 | 2007-02-13 | Cook Incorporated | Stent graft with improved proximal end |
DK1545396T3 (en) | 2002-08-23 | 2009-03-02 | Cook William A Australia | composite prosthesis |
US8518096B2 (en) | 2002-09-03 | 2013-08-27 | Lifeshield Sciences Llc | Elephant trunk thoracic endograft and delivery system |
US7879085B2 (en) | 2002-09-06 | 2011-02-01 | Boston Scientific Scimed, Inc. | ePTFE crimped graft |
CA2496905A1 (en) | 2002-09-06 | 2004-03-18 | Cook Biotech Incorporated | Tissue graft prosthesis devices containing juvenile or small diameter submucosa |
WO2004026183A2 (en) | 2002-09-20 | 2004-04-01 | Nellix, Inc. | Stent-graft with positioning anchor |
EP1405613B1 (en) | 2002-10-04 | 2006-03-22 | Sorin Biomedica Cardio S.R.L. | An implant device for treating aneurisms of the abdominal aorta |
US20040098096A1 (en) | 2002-10-22 | 2004-05-20 | The University Of Miami | Endograft device to inhibit endoleak and migration |
US20040093064A1 (en) | 2002-11-12 | 2004-05-13 | Gjalt Bosma | Drug eluting stent graft combination |
US7491234B2 (en) | 2002-12-03 | 2009-02-17 | Boston Scientific Scimed, Inc. | Medical devices for delivery of therapeutic agents |
US6841213B2 (en) | 2002-12-27 | 2005-01-11 | Scimed Life Systems, Inc | Fiber pattern printing |
US6945957B2 (en) | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
US20040162607A1 (en) | 2002-12-30 | 2004-08-19 | Saqib Masroor | Prosthetic arterial graft with test port |
US7611528B2 (en) | 2003-01-24 | 2009-11-03 | Medtronic Vascular, Inc. | Stent-graft delivery system |
WO2004075789A2 (en) | 2003-02-26 | 2004-09-10 | Cook Incorporated | PROTHESIS ADAPTED FOR PLACEDd UNDER EXTERNAL IMAGING |
EP1605866B1 (en) | 2003-03-03 | 2016-07-06 | Syntach AG | Electrical conduction block implant device |
US7150758B2 (en) | 2003-03-06 | 2006-12-19 | Boston Scientific Santa Rosa Corp. | Kink resistant endovascular graft |
US8109987B2 (en) | 2003-04-14 | 2012-02-07 | Tryton Medical, Inc. | Method of treating a lumenal bifurcation |
US7717953B2 (en) | 2004-10-13 | 2010-05-18 | Tryton Medical, Inc. | Delivery system for placement of prosthesis at luminal OS |
US6945992B2 (en) | 2003-04-22 | 2005-09-20 | Medtronic Vascular, Inc. | Single-piece crown stent |
US7377937B2 (en) | 2003-04-22 | 2008-05-27 | Medtronic Vascular, Inc. | Stent-graft assembly with elution openings |
US7452374B2 (en) | 2003-04-24 | 2008-11-18 | Maquet Cardiovascular, Llc | AV grafts with rapid post-operative self-sealing capabilities |
US7632291B2 (en) | 2003-06-13 | 2009-12-15 | Trivascular2, Inc. | Inflatable implant |
US20050033406A1 (en) | 2003-07-15 | 2005-02-10 | Barnhart William H. | Branch vessel stent and graft |
AU2003272255A1 (en) | 2003-09-02 | 2005-04-06 | University Of Florida | Polymeric reconstrainable, repositionable, detachable, percutaneous endovascular stentgraft |
US8292943B2 (en) | 2003-09-03 | 2012-10-23 | Bolton Medical, Inc. | Stent graft with longitudinal support member |
US8088156B2 (en) | 2003-10-07 | 2012-01-03 | Cordis Corporation | Graft material attachment device and method |
AU2004281704B2 (en) | 2003-10-10 | 2008-11-13 | Cardiaq Valve Technologies, Inc. | System and method for endoluminal grafting of bifurcated and branched vessels |
US20050090804A1 (en) | 2003-10-22 | 2005-04-28 | Trivascular, Inc. | Endoluminal prosthesis endoleak management |
EP1696828B1 (en) | 2003-12-17 | 2010-08-25 | Cook Incorporated | Interconnected leg extensions for an endoluminal prostehsis |
US20050158272A1 (en) | 2004-01-07 | 2005-07-21 | Trivascular, Inc. | Methods, compositions and devices for embolizing body lumens |
US9254213B2 (en) | 2004-01-09 | 2016-02-09 | Rubicon Medical, Inc. | Stent delivery device |
US7803178B2 (en) | 2004-01-30 | 2010-09-28 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
US7243408B2 (en) | 2004-02-09 | 2007-07-17 | Boston Scientific Scimed, Inc. | Process method for attaching radio opaque markers to shape memory stent |
WO2005086942A2 (en) | 2004-03-11 | 2005-09-22 | Trivascular, Inc. | Modular endovascular graft |
US8048140B2 (en) | 2004-03-31 | 2011-11-01 | Cook Medical Technologies Llc | Fenestrated intraluminal stent system |
US20070078506A1 (en) | 2004-04-13 | 2007-04-05 | Mccormick Paul | Method and apparatus for decompressing aneurysms |
US8012201B2 (en) | 2004-05-05 | 2011-09-06 | Direct Flow Medical, Inc. | Translumenally implantable heart valve with multiple chamber formed in place support |
US7758626B2 (en) | 2004-07-20 | 2010-07-20 | Medtronic Vascular, Inc. | Device and method for delivering an endovascular stent-graft having a longitudinally unsupported portion |
US7318835B2 (en) | 2004-07-20 | 2008-01-15 | Medtronic Vascular, Inc. | Endoluminal prosthesis having expandable graft sections |
WO2006012567A2 (en) | 2004-07-22 | 2006-02-02 | Nellix, Inc. | Methods and systems for endovascular aneurysm treatment |
US8048145B2 (en) | 2004-07-22 | 2011-11-01 | Endologix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
US20060030921A1 (en) | 2004-08-03 | 2006-02-09 | Medtronic Vascular, Inc. | Intravascular securement device |
US7284399B1 (en) | 2004-10-29 | 2007-10-23 | Sisco Vernon G | Inmate transport restraint |
WO2006072835A2 (en) | 2004-11-03 | 2006-07-13 | Jacques Seguin | Vascular graft and deployment system |
JP3109404U (en) | 2004-12-15 | 2005-05-19 | 阪和縫製株式会社 | Fastener opening and closing tool |
US20060149364A1 (en) | 2004-12-31 | 2006-07-06 | Steven Walak | Low profile vascular graft |
EP1683541B1 (en) | 2005-01-24 | 2012-04-25 | Makram R. Ebeid | Balloon catheter for use in positioning a stent in a curved segment of a blood vesel |
US7708163B2 (en) | 2005-02-24 | 2010-05-04 | Trivascular2, Inc. | Constant force material delivery system and method |
US20060224232A1 (en) | 2005-04-01 | 2006-10-05 | Trivascular, Inc. | Hybrid modular endovascular graft |
US20060233990A1 (en) | 2005-04-13 | 2006-10-19 | Trivascular, Inc. | PTFE layers and methods of manufacturing |
US20060233991A1 (en) | 2005-04-13 | 2006-10-19 | Trivascular, Inc. | PTFE layers and methods of manufacturing |
WO2006138547A1 (en) * | 2005-06-15 | 2006-12-28 | Med Institute, Inc | Intraluminal device with improved tapered beams |
EP1895952B1 (en) * | 2005-06-15 | 2020-04-15 | Cook Medical Technologies LLC | Intraluminal device with unsymmetric tapered beams |
US7666220B2 (en) | 2005-07-07 | 2010-02-23 | Nellix, Inc. | System and methods for endovascular aneurysm treatment |
US8118852B2 (en) | 2005-07-13 | 2012-02-21 | Cook Medical Technologies Llc | Introducer for self-expandable medical device |
US7476245B2 (en) | 2005-08-16 | 2009-01-13 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
US8663307B2 (en) | 2005-09-02 | 2014-03-04 | Medtronic Vascular, Inc. | Endoluminal prosthesis |
US20070167901A1 (en) | 2005-11-17 | 2007-07-19 | Herrig Judson A | Self-sealing residual compressive stress graft for dialysis |
FR2894131B1 (en) | 2005-12-02 | 2008-12-05 | Perouse Soc Par Actions Simpli | DEVICE FOR TREATING A BLOOD VESSEL, AND ASSOCIATED TREATMENT NECESSARY. |
US8784477B2 (en) | 2011-01-05 | 2014-07-22 | Abbott Cardiovascular Systems Inc. | Stent graft with two layer ePTFE layer system with high plasticity and high rigidity |
WO2007100716A2 (en) | 2006-02-27 | 2007-09-07 | William A. Cook Australia Pty. Ltd. | Retention of stents |
US8025693B2 (en) | 2006-03-01 | 2011-09-27 | Boston Scientific Scimed, Inc. | Stent-graft having flexible geometries and methods of producing the same |
US7955380B2 (en) | 2006-03-17 | 2011-06-07 | Medtronic Vascular, Inc. | Prosthesis fixation apparatus and methods |
US7591848B2 (en) | 2006-04-06 | 2009-09-22 | Medtronic Vascular, Inc. | Riveted stent valve for percutaneous use |
AU2007249300B2 (en) * | 2006-05-12 | 2013-01-31 | Cardinal Health 529, Llc | Baloon expandable bioabsorbable drug eluting stent |
US7790273B2 (en) | 2006-05-24 | 2010-09-07 | Nellix, Inc. | Material for creating multi-layered films and methods for making the same |
WO2008016578A2 (en) | 2006-07-31 | 2008-02-07 | Cartledge Richard G | Sealable endovascular implants and methods for their use |
US8216297B2 (en) | 2006-08-14 | 2012-07-10 | Trivascular, Inc. | Dual chamber cuff structure |
EP2061402A2 (en) | 2006-08-18 | 2009-05-27 | Abbott Laboratories | Bifurcation stent delivery catheter and method |
US7615072B2 (en) | 2006-11-14 | 2009-11-10 | Medtronic Vascular, Inc. | Endoluminal prosthesis |
US7655034B2 (en) | 2006-11-14 | 2010-02-02 | Medtronic Vascular, Inc. | Stent-graft with anchoring pins |
US20080133000A1 (en) * | 2006-12-01 | 2008-06-05 | Medtronic Vascular, Inc. | Bifurcated Stent With Variable Length Branches |
US20080172119A1 (en) | 2007-01-12 | 2008-07-17 | Medtronic Vascular, Inc. | Prosthesis Deployment Apparatus and Methods |
US20080228255A1 (en) | 2007-03-13 | 2008-09-18 | Medtronic Vascular, Inc. | Positionable Stent-Graft Delivery System and Method |
US20080234831A1 (en) | 2007-03-20 | 2008-09-25 | Medtronic Vascular, Inc. | Bioresorbable Stent and Method of Making |
US8133266B2 (en) | 2007-04-12 | 2012-03-13 | Medtronic Vascular, Inc. | Expandable tip delivery system and method |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
US20090082845A1 (en) | 2007-09-26 | 2009-03-26 | Boston Scientific Corporation | Alignment stent apparatus and method |
US20090082841A1 (en) | 2007-09-26 | 2009-03-26 | Boston Scientific Corporation | Apparatus for securing stent barbs |
EP2194919A4 (en) | 2007-09-26 | 2013-05-08 | Trivascular Inc | Alignment stent apparatus and method |
EP2194921B1 (en) | 2007-10-04 | 2018-08-29 | TriVascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
EP3505142B1 (en) | 2007-10-19 | 2020-10-28 | CeloNova Biosciences, Inc. | Implantable and lumen-supporting stents |
US8715337B2 (en) | 2007-11-09 | 2014-05-06 | Cook Medical Technologies Llc | Aortic valve stent graft |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US20100331958A1 (en) | 2007-12-20 | 2010-12-30 | Trivascular, Inc. | Hinged endovascular device |
WO2009086015A2 (en) | 2007-12-21 | 2009-07-09 | Boston Scientific Scimed, Inc. | Flexible stent-graft device having patterned polymeric coverings |
US20090287290A1 (en) | 2008-01-24 | 2009-11-19 | Medtronic, Inc. | Delivery Systems and Methods of Implantation for Prosthetic Heart Valves |
JP5380653B2 (en) | 2008-02-11 | 2014-01-08 | クック メディカル テクノロジーズ エルエルシー | Curvature device and bendable stent graft |
JP5602129B2 (en) | 2008-04-09 | 2014-10-08 | クック メディカル テクノロジーズ エルエルシー | Stent graft and device and attachment method |
AU2009240419A1 (en) | 2008-04-25 | 2009-10-29 | Nellix, Inc. | Stent graft delivery system |
US20100305686A1 (en) | 2008-05-15 | 2010-12-02 | Cragg Andrew H | Low-profile modular abdominal aortic aneurysm graft |
US20090287145A1 (en) | 2008-05-15 | 2009-11-19 | Altura Interventional, Inc. | Devices and methods for treatment of abdominal aortic aneurysms |
WO2009152376A1 (en) * | 2008-06-12 | 2009-12-17 | Elixir Medical Corporation | Intravascular stent |
JP5161665B2 (en) | 2008-06-17 | 2013-03-13 | キヤノン株式会社 | Image forming apparatus, control method thereof, and computer program |
BRPI0913877A2 (en) | 2008-06-30 | 2015-10-27 | Bolton Medical Inc | abdominal aortic aneurysms: systems and methods of use |
GB2464978B (en) | 2008-10-31 | 2010-10-20 | Cook William Europ | Introducer for deploying a stent graft in a curved lumen |
WO2010080427A1 (en) * | 2008-12-18 | 2010-07-15 | Med Institute, Inc. | Stents and stent grafts |
US8858610B2 (en) | 2009-01-19 | 2014-10-14 | W. L. Gore & Associates, Inc. | Forced deployment sequence |
BRPI1008902A2 (en) * | 2009-02-27 | 2016-03-15 | St Jude Medical | prosthetic heart valve. |
US9980818B2 (en) | 2009-03-31 | 2018-05-29 | Edwards Lifesciences Corporation | Prosthetic heart valve system with positioning markers |
CN102413791B (en) | 2009-04-24 | 2014-10-29 | 灵活支架解决方案股份有限公司 | Flexible devices |
US8858613B2 (en) | 2010-09-20 | 2014-10-14 | Altura Medical, Inc. | Stent graft delivery systems and associated methods |
US20110071614A1 (en) * | 2009-09-24 | 2011-03-24 | David Christopher Majercak | Stent - graft suture locks |
US9572652B2 (en) | 2009-12-01 | 2017-02-21 | Altura Medical, Inc. | Modular endograft devices and associated systems and methods |
US20110218609A1 (en) | 2010-02-10 | 2011-09-08 | Trivascular, Inc. | Fill tube manifold and delivery methods for endovascular graft |
US20110295356A1 (en) * | 2010-05-28 | 2011-12-01 | Abbott Cardiovascular Systems Inc. | Stent having optimized expansion ratio |
US20120191174A1 (en) | 2010-11-16 | 2012-07-26 | Trivascular, Inc. | Advanced endovascular graft and delivery system |
US9060852B2 (en) | 2011-04-08 | 2015-06-23 | Cook Medical Technologies Llc | Method for making a flexible stent-graft |
US8978448B2 (en) | 2011-10-11 | 2015-03-17 | Trivascular, Inc. | In vitro testing of endovascular device |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
US9066828B2 (en) | 2012-06-15 | 2015-06-30 | Trivascular, Inc. | Endovascular delivery system with flexible and torqueable hypotube |
US20150073523A1 (en) | 2013-09-10 | 2015-03-12 | Trivascular, Inc. | Endoleak isolation sleeves and methods of use |
JP6672286B2 (en) | 2014-10-23 | 2020-03-25 | トリバスキュラー・インコーポレイテッドTriVascular, INC. | Stent graft delivery system with access conduit |
EP3328326A4 (en) | 2015-07-30 | 2019-03-20 | TriVascular, Inc. | Endoluminal prosthesis deployment devices and methods |
-
2013
- 2013-03-13 US US13/799,207 patent/US8992595B2/en active Active
- 2013-03-29 WO PCT/US2013/034654 patent/WO2013151896A1/en active Application Filing
- 2013-03-29 EP EP13772199.9A patent/EP2833830A4/en not_active Withdrawn
-
2015
- 2015-02-05 US US14/615,337 patent/US11109989B2/en active Active
-
2021
- 2021-09-02 US US17/465,751 patent/US20220087838A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1611867A2 (en) * | 2000-09-23 | 2006-01-04 | Boston Scientific Scimed, Inc. | Intravascular stent |
US20120016457A1 (en) * | 2001-12-20 | 2012-01-19 | Trivascular2, Inc. | Barbed radially expandable stent with slotted struts |
US20120041543A1 (en) * | 2007-06-29 | 2012-02-16 | Abbott Cardiovascular Systems Inc. | Stent having circumferentially deformable stents |
US20090082847A1 (en) * | 2007-09-26 | 2009-03-26 | Boston Scientific Corporation | System and method of securing stent barbs |
EP2158880A1 (en) * | 2008-08-26 | 2010-03-03 | Cordis Corporation | Intravascular stent having improved design for loading and deploying |
Non-Patent Citations (1)
Title |
---|
See also references of EP2833830A4 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015138402A1 (en) | 2014-03-10 | 2015-09-17 | Trivascular, Inc. | Inflatable occlusion wire-balloon for aortic applications |
Also Published As
Publication number | Publication date |
---|---|
EP2833830A4 (en) | 2015-12-09 |
US11109989B2 (en) | 2021-09-07 |
US20220087838A1 (en) | 2022-03-24 |
EP2833830A1 (en) | 2015-02-11 |
US8992595B2 (en) | 2015-03-31 |
US20130268044A1 (en) | 2013-10-10 |
US20150157479A1 (en) | 2015-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220087838A1 (en) | Durable stent graft with tapered struts and stable delivery methods and devices | |
US20210244554A1 (en) | Delivery catheter for endovascular device | |
US20200375725A1 (en) | Modular vascular graft for low profile percutaneous delivery | |
US11559386B2 (en) | Endovascular graft systems and methods for deployment in main and branch arteries | |
US20110218609A1 (en) | Fill tube manifold and delivery methods for endovascular graft | |
US9060853B2 (en) | Stent and stent-graft designs | |
EP2713947B1 (en) | Stent graft prosthesis | |
US8876883B2 (en) | Self-flaring active fixation element for a stent graft | |
KR102032578B1 (en) | Branched stent graft device and deployment | |
WO2012068175A2 (en) | Advanced endovascular graft and delivery system | |
WO2014096811A2 (en) | Graft with leg | |
WO2014096810A1 (en) | Modular fenestrated assembly | |
US9675439B2 (en) | Stent designs for reduced infolding of graft material | |
GB2517689A (en) | Stent-Graft | |
GB2517401A (en) | Graft with moveable fenestration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13772199 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013772199 Country of ref document: EP |